Datasets:

Modalities:
Text
Formats:
parquet
Languages:
English
ArXiv:
Libraries:
Datasets
pandas
License:
dipteshkanojia commited on
Commit
c40ba19
1 Parent(s): a8017ff

Upload 3 files

Browse files
Files changed (3) hide show
  1. data/data_dev.conll +5126 -0
  2. data/data_test.conll +5152 -0
  3. data/data_train.conll +0 -0
data/data_dev.conll ADDED
@@ -0,0 +1,5126 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ = PUNCT B-O
2
+ Manual PROPN B-LF
3
+ Ability PROPN I-LF
4
+ Classification PROPN I-LF
5
+ System PROPN I-LF
6
+ ; PUNCT B-O
7
+ QUEST PROPN B-AC
8
+ = PUNCT B-O
9
+ Quest PROPN B-LF
10
+ - ADJ I-LF
11
+ Quality PROPN I-LF
12
+ of ADP I-LF
13
+ upper ADJ I-LF
14
+ extremity NOUN I-LF
15
+ skills NOUN I-LF
16
+ test NOUN I-LF
17
+ ; PUNCT B-O
18
+ Cont PROPN B-O
19
+ = PUNCT B-O
20
+ control NOUN B-O
21
+ ; PUNCT B-O
22
+ M NOUN B-O
23
+ = PUNCT B-O
24
+ male NOUN B-O
25
+ , PUNCT B-O
26
+ F NOUN B-O
27
+ = PUNCT B-O
28
+ female ADJ B-O
29
+ , PUNCT B-O
30
+ V NOUN B-O
31
+ = PUNCT B-O
32
+ verbal ADJ B-O
33
+ , PUNCT B-O
34
+ nonV NOUN B-O
35
+ = PUNCT B-O
36
+ non ADJ B-O
37
+ - ADJ B-O
38
+ Verbal ADJ B-O
39
+ , PUNCT B-O
40
+ |Quad NOUN B-O
41
+ = PUNCT B-O
42
+ quadriplegia NOUN B-O
43
+ , PUNCT B-O
44
+ Di NOUN B-O
45
+ = PUNCT B-O
46
+ Diplegia NOUN B-O
47
+ , PUNCT B-O
48
+ Hemi NOUN B-O
49
+ = PUNCT B-O
50
+ hemiplegia NOUN B-O
51
+ . PUNCT B-O
52
+
53
+ Electro NOUN B-LF
54
+ - PUNCT I-LF
55
+ oculography NOUN I-LF
56
+ ( PUNCT B-O
57
+ EOG PROPN B-AC
58
+ ) PUNCT B-O
59
+ ( PUNCT B-O
60
+ RetiPort32 PROPN B-O
61
+ , PUNCT B-O
62
+ Roland PROPN B-O
63
+ Consult PROPN B-O
64
+ , PUNCT B-O
65
+ Wiesbaden PROPN B-O
66
+ , PUNCT B-O
67
+ Germany PROPN B-O
68
+ ) PUNCT B-O
69
+ was AUX B-O
70
+ performed VERB B-O
71
+ in ADP B-O
72
+ all DET B-O
73
+ patients NOUN B-O
74
+ according VERB B-O
75
+ to ADP B-O
76
+ the DET B-O
77
+ guidelines NOUN B-O
78
+ of ADP B-O
79
+ the DET B-O
80
+ International PROPN B-O
81
+ Society PROPN B-O
82
+ for ADP B-O
83
+ Clinical PROPN B-O
84
+ Electrophysiology PROPN B-O
85
+ of ADP B-O
86
+ Vision PROPN B-O
87
+ ( PUNCT B-O
88
+ ISCEV).[12 PROPN B-O
89
+ ] PUNCT B-O
90
+ Arden NOUN B-O
91
+ ratios NOUN B-O
92
+ below ADP B-O
93
+ 1.8 NUM B-O
94
+ were AUX B-O
95
+ rated VERB B-O
96
+ as ADP B-O
97
+ pathologic ADJ B-O
98
+ . PUNCT B-O
99
+
100
+ Soluble ADJ B-LF
101
+ N NOUN I-LF
102
+ - NOUN I-LF
103
+ ethylmaleimide NOUN I-LF
104
+ - NOUN I-LF
105
+ sensitive ADJ I-LF
106
+ factor NOUN I-LF
107
+ attachment NOUN I-LF
108
+ protein NOUN I-LF
109
+ receptor NOUN I-LF
110
+ ( PUNCT B-O
111
+ SNARE PROPN B-AC
112
+ ) PUNCT B-O
113
+ proteins NOUN B-O
114
+ , PUNCT B-O
115
+ including VERB B-O
116
+ target- NOUN B-O
117
+ ( PUNCT B-O
118
+ t- NOUN B-O
119
+ ) PUNCT B-O
120
+ membrane NOUN B-O
121
+ SNAREs PROPN B-AC
122
+ ( PUNCT B-O
123
+ Syntaxins PROPN B-LF
124
+ [ X B-O
125
+ Syn PROPN B-AC
126
+ ] PUNCT B-O
127
+ ) PUNCT B-O
128
+ and CCONJ B-O
129
+ synaptosomal NOUN B-O
130
+ - NOUN B-O
131
+ associated VERB B-O
132
+ proteins NOUN B-O
133
+ of ADP B-O
134
+ 25 NUM B-O
135
+ kDa NOUN B-O
136
+ ( PUNCT B-O
137
+ SNAP25 PROPN B-O
138
+ ) PUNCT B-O
139
+ and CCONJ B-O
140
+ vesicle NOUN B-LF
141
+ - NOUN I-LF
142
+ associated VERB I-LF
143
+ membrane NOUN I-LF
144
+ proteins NOUN I-LF
145
+ ( PUNCT B-O
146
+ VAMPs PROPN B-AC
147
+ ) PUNCT B-O
148
+ , PUNCT B-O
149
+ are AUX B-O
150
+ the DET B-O
151
+ fundamental ADJ B-O
152
+ components NOUN B-O
153
+ of ADP B-O
154
+ the DET B-O
155
+ exocytotic ADJ B-O
156
+ machinery NOUN B-O
157
+ required VERB B-O
158
+ for ADP B-O
159
+ the DET B-O
160
+ docking NOUN B-O
161
+ and CCONJ B-O
162
+ fusion NOUN B-O
163
+ of ADP B-O
164
+ secretory ADJ B-O
165
+ granules NOUN B-O
166
+ ( PUNCT B-O
167
+ SGs PROPN B-AC
168
+ ) PUNCT B-O
169
+ with ADP B-O
170
+ the DET B-O
171
+ plasma NOUN B-LF
172
+ membrane NOUN I-LF
173
+ ( PUNCT B-O
174
+ PM PROPN B-AC
175
+ ) PUNCT B-O
176
+ , PUNCT B-O
177
+ which PRON B-O
178
+ have AUX B-O
179
+ been AUX B-O
180
+ well ADV B-O
181
+ studied VERB B-O
182
+ in ADP B-O
183
+ neurons NOUN B-O
184
+ [ X B-O
185
+ 1 NUM B-O
186
+ , PUNCT B-O
187
+ 2 NUM B-O
188
+ ] PUNCT B-O
189
+ and CCONJ B-O
190
+ neuroendocrine ADJ B-O
191
+ cells NOUN B-O
192
+ , PUNCT B-O
193
+ particularly ADV B-O
194
+ pancreatic ADJ B-O
195
+ islet NOUN B-O
196
+ β PUNCT B-O
197
+ - NOUN B-O
198
+ cells NOUN B-O
199
+ [ X B-O
200
+ 3–5 NUM B-O
201
+ ] PUNCT B-O
202
+ . PUNCT B-O
203
+
204
+ t PROPN B-AC
205
+ -SNAREs PROPN B-AC
206
+ Syn-1A PROPN B-AC
207
+ and CCONJ B-O
208
+ SNAP25 PROPN B-O
209
+ through ADP B-O
210
+ their PRON B-O
211
+ interactions NOUN B-O
212
+ with ADP B-O
213
+ PM PROPN B-AC
214
+ - NOUN B-O
215
+ bound VERB B-O
216
+ voltage NOUN B-LF
217
+ - NOUN I-LF
218
+ gated VERB I-LF
219
+ calcium NOUN I-LF
220
+ channels NOUN I-LF
221
+ ( PUNCT B-O
222
+ Cav PROPN B-AC
223
+ ) PUNCT B-O
224
+ , PUNCT B-O
225
+ L NOUN B-O
226
+ - NOUN B-O
227
+ type NOUN B-O
228
+ in ADP B-O
229
+ β PUNCT B-O
230
+ - NOUN B-O
231
+ cells NOUN B-O
232
+ and CCONJ B-O
233
+ N NOUN B-O
234
+ - NOUN B-O
235
+ type NOUN B-O
236
+ in ADP B-O
237
+ neurons NOUN B-O
238
+ , PUNCT B-O
239
+ position VERB B-O
240
+ the DET B-O
241
+ predocked VERB B-O
242
+ SGs PROPN B-AC
243
+ to ADP B-O
244
+ the DET B-O
245
+ site NOUN B-O
246
+ of ADP B-O
247
+ maximum ADJ B-O
248
+ Ca2 NOUN B-O
249
+ + NOUN B-O
250
+ influx NOUN B-O
251
+ for ADP B-O
252
+ efficient ADJ B-O
253
+ exocytosis NOUN B-O
254
+ [ X B-O
255
+ 6–12 NUM B-O
256
+ ] PUNCT B-O
257
+ . PUNCT B-O
258
+
259
+ Large ADJ B-O
260
+ whole ADJ B-LF
261
+ genome NOUN I-LF
262
+ sequencing NOUN I-LF
263
+ ( PUNCT B-O
264
+ WGS PROPN B-AC
265
+ ) PUNCT B-O
266
+ and CCONJ B-O
267
+ whole ADJ B-LF
268
+ exome NOUN I-LF
269
+ sequencing NOUN I-LF
270
+ ( PUNCT B-O
271
+ WES PROPN B-AC
272
+ ) PUNCT B-O
273
+ studies NOUN B-O
274
+ in ADP B-O
275
+ IBD PROPN B-AC
276
+ are AUX B-O
277
+ in ADP B-O
278
+ progress NOUN B-O
279
+ . PUNCT B-O
280
+
281
+ Welsh PROPN B-O
282
+ and CCONJ B-O
283
+ coworkers NOUN B-O
284
+ first ADV B-O
285
+ reported VERB B-O
286
+ that SCONJ B-O
287
+ neurons NOUN B-O
288
+ within ADP B-O
289
+ the DET B-O
290
+ suprachiasmatic ADJ B-LF
291
+ nucleus NOUN I-LF
292
+ ( PUNCT B-O
293
+ SCN PROPN B-AC
294
+ ; PUNCT B-O
295
+ the DET B-O
296
+ master NOUN B-O
297
+ pacemaker NOUN B-O
298
+ in ADP B-O
299
+ the DET B-O
300
+ hypothalamus NOUN B-O
301
+ of ADP B-O
302
+ mammals NOUN B-O
303
+ ) PUNCT B-O
304
+ are AUX B-O
305
+ surprisingly ADV B-O
306
+ heterogeneous ADJ B-O
307
+ in ADP B-O
308
+ their PRON B-O
309
+ intrinsic ADJ B-O
310
+ periods NOUN B-O
311
+ of ADP B-O
312
+ circadian ADJ B-O
313
+ firing NOUN B-O
314
+ pattern NOUN B-O
315
+ [ PUNCT B-O
316
+ 4 NUM B-O
317
+ ] PUNCT B-O
318
+ . PUNCT B-O
319
+
320
+ So ADV B-O
321
+ far ADV B-O
322
+ , PUNCT B-O
323
+ reviews NOUN B-O
324
+ investigating VERB B-O
325
+ insulin NOUN B-O
326
+ pump NOUN B-O
327
+ therapy NOUN B-O
328
+ showed VERB B-O
329
+ mixed ADJ B-O
330
+ results NOUN B-O
331
+ regarding VERB B-O
332
+ the DET B-O
333
+ health NOUN B-LF
334
+ - PUNCT I-LF
335
+ related VERB I-LF
336
+ quality NOUN I-LF
337
+ of ADP I-LF
338
+ life NOUN I-LF
339
+ ( PUNCT B-O
340
+ HRQOL PROPN B-AC
341
+ ) PUNCT B-O
342
+ in ADP B-O
343
+ paediatric ADJ B-O
344
+ diabetes NOUN B-O
345
+ patients.[13 NOUN B-O
346
+ , PUNCT B-O
347
+ 16 NUM B-O
348
+ , PUNCT B-O
349
+ 17 NUM B-O
350
+ ] PUNCT B-O
351
+ According VERB B-O
352
+ to ADP B-O
353
+ recent ADJ B-O
354
+ publications,[15 NOUN B-O
355
+ , PUNCT B-O
356
+ 18–20 NUM B-O
357
+ ] PUNCT B-O
358
+ there PRON B-O
359
+ is VERB B-O
360
+ still ADV B-O
361
+ a DET B-O
362
+ lack NOUN B-O
363
+ of ADP B-O
364
+ adequately ADV B-O
365
+ powered VERB B-O
366
+ studies NOUN B-O
367
+ to ADP B-O
368
+ underpin VERB B-O
369
+ the DET B-O
370
+ advantages NOUN B-O
371
+ of ADP B-O
372
+ CSII PROPN B-AC
373
+ regarding VERB B-O
374
+ QoL PROPN B-AC
375
+ improvement NOUN B-O
376
+ for ADP B-O
377
+ children NOUN B-O
378
+ diagnosed VERB B-O
379
+ with ADP B-O
380
+ DM PROPN B-AC
381
+ and CCONJ B-O
382
+ to ADP B-O
383
+ potentially ADV B-O
384
+ balance VERB B-O
385
+ the DET B-O
386
+ higher ADJ B-O
387
+ treatment NOUN B-O
388
+ cost NOUN B-O
389
+ attached VERB B-O
390
+ to ADP B-O
391
+ it.[8 PRON B-O
392
+ ] PUNCT B-O
393
+ Thus ADV B-O
394
+ , PUNCT B-O
395
+ insulin NOUN B-O
396
+ pumps NOUN B-O
397
+ are AUX B-O
398
+ – PUNCT B-O
399
+ forty NUM B-O
400
+ years NOUN B-O
401
+ after SCONJ B-O
402
+ they PRON B-O
403
+ were AUX B-O
404
+ first ADJ B-O
405
+ introduced VERB B-O
406
+ to ADP B-O
407
+ the DET B-O
408
+ market NOUN B-O
409
+ – PUNCT B-O
410
+ still ADV B-O
411
+ not PART B-O
412
+ part NOUN B-O
413
+ of ADP B-O
414
+ first ADJ B-O
415
+ - PUNCT B-O
416
+ line NOUN B-O
417
+ recommendations NOUN B-O
418
+ in ADP B-O
419
+ most ADJ B-O
420
+ countries NOUN B-O
421
+ around ADP B-O
422
+ the DET B-O
423
+ world NOUN B-O
424
+ . PUNCT B-O
425
+
426
+ The DET B-O
427
+ data NOUN B-O
428
+ are AUX B-O
429
+ reported VERB B-O
430
+ as ADP B-O
431
+ mean NOUN B-O
432
+ ± SYM B-O
433
+ standard ADJ B-LF
434
+ deviation NOUN I-LF
435
+ ( PUNCT B-O
436
+ SD PROPN B-AC
437
+ ) PUNCT B-O
438
+ ( PUNCT B-O
439
+ n NOUN B-O
440
+ ≥ PUNCT B-O
441
+ 3 NUM B-O
442
+ ) PUNCT B-O
443
+ . PUNCT B-O
444
+
445
+ The DET B-O
446
+ lack NOUN B-O
447
+ of ADP B-O
448
+ dystrophin NOUN B-O
449
+ in ADP B-O
450
+ Duchenne PROPN B-LF
451
+ muscular ADJ I-LF
452
+ dystrophy NOUN I-LF
453
+ ( PUNCT B-O
454
+ DMD PROPN B-AC
455
+ ) PUNCT B-O
456
+ compromises VERB B-O
457
+ the DET B-O
458
+ integrity NOUN B-O
459
+ and CCONJ B-O
460
+ function NOUN B-O
461
+ of ADP B-O
462
+ muscle NOUN B-O
463
+ fibers NOUN B-O
464
+ . PUNCT B-O
465
+
466
+ The DET B-O
467
+ respondents NOUN B-O
468
+ consisted VERB B-O
469
+ of ADP B-O
470
+ 20 NUM B-O
471
+ to PART B-O
472
+ 42 NUM B-O
473
+ years NOUN B-O
474
+ of ADP B-O
475
+ age NOUN B-O
476
+ with ADP B-O
477
+ a DET B-O
478
+ mean ADJ B-O
479
+ age NOUN B-O
480
+ and CCONJ B-O
481
+ standard ADJ B-LF
482
+ deviation NOUN I-LF
483
+ ( PUNCT B-O
484
+ SD PROPN B-AC
485
+ ) PUNCT B-O
486
+ of ADP B-O
487
+ 25.95±3.81 NUM B-O
488
+ . PUNCT B-O
489
+
490
+ Here ADV B-O
491
+ we PRON B-O
492
+ provide VERB B-O
493
+ a DET B-O
494
+ direct ADJ B-O
495
+ demonstration NOUN B-O
496
+ , PUNCT B-O
497
+ based VERB B-O
498
+ on ADP B-O
499
+ our PRON B-O
500
+ analysis NOUN B-O
501
+ of ADP B-O
502
+ rad-50 NOUN B-O
503
+ mutants NOUN B-O
504
+ , PUNCT B-O
505
+ that SCONJ B-O
506
+ the DET B-O
507
+ meiotic ADJ B-O
508
+ program NOUN B-O
509
+ in ADP B-O
510
+ Caenorhabditis PROPN B-O
511
+ elegans NOUN B-O
512
+ involves VERB B-O
513
+ both DET B-O
514
+ acquisition NOUN B-O
515
+ and CCONJ B-O
516
+ loss NOUN B-O
517
+ of ADP B-O
518
+ a DET B-O
519
+ specialized ADJ B-O
520
+ mode NOUN B-O
521
+ of ADP B-O
522
+ double ADJ B-LF
523
+ - PUNCT I-LF
524
+ strand NOUN I-LF
525
+ break NOUN I-LF
526
+ repair NOUN I-LF
527
+ ( PUNCT B-O
528
+ DSBR PROPN B-AC
529
+ ) PUNCT B-O
530
+ . PUNCT B-O
531
+
532
+ In ADP B-O
533
+ premeiotic ADJ B-O
534
+ germ NOUN B-O
535
+ cells NOUN B-O
536
+ , PUNCT B-O
537
+ RAD-50 PROPN B-O
538
+ is AUX B-O
539
+ not PART B-O
540
+ required VERB B-O
541
+ to PART B-O
542
+ load VERB B-O
543
+ strand NOUN B-O
544
+ - PUNCT B-O
545
+ exchange NOUN B-O
546
+ protein NOUN B-O
547
+ RAD-51 PROPN B-O
548
+ at ADP B-O
549
+ sites NOUN B-O
550
+ of ADP B-O
551
+ spontaneous ADJ B-O
552
+ or CCONJ B-O
553
+ ionizing ADJ B-LF
554
+ radiation NOUN I-LF
555
+ ( PUNCT B-O
556
+ IR)-inducedDSBs PROPN B-AC
557
+ . PUNCT B-O
558
+
559
+ A DET B-O
560
+ specialized ADJ B-O
561
+ meiotic ADJ B-O
562
+ DSBR PROPN B-AC
563
+ mode NOUN B-O
564
+ is AUX B-O
565
+ engaged VERB B-O
566
+ at ADP B-O
567
+ the DET B-O
568
+ onset NOUN B-O
569
+ of ADP B-O
570
+ meiotic ADJ B-O
571
+ prophase NOUN B-O
572
+ , PUNCT B-O
573
+ coincident ADJ B-O
574
+ with ADP B-O
575
+ assembly NOUN B-O
576
+ of ADP B-O
577
+ meiotic ADJ B-O
578
+ chromosome NOUN B-O
579
+ axis NOUN B-O
580
+ structures NOUN B-O
581
+ . PUNCT B-O
582
+
583
+ Figure NOUN B-O
584
+ 3 NUM B-O
585
+ illustrates VERB B-O
586
+ the DET B-O
587
+ differences NOUN B-O
588
+ in ADP B-O
589
+ the DET B-O
590
+ estimates NOUN B-O
591
+ of ADP B-O
592
+ the DET B-O
593
+ annual ADJ B-LF
594
+ rate NOUN I-LF
595
+ of ADP I-LF
596
+ reduction NOUN I-LF
597
+ ( PUNCT B-O
598
+ ARR PROPN B-AC
599
+ ) PUNCT B-O
600
+ from ADP B-O
601
+ 1990 NUM B-O
602
+ to ADP B-O
603
+ 2010 NUM B-O
604
+ for ADP B-O
605
+ all DET B-O
606
+ countries NOUN B-O
607
+ . PUNCT B-O
608
+
609
+ In ADP B-O
610
+ order NOUN B-O
611
+ to PART B-O
612
+ further ADV B-O
613
+ confirm VERB B-O
614
+ that SCONJ B-O
615
+ the DET B-O
616
+ interaction NOUN B-O
617
+ of ADP B-O
618
+ the DET B-O
619
+ η8 NUM B-O
620
+ helix NOUN B-O
621
+ with ADP B-O
622
+ Rps14 NOUN B-O
623
+ is AUX B-O
624
+ not PART B-O
625
+ an DET B-O
626
+ artifact NOUN B-O
627
+ of ADP B-O
628
+ crystal NOUN B-O
629
+ packing NOUN B-O
630
+ , PUNCT B-O
631
+ we PRON B-O
632
+ have AUX B-O
633
+ conducted VERB B-O
634
+ structural ADJ B-O
635
+ studies NOUN B-O
636
+ in ADP B-O
637
+ solution NOUN B-O
638
+ by ADP B-O
639
+ small ADJ B-LF
640
+ angle NOUN I-LF
641
+ X NOUN I-LF
642
+ - NOUN I-LF
643
+ ray NOUN I-LF
644
+ scattering NOUN I-LF
645
+ ( PUNCT B-O
646
+ SAXS PROPN B-AC
647
+ ) PUNCT B-O
648
+ on ADP B-O
649
+ the DET B-O
650
+ aFap7 NOUN B-O
651
+ – PUNCT B-O
652
+ aRps14 NOUN B-O
653
+ complex NOUN B-O
654
+ . PUNCT B-O
655
+
656
+ To PART B-O
657
+ identify VERB B-O
658
+ the DET B-O
659
+ BDNF PROPN B-AC
660
+ - PUNCT B-O
661
+ responsive ADJ B-O
662
+ proliferating VERB B-O
663
+ cells NOUN B-O
664
+ , PUNCT B-O
665
+ we PRON B-O
666
+ performed VERB B-O
667
+ co NOUN B-O
668
+ - PUNCT B-O
669
+ staining NOUN B-O
670
+ with ADP B-O
671
+ astrocyte NOUN B-O
672
+ marker NOUN B-O
673
+ GFAP PROPN B-O
674
+ and CCONJ B-O
675
+ found VERB B-O
676
+ that SCONJ B-O
677
+ the DET B-O
678
+ cells NOUN B-O
679
+ positive ADJ B-O
680
+ for ADP B-O
681
+ Ki67 PROPN B-AC
682
+ ( PUNCT B-O
683
+ antigen NOUN B-LF
684
+ identified VERB I-LF
685
+ by ADP I-LF
686
+ monoclonal ADJ I-LF
687
+ antibody NOUN I-LF
688
+ Ki-67 PROPN I-LF
689
+ , PUNCT B-O
690
+ a DET B-O
691
+ marker NOUN B-O
692
+ for ADP B-O
693
+ proliferating VERB B-O
694
+ cells NOUN B-O
695
+ ) PUNCT B-O
696
+ are AUX B-O
697
+ GFAP PROPN B-O
698
+ negative ADJ B-O
699
+ , PUNCT B-O
700
+ suggesting VERB B-O
701
+ that SCONJ B-O
702
+ BDNF PROPN B-AC
703
+ - PUNCT B-O
704
+ responsive ADJ B-O
705
+ proliferating VERB B-O
706
+ cells NOUN B-O
707
+ are AUX B-O
708
+ not PART B-O
709
+ astrocytes NOUN B-O
710
+ ( PUNCT B-O
711
+ S7 NUM B-O
712
+ Fig NOUN B-O
713
+ , PUNCT B-O
714
+ S10 NUM B-O
715
+ Fig NOUN B-O
716
+ ) PUNCT B-O
717
+ . PUNCT B-O
718
+
719
+ In ADP B-O
720
+ particular ADJ B-O
721
+ , PUNCT B-O
722
+ experiencing VERB B-O
723
+ moderate ADJ B-O
724
+ / SYM B-O
725
+ high ADJ B-O
726
+ levels NOUN B-O
727
+ of ADP B-O
728
+ perceived VERB B-O
729
+ stress NOUN B-O
730
+ was AUX B-O
731
+ associated VERB B-O
732
+ with ADP B-O
733
+ a DET B-O
734
+ 1.61 ADJ B-O
735
+ - ADJ B-O
736
+ fold ADJ B-O
737
+ increase NOUN B-O
738
+ in ADP B-O
739
+ the DET B-O
740
+ odds NOUN B-LF
741
+ ratio NOUN I-LF
742
+ ( PUNCT B-O
743
+ OR PROPN B-AC
744
+ ) PUNCT B-O
745
+ of ADP B-O
746
+ having AUX B-O
747
+ ever ADV B-O
748
+ smoked VERB B-O
749
+ ( PUNCT B-O
750
+ 95%CI PROPN B-AC
751
+ 1.42 NUM B-O
752
+ , PUNCT B-O
753
+ 1.83 NUM B-O
754
+ ; PUNCT B-O
755
+ P<0.001 NUM B-O
756
+ ) PUNCT B-O
757
+ , PUNCT B-O
758
+ and CCONJ B-O
759
+ a DET B-O
760
+ 1.67 ADJ B-O
761
+ - ADJ B-O
762
+ fold ADJ B-O
763
+ increase NOUN B-O
764
+ in ADP B-O
765
+ having AUX B-O
766
+ been AUX B-O
767
+ diagnosed VERB B-O
768
+ or CCONJ B-O
769
+ treated VERB B-O
770
+ for ADP B-O
771
+ hypertension NOUN B-O
772
+ ( PUNCT B-O
773
+ 95%CI PROPN B-AC
774
+ 1.46 NUM B-O
775
+ , PUNCT B-O
776
+ 1.90 NUM B-O
777
+ ; PUNCT B-O
778
+ P<0.001 NUM B-O
779
+ ) PUNCT B-O
780
+ . PUNCT B-O
781
+
782
+ Kaposi PROPN B-LF
783
+ 's PART I-LF
784
+ sarcoma NOUN I-LF
785
+ - PUNCT I-LF
786
+ associated VERB I-LF
787
+ herpesvirus NOUN I-LF
788
+ ( PUNCT B-O
789
+ KSHV PROPN B-AC
790
+ ) PUNCT B-O
791
+ is AUX B-O
792
+ the DET B-O
793
+ most ADV B-O
794
+ recently ADV B-O
795
+ discovered VERB B-O
796
+ human ADJ B-O
797
+ herpesvirus NOUN B-O
798
+ and CCONJ B-O
799
+ the DET B-O
800
+ etiologic ADJ B-O
801
+ agent NOUN B-O
802
+ of ADP B-O
803
+ several ADJ B-O
804
+ neoplasms NOUN B-O
805
+ , PUNCT B-O
806
+ the DET B-O
807
+ most ADV B-O
808
+ prominent ADJ B-O
809
+ of ADP B-O
810
+ which PRON B-O
811
+ is AUX B-O
812
+ Kaposi PROPN B-O
813
+ 's PART B-O
814
+ sarcoma NOUN B-O
815
+ ( PUNCT B-O
816
+ KS PROPN B-O
817
+ ) PUNCT B-O
818
+ [ PUNCT B-O
819
+ 1 NUM B-O
820
+ ] PUNCT B-O
821
+ . PUNCT B-O
822
+
823
+ Other ADJ B-O
824
+ methods NOUN B-O
825
+ of ADP B-O
826
+ assaying VERB B-O
827
+ recombination NOUN B-O
828
+ in ADP B-O
829
+ A. NOUN B-O
830
+ thaliana PROPN B-O
831
+ have AUX B-O
832
+ been AUX B-O
833
+ developed VERB B-O
834
+ , PUNCT B-O
835
+ and CCONJ B-O
836
+ one NUM B-O
837
+ in ADP B-O
838
+ particular ADJ B-O
839
+ involving VERB B-O
840
+ a DET B-O
841
+ tandem NOUN B-O
842
+ disrupted VERB B-O
843
+ beta NOUN B-LF
844
+ - PUNCT I-LF
845
+ D NOUN I-LF
846
+ - PUNCT I-LF
847
+ glucuronidase NOUN I-LF
848
+ ( PUNCT B-O
849
+ GUS PROPN B-AC
850
+ ) PUNCT B-O
851
+ gene NOUN B-O
852
+ [ X B-O
853
+ 43 X B-O
854
+ ] PUNCT B-O
855
+ was AUX B-O
856
+ recently ADV B-O
857
+ applied VERB B-O
858
+ to PART B-O
859
+ study VERB B-O
860
+ recombination NOUN B-O
861
+ in ADP B-O
862
+ Atmus81 PROPN B-O
863
+ mutants NOUN B-O
864
+ [ X B-O
865
+ 27 NUM B-O
866
+ ] PUNCT B-O
867
+ . PUNCT B-O
868
+
869
+ Although SCONJ B-O
870
+ one PRON B-O
871
+ should AUX B-O
872
+ be AUX B-O
873
+ careful ADJ B-O
874
+ to ADP B-O
875
+ relate VERB B-O
876
+ absolute ADJ B-O
877
+ concentrations NOUN B-O
878
+ from ADP B-O
879
+ an DET B-O
880
+ in ADP B-O
881
+ vitro X B-O
882
+ assay NOUN B-O
883
+ to ADP B-O
884
+ actual ADJ B-O
885
+ drug NOUN B-O
886
+ concentrations NOUN B-O
887
+ administered VERB B-O
888
+ to ADP B-O
889
+ patients NOUN B-O
890
+ and CCONJ B-O
891
+ clinical ADJ B-O
892
+ antibiotic ADJ B-O
893
+ breakpoints NOUN B-O
894
+ [ PUNCT B-O
895
+ 61 NUM B-O
896
+ ] PUNCT B-O
897
+ , PUNCT B-O
898
+ we PRON B-O
899
+ found VERB B-O
900
+ that SCONJ B-O
901
+ the DET B-O
902
+ dose NOUN B-O
903
+ - PUNCT B-O
904
+ responses NOUN B-O
905
+ of ADP B-O
906
+ our PRON B-O
907
+ PAO1 PROPN B-O
908
+ WT PROPN B-AC
909
+ strain NOUN B-O
910
+ ( PUNCT B-O
911
+ and CCONJ B-O
912
+ the DET B-O
913
+ resulting VERB B-O
914
+ minimal ADJ B-LF
915
+ inhibitory ADJ I-LF
916
+ concentrations NOUN I-LF
917
+ [ PUNCT B-O
918
+ MICs PROPN B-AC
919
+ ] PUNCT B-O
920
+ , PUNCT B-O
921
+ Fig NUM B-O
922
+ 1 NUM B-O
923
+ ) PUNCT B-O
924
+ are AUX B-O
925
+ close ADJ B-O
926
+ to ADP B-O
927
+ the DET B-O
928
+ average ADJ B-O
929
+ MIC PROPN B-AC
930
+ values NOUN B-O
931
+ ( PUNCT B-O
932
+ MIC50 NUM B-O
933
+ ) PUNCT B-O
934
+ reported VERB B-O
935
+ in ADP B-O
936
+ a DET B-O
937
+ study NOUN B-O
938
+ across ADP B-O
939
+ 7,452 NUM B-O
940
+ clinical ADJ B-O
941
+ P. PROPN B-O
942
+ aeruginosa PROPN B-O
943
+ isolates NOUN B-O
944
+ [ PUNCT B-O
945
+ 62 NUM B-O
946
+ ] PUNCT B-O
947
+ . PUNCT B-O
948
+
949
+ A DET B-O
950
+ 15 NUM B-O
951
+ - PUNCT B-O
952
+ s NOUN B-O
953
+ rest NOUN B-O
954
+ period NOUN B-O
955
+ preceded VERB B-O
956
+ and CCONJ B-O
957
+ followed VERB B-O
958
+ each DET B-O
959
+ block NOUN B-O
960
+ . PUNCT B-O
961
+
962
+ ( PUNCT B-O
963
+ C X B-O
964
+ ) PUNCT B-O
965
+ Functional ADJ B-O
966
+ axial ADJ B-O
967
+ slices NOUN B-O
968
+ ( PUNCT B-O
969
+ displayed VERB B-O
970
+ here ADV B-O
971
+ over ADP B-O
972
+ the DET B-O
973
+ anatomical ADJ B-O
974
+ image NOUN B-O
975
+ of ADP B-O
976
+ a DET B-O
977
+ representative ADJ B-O
978
+ subject NOUN B-O
979
+ ) PUNCT B-O
980
+ were AUX B-O
981
+ acquired VERB B-O
982
+ and CCONJ B-O
983
+ covered VERB B-O
984
+ both CCONJ B-O
985
+ brain NOUN B-O
986
+ and CCONJ B-O
987
+ cervical ADJ B-O
988
+ spinal ADJ B-O
989
+ cord NOUN B-O
990
+ up ADP B-O
991
+ to ADP B-O
992
+ the DET B-O
993
+ first ADJ B-LF
994
+ thoracic ADJ I-LF
995
+ ( PUNCT B-O
996
+ T1 PROPN B-AC
997
+ ) PUNCT B-O
998
+ segment NOUN B-O
999
+ , PUNCT B-O
1000
+ and CCONJ B-O
1001
+ they PRON B-O
1002
+ were AUX B-O
1003
+ placed VERB B-O
1004
+ at ADP B-O
1005
+ an DET B-O
1006
+ angle NOUN B-O
1007
+ that SCONJ B-O
1008
+ was AUX B-O
1009
+ perpendicular ADJ B-O
1010
+ to ADP B-O
1011
+ the DET B-O
1012
+ C4 NOUN B-O
1013
+ vertebral ADJ B-O
1014
+ segment NOUN B-O
1015
+ . PUNCT B-O
1016
+
1017
+ ( PUNCT B-O
1018
+ D NOUN B-O
1019
+ ) PUNCT B-O
1020
+ Performance NOUN B-O
1021
+ speeds NOUN B-O
1022
+ ( PUNCT B-O
1023
+ i.e. X B-O
1024
+ , PUNCT B-O
1025
+ block NOUN B-O
1026
+ duration NOUN B-O
1027
+ ) PUNCT B-O
1028
+ averaged VERB B-O
1029
+ across ADP B-O
1030
+ all DET B-O
1031
+ subjects NOUN B-O
1032
+ show VERB B-O
1033
+ that SCONJ B-O
1034
+ the DET B-O
1035
+ learning NOUN B-O
1036
+ curves NOUN B-O
1037
+ differed VERB B-O
1038
+ between ADP B-O
1039
+ the DET B-O
1040
+ CS PROPN B-AC
1041
+ ( PUNCT B-O
1042
+ red ADJ B-O
1043
+ ) PUNCT B-O
1044
+ and CCONJ B-O
1045
+ SS PROPN B-AC
1046
+ ( PUNCT B-O
1047
+ blue ADJ B-O
1048
+ ) PUNCT B-O
1049
+ conditions NOUN B-O
1050
+ . PUNCT B-O
1051
+
1052
+ We PRON B-O
1053
+ found VERB B-O
1054
+ that SCONJ B-O
1055
+ SOCS1 PROPN B-O
1056
+ - PUNCT B-O
1057
+ silenced VERB B-O
1058
+ DCs PROPN B-AC
1059
+ broadly ADV B-O
1060
+ induced VERB B-O
1061
+ enhanced ADJ B-O
1062
+ envelope NOUN B-LF
1063
+ HIV-1 PROPN B-AC
1064
+ ( PUNCT B-O
1065
+ Env)-specific PROPN B-AC
1066
+ CD8 NOUN B-O
1067
+ + NOUN B-O
1068
+ cytotoxic ADJ B-O
1069
+ T NOUN B-O
1070
+ lymphocytes NOUN B-O
1071
+ and CCONJ B-O
1072
+ CD4 NOUN B-O
1073
+ + NOUN B-O
1074
+ T NOUN B-O
1075
+ helper NOUN B-O
1076
+ cells NOUN B-O
1077
+ , PUNCT B-O
1078
+ as ADP B-O
1079
+ well ADV B-O
1080
+ as ADP B-O
1081
+ antibody NOUN B-O
1082
+ responses NOUN B-O
1083
+ , PUNCT B-O
1084
+ in ADP B-O
1085
+ mice NOUN B-O
1086
+ . PUNCT B-O
1087
+
1088
+ This PRON B-O
1089
+ is AUX B-O
1090
+ potentially ADV B-O
1091
+ attributed VERB B-O
1092
+ to ADP B-O
1093
+ decreased VERB B-O
1094
+ T PROPN B-LF
1095
+ cell NOUN I-LF
1096
+ receptor NOUN I-LF
1097
+ ( PUNCT B-O
1098
+ TCR PROPN B-AC
1099
+ ) PUNCT B-O
1100
+ signaling NOUN B-O
1101
+ strength NOUN B-O
1102
+ due ADP B-O
1103
+ to ADP B-O
1104
+ inefficiency NOUN B-O
1105
+ in ADP B-O
1106
+ promiscuous ADJ B-O
1107
+ expression NOUN B-O
1108
+ of ADP B-O
1109
+ self NOUN B-O
1110
+ - PUNCT B-O
1111
+ antigens NOUN B-O
1112
+ or CCONJ B-O
1113
+ presenting VERB B-O
1114
+ a DET B-O
1115
+ neo NOUN B-O
1116
+ - PUNCT B-O
1117
+ self NOUN B-O
1118
+ - PUNCT B-O
1119
+ antigen NOUN B-O
1120
+ by ADP B-O
1121
+ medullary ADJ B-O
1122
+ TECs PROPN B-AC
1123
+ , PUNCT B-O
1124
+ displaying VERB B-O
1125
+ decreased VERB B-O
1126
+ negative ADJ B-O
1127
+ selection NOUN B-O
1128
+ - PUNCT B-O
1129
+ related VERB B-O
1130
+ marker NOUN B-O
1131
+ genes NOUN B-O
1132
+ ( PUNCT B-O
1133
+ Nur77 PROPN B-O
1134
+ and CCONJ B-O
1135
+ CD5high PROPN B-O
1136
+ ) PUNCT B-O
1137
+ in ADP B-O
1138
+ CD4 PROPN B-O
1139
+ single ADJ B-LF
1140
+ positive ADJ I-LF
1141
+ ( PUNCT B-O
1142
+ SP PROPN B-AC
1143
+ ) PUNCT B-O
1144
+ thymocytes NOUN B-O
1145
+ . PUNCT B-O
1146
+
1147
+ Members NOUN B-O
1148
+ of ADP B-O
1149
+ the DET B-O
1150
+ plant NOUN B-O
1151
+ Heme PROPN B-LF
1152
+ Activator PROPN I-LF
1153
+ Protein PROPN I-LF
1154
+ ( PUNCT B-O
1155
+ HAP PROPN B-AC
1156
+ ) PUNCT B-O
1157
+ or CCONJ B-O
1158
+ NUCLEAR PROPN B-O
1159
+ FACTOR PROPN B-O
1160
+ Y PROPN B-O
1161
+ ( PUNCT B-O
1162
+ NF PROPN B-O
1163
+ - PUNCT B-O
1164
+ Y PROPN B-O
1165
+ ) PUNCT B-O
1166
+ are AUX B-O
1167
+ trimeric ADJ B-O
1168
+ transcription NOUN B-O
1169
+ factor NOUN B-O
1170
+ complexes NOUN B-O
1171
+ composed VERB B-O
1172
+ of ADP B-O
1173
+ the DET B-O
1174
+ NF PROPN B-O
1175
+ - PUNCT B-O
1176
+ YA PROPN B-O
1177
+ , PUNCT B-O
1178
+ NF PROPN B-O
1179
+ - PUNCT B-O
1180
+ YB PROPN B-O
1181
+ and CCONJ B-O
1182
+ NF PROPN B-O
1183
+ - PUNCT B-O
1184
+ YC PROPN B-O
1185
+ subfamilies NOUN B-O
1186
+ . PUNCT B-O
1187
+
1188
+ The DET B-O
1189
+ wing NOUN B-O
1190
+ cuticle NOUN B-O
1191
+ is AUX B-O
1192
+ a DET B-O
1193
+ multilayered ADJ B-O
1194
+ structure NOUN B-O
1195
+ , PUNCT B-O
1196
+ and CCONJ B-O
1197
+ its PRON B-O
1198
+ formation NOUN B-O
1199
+ requires VERB B-O
1200
+ the DET B-O
1201
+ proper ADJ B-O
1202
+ expression NOUN B-O
1203
+ of ADP B-O
1204
+ cuticle NOUN B-O
1205
+ - PUNCT B-O
1206
+ related VERB B-O
1207
+ genes NOUN B-O
1208
+ , PUNCT B-O
1209
+ such ADJ B-O
1210
+ as ADP B-O
1211
+ enzymes NOUN B-O
1212
+ involved VERB B-O
1213
+ in ADP B-O
1214
+ cuticle NOUN B-O
1215
+ deposition NOUN B-O
1216
+ , PUNCT B-O
1217
+ and CCONJ B-O
1218
+ zona NOUN B-LF
1219
+ pellucida NOUN I-LF
1220
+ ( PUNCT B-O
1221
+ ZP PROPN B-AC
1222
+ ) PUNCT B-O
1223
+ domain NOUN B-O
1224
+ proteins NOUN B-O
1225
+ , PUNCT B-O
1226
+ which PRON B-O
1227
+ link VERB B-O
1228
+ the DET B-O
1229
+ apical ADJ B-O
1230
+ surface NOUN B-O
1231
+ of ADP B-O
1232
+ wing NOUN B-O
1233
+ cells NOUN B-O
1234
+ to ADP B-O
1235
+ the DET B-O
1236
+ overlying VERB B-O
1237
+ cuticle NOUN B-O
1238
+ [ PUNCT B-O
1239
+ 37 NUM B-O
1240
+ ] PUNCT B-O
1241
+ . PUNCT B-O
1242
+
1243
+ After ADP B-O
1244
+ confirming VERB B-O
1245
+ this DET B-O
1246
+ result NOUN B-O
1247
+ by ADP B-O
1248
+ quantitative ADJ B-LF
1249
+ real ADJ I-LF
1250
+ - PUNCT I-LF
1251
+ time NOUN I-LF
1252
+ reverse ADJ I-LF
1253
+ transcription NOUN I-LF
1254
+ polymerase NOUN I-LF
1255
+ chain NOUN I-LF
1256
+ reaction NOUN I-LF
1257
+ ( PUNCT B-O
1258
+ qRT-PCR PROPN B-AC
1259
+ ) PUNCT B-O
1260
+ , PUNCT B-O
1261
+ we PRON B-O
1262
+ extended VERB B-O
1263
+ the DET B-O
1264
+ qRT PROPN B-AC
1265
+ analysis NOUN B-O
1266
+ to ADP B-O
1267
+ other ADJ B-O
1268
+ kidney NOUN B-O
1269
+ diseases NOUN B-O
1270
+ and CCONJ B-O
1271
+ found VERB B-O
1272
+ that SCONJ B-O
1273
+ -PCRIFI27 PROPN B-AC
1274
+ mRNA NOUN B-O
1275
+ levels NOUN B-O
1276
+ were AUX B-O
1277
+ reduced VERB B-O
1278
+ in ADP B-O
1279
+ PBMCs PROPN B-AC
1280
+ of ADP B-O
1281
+ many ADJ B-O
1282
+ patients NOUN B-O
1283
+ . PUNCT B-O
1284
+
1285
+ a X B-O
1286
+ ) PUNCT B-O
1287
+ correlation NOUN B-LF
1288
+ coefficient NOUN B-O
1289
+ r PROPN B-AC
1290
+ , PUNCT B-O
1291
+ which PRON B-O
1292
+ ranges VERB B-O
1293
+ between ADP B-O
1294
+ 0 NUM B-O
1295
+ ( PUNCT B-O
1296
+ no DET B-O
1297
+ relationship NOUN B-O
1298
+ ) PUNCT B-O
1299
+ to ADP B-O
1300
+ 1 NUM B-O
1301
+ ( PUNCT B-O
1302
+ perfect ADJ B-O
1303
+ relationship NOUN B-O
1304
+ ) PUNCT B-O
1305
+ or CCONJ B-O
1306
+ -1 NUM B-O
1307
+ ( PUNCT B-O
1308
+ perfect ADJ B-O
1309
+ negative ADJ B-O
1310
+ relationship NOUN B-O
1311
+ ) PUNCT B-O
1312
+ respectively ADV B-O
1313
+ . PUNCT B-O
1314
+
1315
+ Therefore ADV B-O
1316
+ , PUNCT B-O
1317
+ the DET B-O
1318
+ aim NOUN B-O
1319
+ of ADP B-O
1320
+ this DET B-O
1321
+ study NOUN B-O
1322
+ was AUX B-O
1323
+ to ADP B-O
1324
+ evaluate VERB B-O
1325
+ the DET B-O
1326
+ importance NOUN B-O
1327
+ of ADP B-O
1328
+ both CCONJ B-O
1329
+ systemic ADJ B-O
1330
+ oxygen NOUN B-O
1331
+ delivery NOUN B-O
1332
+ factors NOUN B-O
1333
+ and CCONJ B-O
1334
+ peripheral ADJ B-O
1335
+ factors NOUN B-O
1336
+ for ADP B-O
1337
+ aerobic ADJ B-O
1338
+ ExCap PROPN B-AC
1339
+ in ADP B-O
1340
+ mild ADJ B-O
1341
+ - ADJ B-O
1342
+ to ADP B-O
1343
+ - ADJ B-O
1344
+ severe ADJ B-O
1345
+ non ADJ B-O
1346
+ - ADJ B-O
1347
+ dialysis ADJ B-O
1348
+ CKD PROPN B-AC
1349
+ . PUNCT B-O
1350
+
1351
+ Handgrip NOUN B-O
1352
+ strength NOUN B-O
1353
+ , PUNCT B-O
1354
+ lean ADJ B-LF
1355
+ body NOUN I-LF
1356
+ mass NOUN I-LF
1357
+ ( PUNCT B-O
1358
+ LBM PROPN B-AC
1359
+ ) PUNCT B-O
1360
+ and CCONJ B-O
1361
+ vascular ADJ B-O
1362
+ stiffness NOUN B-O
1363
+ represent VERB B-O
1364
+ peripheral ADJ B-O
1365
+ factors NOUN B-O
1366
+ in ADP B-O
1367
+ the DET B-O
1368
+ present ADJ B-O
1369
+ study NOUN B-O
1370
+ . PUNCT B-O
1371
+
1372
+ To PART B-O
1373
+ further ADV B-O
1374
+ investigate VERB B-O
1375
+ whether SCONJ B-O
1376
+ BMAL1 PROPN B-O
1377
+ - PUNCT B-O
1378
+ K537 PROPN B-O
1379
+ acetylation NOUN B-O
1380
+ up ADV B-O
1381
+ - PUNCT B-O
1382
+ regulates VERB B-O
1383
+ BMAL1 PROPN B-O
1384
+ – PUNCT B-O
1385
+ CK2β NOUN B-O
1386
+ binding VERB B-O
1387
+ and CCONJ B-O
1388
+ subsequently ADV B-O
1389
+ represses VERB B-O
1390
+ BMAL1 PROPN B-O
1391
+ - PUNCT B-O
1392
+ S90 NOUN B-O
1393
+ phosphorylation NOUN B-O
1394
+ , PUNCT B-O
1395
+ we PRON B-O
1396
+ utilized VERB B-O
1397
+ a DET B-O
1398
+ mouse NOUN B-O
1399
+ fibroblast NOUN B-O
1400
+ cell NOUN B-O
1401
+ line NOUN B-O
1402
+ deficient ADJ B-O
1403
+ in ADP B-O
1404
+ silent ADJ B-O
1405
+ information NOUN B-O
1406
+ regulator NOUN B-O
1407
+ 1 NUM B-O
1408
+ ( PUNCT B-O
1409
+ SIRT1 PROPN B-O
1410
+ ) PUNCT B-O
1411
+ , PUNCT B-O
1412
+ a DET B-O
1413
+ member NOUN B-O
1414
+ of ADP B-O
1415
+ the DET B-O
1416
+ sirtuin NOUN B-O
1417
+ family NOUN B-O
1418
+ of ADP B-O
1419
+ NAD+-dependent PROPN B-O
1420
+ histone NOUN B-LF
1421
+ deacetylases NOUN I-LF
1422
+ ( PUNCT B-O
1423
+ HDACs PROPN B-AC
1424
+ ) PUNCT B-O
1425
+ that PRON B-O
1426
+ also ADV B-O
1427
+ targets VERB B-O
1428
+ acetyl NOUN B-O
1429
+ BMAL1 PROPN B-O
1430
+ - PUNCT B-O
1431
+ K537 PROPN B-O
1432
+ [ PUNCT B-O
1433
+ 30 NUM B-O
1434
+ ] PUNCT B-O
1435
+ . PUNCT B-O
1436
+
1437
+ EP PROPN B-AC
1438
+ : PUNCT B-O
1439
+ Group NOUN B-O
1440
+ : PUNCT B-O
1441
+ extra ADJ B-LF
1442
+ - ADJ I-LF
1443
+ perigastric ADJ I-LF
1444
+ lymph NOUN B-O
1445
+ node NOUN B-O
1446
+ group NOUN B-O
1447
+ A DET B-O
1448
+ recent ADJ B-O
1449
+ result NOUN B-O
1450
+ from ADP B-O
1451
+ S. PROPN B-O
1452
+ pombe PROPN B-O
1453
+ suggests VERB B-O
1454
+ that SCONJ B-O
1455
+ in ADP B-O
1456
+ this DET B-O
1457
+ organism NOUN B-O
1458
+ , PUNCT B-O
1459
+ in ADP B-O
1460
+ which PRON B-O
1461
+ all DET B-O
1462
+ COs PROPN B-AC
1463
+ are AUX B-O
1464
+ mediated VERB B-O
1465
+ by ADP B-O
1466
+ Mus81 PROPN B-O
1467
+ - PUNCT B-O
1468
+ Eme1 PROPN B-O
1469
+ , PUNCT B-O
1470
+ the DET B-O
1471
+ predominant ADJ B-O
1472
+ meiotic ADJ B-O
1473
+ recombination NOUN B-O
1474
+ intermediate NOUN B-O
1475
+ is AUX B-O
1476
+ a DET B-O
1477
+ single ADJ B-LF
1478
+ Holliday PROPN I-LF
1479
+ junction NOUN I-LF
1480
+ ( PUNCT B-O
1481
+ sHJ PROPN B-AC
1482
+ ) PUNCT B-O
1483
+ [ PUNCT B-O
1484
+ 26 NUM B-O
1485
+ ] PUNCT B-O
1486
+ . PUNCT B-O
1487
+
1488
+ Ab PROPN B-AC
1489
+ , PUNCT B-O
1490
+ antibody NOUN B-LF
1491
+ ; PUNCT B-O
1492
+ EC50 PROPN B-AC
1493
+ , PUNCT B-O
1494
+ half ADJ B-LF
1495
+ - PUNCT I-LF
1496
+ maximal ADJ I-LF
1497
+ effective ADJ I-LF
1498
+ concentration NOUN I-LF
1499
+ ; PUNCT B-O
1500
+ IL-6R PROPN B-AC
1501
+ , PUNCT B-O
1502
+ interleukin-6 NOUN B-LF
1503
+ receptor NOUN I-LF
1504
+ ; PUNCT B-O
1505
+ MMP PROPN B-AC
1506
+ , PUNCT B-O
1507
+ matrix NOUN B-LF
1508
+ metalloproteinase NOUN I-LF
1509
+ . PUNCT B-O
1510
+
1511
+ QALY PROPN B-AC
1512
+ , PUNCT B-O
1513
+ quality NOUN B-LF
1514
+ - PUNCT I-LF
1515
+ adjusted VERB I-LF
1516
+ life NOUN I-LF
1517
+ year NOUN I-LF
1518
+ ; PUNCT B-O
1519
+ USD PROPN B-O
1520
+ , PUNCT B-O
1521
+ US PROPN B-O
1522
+ dollars NOUN B-O
1523
+ . PUNCT B-O
1524
+
1525
+ We PRON B-O
1526
+ adapted VERB B-O
1527
+ the DET B-O
1528
+ Preferred ADJ B-LF
1529
+ Reporting PROPN I-LF
1530
+ Items PROPN I-LF
1531
+ for ADP I-LF
1532
+ Systematic PROPN I-LF
1533
+ Reviews PROPN I-LF
1534
+ and CCONJ I-LF
1535
+ Meta PROPN I-LF
1536
+ - PUNCT I-LF
1537
+ Analyses PROPN I-LF
1538
+ ( PUNCT B-O
1539
+ PRISMA PROPN B-AC
1540
+ ) PUNCT B-O
1541
+ statement NOUN B-O
1542
+ for ADP B-O
1543
+ scoping NOUN B-O
1544
+ reviews NOUN B-O
1545
+ to PART B-O
1546
+ report VERB B-O
1547
+ our PRON B-O
1548
+ systematic ADJ B-O
1549
+ review NOUN B-O
1550
+ of ADP B-O
1551
+ observational ADJ B-O
1552
+ and CCONJ B-O
1553
+ interventional ADJ B-O
1554
+ studies NOUN B-O
1555
+ [ X B-O
1556
+ 19 X B-O
1557
+ ] X B-O
1558
+ ( PUNCT B-O
1559
+ S1 PROPN B-O
1560
+ Table NOUN B-O
1561
+ ) PUNCT B-O
1562
+ . PUNCT B-O
1563
+
1564
+ Plates NOUN B-O
1565
+ were AUX B-O
1566
+ developed VERB B-O
1567
+ , PUNCT B-O
1568
+ and CCONJ B-O
1569
+ the DET B-O
1570
+ optical ADJ B-LF
1571
+ density NOUN I-LF
1572
+ ( PUNCT B-O
1573
+ OD PROPN B-AC
1574
+ ) PUNCT B-O
1575
+ was AUX B-O
1576
+ read VERB B-O
1577
+ using VERB B-O
1578
+ a DET B-O
1579
+ spectrophotometer NOUN B-O
1580
+ ( PUNCT B-O
1581
+ microplate NOUN B-O
1582
+ reader NOUN B-O
1583
+ ; PUNCT B-O
1584
+ Molecular PROPN B-O
1585
+ Devices PROPN B-O
1586
+ , PUNCT B-O
1587
+ Sunnyvale PROPN B-O
1588
+ , PUNCT B-O
1589
+ CA PROPN B-O
1590
+ , PUNCT B-O
1591
+ US PROPN B-O
1592
+ ) PUNCT B-O
1593
+ . PUNCT B-O
1594
+
1595
+ Raw ADJ B-O
1596
+ OD PROPN B-AC
1597
+ for ADP B-O
1598
+ each DET B-O
1599
+ specimen NOUN B-O
1600
+ was AUX B-O
1601
+ normalized VERB B-O
1602
+ using VERB B-O
1603
+ the DET B-O
1604
+ calibrator NOUN B-O
1605
+ OD PROPN B-AC
1606
+ on ADP B-O
1607
+ each DET B-O
1608
+ plate NOUN B-O
1609
+ as ADP B-O
1610
+ a DET B-O
1611
+ ratio NOUN B-O
1612
+ , PUNCT B-O
1613
+ such ADJ B-O
1614
+ that SCONJ B-O
1615
+ normalized VERB B-O
1616
+ OD PROPN B-AC
1617
+ = SYM B-O
1618
+ OD PROPN B-AC
1619
+ of ADP B-O
1620
+ specimen NOUN B-O
1621
+ / SYM B-O
1622
+ median NOUN B-O
1623
+ OD PROPN B-AC
1624
+ of ADP B-O
1625
+ calibrator NOUN B-O
1626
+ . PUNCT B-O
1627
+
1628
+ Hemophagocytic ADJ B-LF
1629
+ lymphohistiocytosis NOUN I-LF
1630
+ ( PUNCT B-O
1631
+ HLH PROPN B-AC
1632
+ ) PUNCT B-O
1633
+ , PUNCT B-O
1634
+ also ADV B-O
1635
+ known VERB B-O
1636
+ as ADP B-O
1637
+ hemophagocytic ADJ B-O
1638
+ syndrome NOUN B-O
1639
+ , PUNCT B-O
1640
+ is AUX B-O
1641
+ a DET B-O
1642
+ rare ADJ B-O
1643
+ , PUNCT B-O
1644
+ life NOUN B-O
1645
+ threatening VERB B-O
1646
+ hyperinflammatory ADJ B-O
1647
+ syndrome NOUN B-O
1648
+ characterized VERB B-O
1649
+ by ADP B-O
1650
+ excessive ADJ B-O
1651
+ activation NOUN B-O
1652
+ of ADP B-O
1653
+ histiocytes NOUN B-O
1654
+ and CCONJ B-O
1655
+ T NOUN B-O
1656
+ lymphocytes NOUN B-O
1657
+ leading VERB B-O
1658
+ to ADP B-O
1659
+ highly ADV B-O
1660
+ active ADJ B-O
1661
+ but CCONJ B-O
1662
+ ineffective ADJ B-O
1663
+ immune ADJ B-O
1664
+ response NOUN B-O
1665
+ [ PUNCT B-O
1666
+ 1 NUM B-O
1667
+ ] PUNCT B-O
1668
+ . PUNCT B-O
1669
+
1670
+ Our PRON B-O
1671
+ assumption NOUN B-O
1672
+ of ADP B-O
1673
+ constant ADJ B-O
1674
+ As PROPN B-AC
1675
+ levels NOUN B-O
1676
+ throughout ADP B-O
1677
+ the DET B-O
1678
+ study NOUN B-O
1679
+ period NOUN B-O
1680
+ is AUX B-O
1681
+ supported VERB B-O
1682
+ by ADP B-O
1683
+ geological ADJ B-O
1684
+ data NOUN B-O
1685
+ which PRON B-O
1686
+ document VERB B-O
1687
+ stable ADJ B-O
1688
+ arsenic NOUN B-LF
1689
+ contamination NOUN B-O
1690
+ of ADP B-O
1691
+ the DET B-O
1692
+ hydrothermal ADJ B-O
1693
+ system NOUN B-O
1694
+ that DET B-O
1695
+ has AUX B-O
1696
+ supplied VERB B-O
1697
+ drinking NOUN B-O
1698
+ water NOUN B-O
1699
+ in ADP B-O
1700
+ the DET B-O
1701
+ study NOUN B-O
1702
+ area NOUN B-O
1703
+ since SCONJ B-O
1704
+ the DET B-O
1705
+ ‘ PUNCT B-O
1706
+ 70s NOUN B-O
1707
+ [ PUNCT B-O
1708
+ 14 NUM B-O
1709
+ , PUNCT B-O
1710
+ 15 NUM B-O
1711
+ , PUNCT B-O
1712
+ 17–19 NUM B-O
1713
+ ] PUNCT B-O
1714
+ and CCONJ B-O
1715
+ to ADP B-O
1716
+ the DET B-O
1717
+ lack NOUN B-O
1718
+ of ADP B-O
1719
+ any DET B-O
1720
+ remediation NOUN B-O
1721
+ treatment NOUN B-O
1722
+ in ADP B-O
1723
+ that DET B-O
1724
+ time NOUN B-O
1725
+ due ADP B-O
1726
+ to ADP B-O
1727
+ the DET B-O
1728
+ long ADJ B-O
1729
+ period NOUN B-O
1730
+ of ADP B-O
1731
+ derogations NOUN B-O
1732
+ [ PUNCT B-O
1733
+ 68 NUM B-O
1734
+ ] PUNCT B-O
1735
+ . PUNCT B-O
1736
+
1737
+ NCD PROPN B-AC
1738
+ , PUNCT B-O
1739
+ noncommunicable ADJ B-LF
1740
+ disease NOUN I-LF
1741
+ ; PUNCT B-O
1742
+ OLS PROPN B-AC
1743
+ , PUNCT B-O
1744
+ ordinary ADJ B-LF
1745
+ least ADJ I-LF
1746
+ squares NOUN I-LF
1747
+ . PUNCT B-O
1748
+
1749
+ To PART B-O
1750
+ further ADV B-O
1751
+ identify VERB B-O
1752
+ the DET B-O
1753
+ molecular ADJ B-O
1754
+ mechanism NOUN B-O
1755
+ of ADP B-O
1756
+ sIBM PROPN B-AC
1757
+ , PUNCT B-O
1758
+ we PRON B-O
1759
+ amplified VERB B-O
1760
+ whole ADJ B-O
1761
+ mitochondrial ADJ B-LF
1762
+ DNA NOUN I-LF
1763
+ ( PUNCT B-O
1764
+ mtDNA PROPN B-AC
1765
+ ) PUNCT B-O
1766
+ from ADP B-O
1767
+ myoblasts NOUN B-O
1768
+ from ADP B-O
1769
+ normal ADJ B-O
1770
+ controls NOUN B-O
1771
+ and CCONJ B-O
1772
+ 3 NUM B-O
1773
+ sIBM PROPN B-AC
1774
+ patients NOUN B-O
1775
+ . PUNCT B-O
1776
+
1777
+ To PART B-O
1778
+ test VERB B-O
1779
+ whether SCONJ B-O
1780
+ F NOUN B-O
1781
+ - PUNCT B-O
1782
+ actin NOUN B-O
1783
+ polymerization NOUN B-O
1784
+ dynamics NOUN B-O
1785
+ are AUX B-O
1786
+ required VERB B-O
1787
+ for ADP B-O
1788
+ proper ADJ B-O
1789
+ VP26 PROPN B-O
1790
+ organization NOUN B-O
1791
+ , PUNCT B-O
1792
+ we PRON B-O
1793
+ treated VERB B-O
1794
+ cells NOUN B-O
1795
+ with ADP B-O
1796
+ the DET B-O
1797
+ actin NOUN B-O
1798
+ filament NOUN B-O
1799
+ - PUNCT B-O
1800
+ stabilizing VERB B-O
1801
+ drug NOUN B-O
1802
+ jasplakinolide PROPN B-LF
1803
+ ( PUNCT B-O
1804
+ jasp PROPN B-AC
1805
+ ) PUNCT B-O
1806
+ . PUNCT B-O
1807
+
1808
+ There PRON B-O
1809
+ were VERB B-O
1810
+ no DET B-O
1811
+ reported VERB B-O
1812
+ differences NOUN B-O
1813
+ between ADP B-O
1814
+ deaths NOUN B-O
1815
+ in ADP B-O
1816
+ males NOUN B-O
1817
+ and CCONJ B-O
1818
+ females NOUN B-O
1819
+ in ADP B-O
1820
+ Boukoki PROPN B-O
1821
+ ( PUNCT B-O
1822
+ male NOUN B-LF
1823
+ - PUNCT I-LF
1824
+ to ADP I-LF
1825
+ - PUNCT I-LF
1826
+ female NOUN I-LF
1827
+ ratio NOUN I-LF
1828
+ [ PUNCT B-O
1829
+ M:Fratio PROPN B-AC
1830
+ ] PUNCT B-O
1831
+ 1.3:1 NUM B-O
1832
+ [ PUNCT B-O
1833
+ 17:13 NUM B-O
1834
+ , PUNCT B-O
1835
+ p NOUN B-O
1836
+ = SYM B-O
1837
+ 0.79 NUM B-O
1838
+ ] PUNCT B-O
1839
+ ) PUNCT B-O
1840
+ or CCONJ B-O
1841
+ in ADP B-O
1842
+ Moursal PROPN B-O
1843
+ ( PUNCT B-O
1844
+ M PROPN B-AC
1845
+ 1.5:1 NUM B-O
1846
+ [ PUNCT B-O
1847
+ 12:8 NUM B-O
1848
+ , PUNCT B-O
1849
+ p NOUN B-O
1850
+ = SYM B-O
1851
+ 0.75 NUM B-O
1852
+ ] PUNCT B-O
1853
+ ) PUNCT B-O
1854
+ . PUNCT B-O
1855
+
1856
+ Rev NOUN B-O
1857
+ # NOUN B-O
1858
+ 3 NUM B-O
1859
+ : PUNCT B-O
1860
+ “ PUNCT B-O
1861
+ Is AUX B-O
1862
+ GAL PROPN B-AC
1863
+ gene NOUN B-O
1864
+ optimization NOUN B-O
1865
+ not PART B-O
1866
+ correlated VERB B-O
1867
+ with ADP B-O
1868
+ growth NOUN B-O
1869
+ under ADP B-O
1870
+ other ADJ B-O
1871
+ ( PUNCT B-O
1872
+ non ADJ B-O
1873
+ - ADJ B-O
1874
+ galactose ADJ B-LF
1875
+ ) PUNCT B-O
1876
+ growth NOUN B-O
1877
+ conditions NOUN B-O
1878
+ ? PUNCT B-O
1879
+ ” PUNCT B-O
1880
+ As SCONJ B-O
1881
+ the DET B-O
1882
+ world NOUN B-O
1883
+ edges VERB B-O
1884
+ closer ADV B-O
1885
+ to ADP B-O
1886
+ global ADJ B-O
1887
+ polio NOUN B-O
1888
+ eradication NOUN B-O
1889
+ and CCONJ B-O
1890
+ continues VERB B-O
1891
+ the DET B-O
1892
+ strategic ADJ B-O
1893
+ withdrawal NOUN B-O
1894
+ of ADP B-O
1895
+ the DET B-O
1896
+ Oral PROPN B-LF
1897
+ Polio PROPN I-LF
1898
+ Vaccine PROPN I-LF
1899
+ ( PUNCT B-O
1900
+ OPV PROPN B-AC
1901
+ ) PUNCT B-O
1902
+ , PUNCT B-O
1903
+ the DET B-O
1904
+ regular ADJ B-O
1905
+ identification NOUN B-O
1906
+ of ADP B-O
1907
+ , PUNCT B-O
1908
+ and CCONJ B-O
1909
+ rapid ADJ B-O
1910
+ response NOUN B-O
1911
+ to ADP B-O
1912
+ , PUNCT B-O
1913
+ these DET B-O
1914
+ silent ADJ B-O
1915
+ chains NOUN B-O
1916
+ of ADP B-O
1917
+ transmission NOUN B-O
1918
+ is AUX B-O
1919
+ of ADP B-O
1920
+ the DET B-O
1921
+ utmost ADJ B-O
1922
+ importance NOUN B-O
1923
+ . PUNCT B-O
1924
+
1925
+ ABA PROPN B-AC
1926
+ , PUNCT B-O
1927
+ abscisic NOUN B-LF
1928
+ acid NOUN I-LF
1929
+ ; PUNCT B-O
1930
+ BR PROPN B-AC
1931
+ , PUNCT B-O
1932
+ brassinosteroid NOUN B-LF
1933
+ ; PUNCT B-O
1934
+ GA3 PROPN B-AC
1935
+ , PUNCT B-O
1936
+ gibberellic NOUN B-LF
1937
+ acid3 NOUN I-LF
1938
+ ; PUNCT B-O
1939
+ ZR PROPN B-AC
1940
+ , PUNCT B-O
1941
+ zeatin NOUN B-LF
1942
+ riboside NOUN I-LF
1943
+ Green ADJ B-LF
1944
+ tea NOUN I-LF
1945
+ ( PUNCT B-O
1946
+ GT PROPN B-AC
1947
+ ) PUNCT B-O
1948
+ catechins NOUN B-O
1949
+ have VERB B-O
1950
+ been AUX B-O
1951
+ shown VERB B-O
1952
+ to PART B-O
1953
+ have VERB B-O
1954
+ anti ADJ B-O
1955
+ - ADJ B-O
1956
+ obesity ADJ B-O
1957
+ effects NOUN B-O
1958
+ in ADP B-O
1959
+ humans NOUN B-O
1960
+ . PUNCT B-O
1961
+
1962
+ We PRON B-O
1963
+ inserted VERB B-O
1964
+ the DET B-O
1965
+ CAN1 PROPN B-O
1966
+ and CCONJ B-O
1967
+ URA3 PROPN B-O
1968
+ genes NOUN B-O
1969
+ , PUNCT B-O
1970
+ two NUM B-O
1971
+ counter ADJ B-O
1972
+ - PUNCT B-O
1973
+ selectable ADJ B-O
1974
+ markers NOUN B-O
1975
+ , PUNCT B-O
1976
+ ∼10 NUM B-O
1977
+ kb NOUN B-O
1978
+ from ADP B-O
1979
+ the DET B-O
1980
+ telomere NOUN B-O
1981
+ of ADP B-O
1982
+ ChrXV PROPN B-O
1983
+ - PUNCT B-O
1984
+ L PROPN B-O
1985
+ ( PUNCT B-O
1986
+ Figure PROPN B-O
1987
+ 1A NUM B-O
1988
+ ) PUNCT B-O
1989
+ . PUNCT B-O
1990
+
1991
+ The DET B-O
1992
+ simultaneous ADJ B-O
1993
+ loss NOUN B-O
1994
+ of ADP B-O
1995
+ CAN1 PROPN B-O
1996
+ and CCONJ B-O
1997
+ URA3 PROPN B-O
1998
+ ( PUNCT B-O
1999
+ detected VERB B-O
2000
+ on ADP B-O
2001
+ media NOUN B-O
2002
+ containing VERB B-O
2003
+ canavinine NOUN B-LF
2004
+ [ X B-O
2005
+ can PROPN B-AC
2006
+ ] PUNCT B-O
2007
+ and CCONJ B-O
2008
+ 5 NUM B-O
2009
+ - PUNCT B-O
2010
+ fluoro NOUN B-O
2011
+ - PUNCT B-O
2012
+ orotic ADJ B-O
2013
+ acid NOUN B-O
2014
+ [ X B-O
2015
+ 5 NUM B-O
2016
+ - PUNCT B-O
2017
+ FOA NOUN B-O
2018
+ ] PUNCT B-O
2019
+ ) PUNCT B-O
2020
+ at ADP B-O
2021
+ this DET B-O
2022
+ locus NOUN B-O
2023
+ occurs VERB B-O
2024
+ at ADP B-O
2025
+ a DET B-O
2026
+ rate NOUN B-O
2027
+ of ADP B-O
2028
+ 8.9 NUM B-O
2029
+ × PUNCT B-O
2030
+ 10−8 NUM B-O
2031
+ ( PUNCT B-O
2032
+ Table PROPN B-O
2033
+ 1 NUM B-O
2034
+ ) PUNCT B-O
2035
+ , PUNCT B-O
2036
+ approximately ADV B-O
2037
+ 250 NUM B-O
2038
+ - PUNCT B-O
2039
+ fold ADJ B-O
2040
+ higher ADJ B-O
2041
+ than ADP B-O
2042
+ the DET B-O
2043
+ rate NOUN B-O
2044
+ observed VERB B-O
2045
+ at ADP B-O
2046
+ ChrV PROPN B-O
2047
+ - PUNCT B-O
2048
+ L PROPN B-O
2049
+ ( PUNCT B-O
2050
+ 3.5 NUM B-O
2051
+ × PUNCT B-O
2052
+ 10−10 NUM B-O
2053
+ ; PUNCT B-O
2054
+ Table PROPN B-O
2055
+ 2 NUM B-O
2056
+ ) PUNCT B-O
2057
+ . PUNCT B-O
2058
+
2059
+ Pilot NOUN B-O
2060
+ studies NOUN B-O
2061
+ with ADP B-O
2062
+ exhaustive ADJ B-O
2063
+ sampling NOUN B-O
2064
+ , PUNCT B-O
2065
+ progressive ADJ B-O
2066
+ means NOUN B-O
2067
+ analysis NOUN B-O
2068
+ , PUNCT B-O
2069
+ and CCONJ B-O
2070
+ the DET B-O
2071
+ formula NOUN B-O
2072
+ of ADP B-O
2073
+ West PROPN B-O
2074
+ et PROPN B-O
2075
+ al PROPN B-O
2076
+ . PUNCT B-O
2077
+
2078
+ , PUNCT B-O
2079
+ [ PUNCT B-O
2080
+ 166 NUM B-O
2081
+ ] PUNCT B-O
2082
+ , PUNCT B-O
2083
+ as ADP B-O
2084
+ well ADV B-O
2085
+ as ADP B-O
2086
+ a PRON B-O
2087
+ posteriori X B-O
2088
+ power NOUN B-O
2089
+ analysis NOUN B-O
2090
+ , PUNCT B-O
2091
+ using VERB B-O
2092
+ data NOUN B-O
2093
+ from ADP B-O
2094
+ our PRON B-O
2095
+ previous ADJ B-O
2096
+ studies NOUN B-O
2097
+ of ADP B-O
2098
+ cell NOUN B-O
2099
+ and CCONJ B-O
2100
+ axon NOUN B-O
2101
+ densities NOUN B-O
2102
+ , PUNCT B-O
2103
+ or CCONJ B-O
2104
+ tract NOUN B-O
2105
+ tracing NOUN B-O
2106
+ of ADP B-O
2107
+ pathways NOUN B-O
2108
+ , PUNCT B-O
2109
+ took VERB B-O
2110
+ into ADP B-O
2111
+ consideration NOUN B-O
2112
+ all DET B-O
2113
+ known VERB B-O
2114
+ and CCONJ B-O
2115
+ estimated VERB B-O
2116
+ variables NOUN B-O
2117
+ , PUNCT B-O
2118
+ including VERB B-O
2119
+ age NOUN B-O
2120
+ , PUNCT B-O
2121
+ sex NOUN B-O
2122
+ , PUNCT B-O
2123
+ postmortem ADJ B-LF
2124
+ interval NOUN I-LF
2125
+ ( PUNCT B-O
2126
+ PMI PROPN B-AC
2127
+ ) PUNCT B-O
2128
+ , PUNCT B-O
2129
+ and CCONJ B-O
2130
+ other ADJ B-O
2131
+ diagnoses NOUN B-O
2132
+ . PUNCT B-O
2133
+
2134
+ A DET B-O
2135
+ series NOUN B-O
2136
+ of ADP B-O
2137
+ computer NOUN B-O
2138
+ - PUNCT B-O
2139
+ aided VERB B-O
2140
+ virtual ADJ B-O
2141
+ screening VERB B-O
2142
+ techniques NOUN B-O
2143
+ were AUX B-O
2144
+ utilized VERB B-O
2145
+ to PART B-O
2146
+ identify VERB B-O
2147
+ potential ADJ B-O
2148
+ agonists NOUN B-O
2149
+ of ADP B-O
2150
+ STING PROPN B-AC
2151
+ . PUNCT B-O
2152
+
2153
+ Structure NOUN B-O
2154
+ - PUNCT B-O
2155
+ based VERB B-O
2156
+ screening VERB B-O
2157
+ using VERB B-O
2158
+ Libdock PROPN B-O
2159
+ was AUX B-O
2160
+ carried VERB B-O
2161
+ out ADP B-O
2162
+ followed VERB B-O
2163
+ by ADP B-O
2164
+ ADME PROPN B-AC
2165
+ ( PUNCT B-O
2166
+ absorption NOUN B-LF
2167
+ , PUNCT I-LF
2168
+ distribution NOUN I-LF
2169
+ , PUNCT I-LF
2170
+ metabolism NOUN I-LF
2171
+ , PUNCT I-LF
2172
+ excretion NOUN I-LF
2173
+ ) PUNCT B-O
2174
+ and CCONJ B-O
2175
+ toxicity NOUN B-O
2176
+ prediction NOUN B-O
2177
+ . PUNCT B-O
2178
+
2179
+ Since SCONJ B-O
2180
+ the DET B-O
2181
+ absolute ADJ B-O
2182
+ precision NOUN B-O
2183
+ is AUX B-O
2184
+ depending VERB B-O
2185
+ on ADP B-O
2186
+ prevalence NOUN B-O
2187
+ of ADP B-O
2188
+ atrial ADJ B-LF
2189
+ fibrillation NOUN I-LF
2190
+ , PUNCT B-O
2191
+ which PRON B-O
2192
+ was AUX B-O
2193
+ low ADJ B-O
2194
+ in ADP B-O
2195
+ the DET B-O
2196
+ screened VERB B-O
2197
+ population NOUN B-O
2198
+ , PUNCT B-O
2199
+ one PRON B-O
2200
+ must AUX B-O
2201
+ consider VERB B-O
2202
+ sample NOUN B-O
2203
+ size NOUN B-O
2204
+ , PUNCT B-O
2205
+ i.e. X B-O
2206
+ what PRON B-O
2207
+ is AUX B-O
2208
+ the DET B-O
2209
+ absolute ADJ B-O
2210
+ precision NOUN B-O
2211
+ in ADP B-O
2212
+ the DET B-O
2213
+ validation NOUN B-O
2214
+ trial NOUN B-O
2215
+ with ADP B-O
2216
+ the DET B-O
2217
+ reported VERB B-O
2218
+ sample NOUN B-O
2219
+ size NOUN B-O
2220
+ and CCONJ B-O
2221
+ AF PROPN B-AC
2222
+ prevalence NOUN B-O
2223
+ ? PUNCT B-O
2224
+ We PRON B-O
2225
+ also ADV B-O
2226
+ described VERB B-O
2227
+ the DET B-O
2228
+ dilutions NOUN B-O
2229
+ of ADP B-O
2230
+ the DET B-O
2231
+ antibody NOUN B-O
2232
+ in ADP B-O
2233
+ the DET B-O
2234
+ “ PUNCT B-O
2235
+ Results NOUN B-O
2236
+ ” PUNCT B-O
2237
+ section NOUN B-O
2238
+ under ADP B-O
2239
+ the DET B-O
2240
+ heading NOUN B-O
2241
+ “ PUNCT B-O
2242
+ Detection NOUN B-O
2243
+ of ADP B-O
2244
+ anti ADJ B-O
2245
+ - PUNCT B-O
2246
+ FXIII/13 PROPN B-AC
2247
+ - PUNCT B-O
2248
+ A NOUN B-O
2249
+ autoantibodies NOUN B-O
2250
+ using VERB B-O
2251
+ enzyme NOUN B-LF
2252
+ - PUNCT I-LF
2253
+ linked VERB I-LF
2254
+ immunosorbent ADJ I-LF
2255
+ assay NOUN I-LF
2256
+ ( PUNCT B-O
2257
+ ELISA PROPN B-AC
2258
+ ) PUNCT B-O
2259
+ ” PUNCT B-O
2260
+ ( PUNCT B-O
2261
+ p.12 NOUN B-O
2262
+ , PUNCT B-O
2263
+ lane NOUN B-O
2264
+ 3 NUM B-O
2265
+ ) PUNCT B-O
2266
+ . PUNCT B-O
2267
+
2268
+ They PRON B-O
2269
+ invade VERB B-O
2270
+ primary ADJ B-O
2271
+ tumors NOUN B-O
2272
+ , PUNCT B-O
2273
+ where SCONJ B-O
2274
+ they PRON B-O
2275
+ promote VERB B-O
2276
+ angiogenesis NOUN B-O
2277
+ , PUNCT B-O
2278
+ via ADP B-O
2279
+ Matrix PROPN B-LF
2280
+ Metaloproteinases PROPN I-LF
2281
+ ( PUNCT B-O
2282
+ MMP PROPN B-AC
2283
+ ) PUNCT B-O
2284
+ secretion NOUN B-O
2285
+ and CCONJ B-O
2286
+ Vascular PROPN B-LF
2287
+ Endothelial PROPN I-LF
2288
+ Growth PROPN I-LF
2289
+ Factor PROPN I-LF
2290
+ ( PUNCT B-O
2291
+ VEGF PROPN B-AC
2292
+ ) PUNCT B-O
2293
+ production NOUN B-O
2294
+ [ PUNCT B-O
2295
+ 24 NUM B-O
2296
+ ] PUNCT B-O
2297
+ . PUNCT B-O
2298
+
2299
+ All DET B-O
2300
+ AmpC NOUN B-LF
2301
+ beta NOUN I-LF
2302
+ AmpC PROPN B-AC
2303
+ - PUNCT I-LF
2304
+ lactamase NOUN I-LF
2305
+ producing VERB B-O
2306
+ GNB PROPN B-AC
2307
+ were AUX B-O
2308
+ detected VERB B-O
2309
+ in ADP B-O
2310
+ urine NOUN B-O
2311
+ specimens NOUN B-O
2312
+ 3.3 NUM B-O
2313
+ % PUNCT B-O
2314
+ ( PUNCT B-O
2315
+ 8/244 NUM B-O
2316
+ ) PUNCT B-O
2317
+ and CCONJ B-O
2318
+ in ADP B-O
2319
+ patients NOUN B-O
2320
+ whose DET B-O
2321
+ age NOUN B-O
2322
+ group NOUN B-O
2323
+ was AUX B-O
2324
+ above ADP B-O
2325
+ 61 NUM B-O
2326
+ years NOUN B-O
2327
+ ( PUNCT B-O
2328
+ 40.1 NUM B-O
2329
+ % PUNCT B-O
2330
+ ) PUNCT B-O
2331
+ . PUNCT B-O
2332
+
2333
+ Temperature NOUN B-O
2334
+ data NOUN B-O
2335
+ such ADJ B-O
2336
+ as ADP B-O
2337
+ the DET B-O
2338
+ decadal ADJ B-O
2339
+ ( PUNCT B-O
2340
+ 10 NUM B-O
2341
+ - PUNCT B-O
2342
+ day NOUN B-O
2343
+ ) PUNCT B-O
2344
+ mean ADJ B-O
2345
+ daily ADJ B-O
2346
+ maximum ADJ B-O
2347
+ air NOUN B-O
2348
+ temperature NOUN B-O
2349
+ ( PUNCT B-O
2350
+ DMDMAT PROPN B-AC
2351
+ ) PUNCT B-O
2352
+ were AUX B-O
2353
+ obtained VERB B-O
2354
+ from ADP B-O
2355
+ a DET B-O
2356
+ nearby ADJ B-O
2357
+ weather NOUN B-O
2358
+ station NOUN B-O
2359
+ and CCONJ B-O
2360
+ statistical ADJ B-O
2361
+ correlations NOUN B-O
2362
+ between ADP B-O
2363
+ tick NOUN B-O
2364
+ occurrence NOUN B-O
2365
+ and CCONJ B-O
2366
+ minimal ADJ B-LF
2367
+ infection NOUN I-LF
2368
+ rates NOUN I-LF
2369
+ ( PUNCT B-O
2370
+ MIR PROPN B-AC
2371
+ ) PUNCT B-O
2372
+ were AUX B-O
2373
+ calculated VERB B-O
2374
+ . PUNCT B-O
2375
+
2376
+ In ADP B-O
2377
+ the DET B-O
2378
+ case NOUN B-O
2379
+ of ADP B-O
2380
+ the DET B-O
2381
+ Schizophrenia PROPN B-LF
2382
+ ( PUNCT B-O
2383
+ SZ PROPN B-AC
2384
+ ) PUNCT B-O
2385
+ GWAS PROPN B-AC
2386
+ original ADJ B-O
2387
+ report NOUN B-O
2388
+ , PUNCT B-O
2389
+ 16 NUM B-O
2390
+ % NOUN B-O
2391
+ of ADP B-O
2392
+ the DET B-O
2393
+ findings NOUN B-O
2394
+ were AUX B-O
2395
+ shown VERB B-O
2396
+ to PART B-O
2397
+ have VERB B-O
2398
+ brain NOUN B-O
2399
+ eQTL PROPN B-AC
2400
+ effects NOUN B-O
2401
+ at ADP B-O
2402
+ the DET B-O
2403
+ gene NOUN B-O
2404
+ level NOUN B-O
2405
+ [ PUNCT B-O
2406
+ 1 NUM B-O
2407
+ ] PUNCT B-O
2408
+ , PUNCT B-O
2409
+ but CCONJ B-O
2410
+ further ADJ B-O
2411
+ studies NOUN B-O
2412
+ are AUX B-O
2413
+ increasing VERB B-O
2414
+ this DET B-O
2415
+ number NOUN B-O
2416
+ [ PUNCT B-O
2417
+ 6 NUM B-O
2418
+ , PUNCT B-O
2419
+ 7 NUM B-O
2420
+ ] PUNCT B-O
2421
+ . PUNCT B-O
2422
+
2423
+ To PART B-O
2424
+ explore VERB B-O
2425
+ the DET B-O
2426
+ relationships NOUN B-O
2427
+ between ADP B-O
2428
+ HP1 PROPN B-AC
2429
+ and CCONJ B-O
2430
+ these DET B-O
2431
+ marks NOUN B-O
2432
+ , PUNCT B-O
2433
+ we PRON B-O
2434
+ re VERB B-O
2435
+ - PUNCT B-O
2436
+ analyzed VERB B-O
2437
+ available ADJ B-O
2438
+ high ADJ B-O
2439
+ - PUNCT B-O
2440
+ resolution NOUN B-O
2441
+ chromosomal ADJ B-O
2442
+ maps NOUN B-O
2443
+ of ADP B-O
2444
+ dimethylated VERB B-LF
2445
+ histone NOUN I-LF
2446
+ 3 NUM I-LF
2447
+ lysine NOUN I-LF
2448
+ 4 NUM I-LF
2449
+ ( PUNCT B-O
2450
+ H3K4me2 PROPN B-AC
2451
+ ) PUNCT B-O
2452
+ and CCONJ B-O
2453
+ H3.3 NOUN B-O
2454
+ , PUNCT B-O
2455
+ which PRON B-O
2456
+ were AUX B-O
2457
+ generated VERB B-O
2458
+ in ADP B-O
2459
+ the DET B-O
2460
+ Drosophila PROPN B-O
2461
+ Kc PROPN B-O
2462
+ cell NOUN B-O
2463
+ line NOUN B-O
2464
+ or CCONJ B-O
2465
+ in ADP B-O
2466
+ the DET B-O
2467
+ closely ADV B-O
2468
+ related VERB B-O
2469
+ S2 PROPN B-O
2470
+ cell NOUN B-O
2471
+ line NOUN B-O
2472
+ [ X B-O
2473
+ 51,53 X B-O
2474
+ ] X B-O
2475
+ ( PUNCT B-O
2476
+ see VERB B-O
2477
+ Materials NOUN B-O
2478
+ and CCONJ B-O
2479
+ Methods PROPN B-O
2480
+ ) PUNCT B-O
2481
+ . PUNCT B-O
2482
+
2483
+ This DET B-O
2484
+ virus NOUN B-O
2485
+ quickly ADV B-O
2486
+ spread VERB B-O
2487
+ globally ADV B-O
2488
+ , PUNCT B-O
2489
+ and CCONJ B-O
2490
+ on ADP B-O
2491
+ June PROPN B-O
2492
+ 11 NUM B-O
2493
+ , PUNCT B-O
2494
+ 2009 NUM B-O
2495
+ , PUNCT B-O
2496
+ the DET B-O
2497
+ World PROPN B-LF
2498
+ Health PROPN I-LF
2499
+ Organization PROPN I-LF
2500
+ ( PUNCT B-O
2501
+ WHO PROPN B-AC
2502
+ ) PUNCT B-O
2503
+ declared VERB B-O
2504
+ a DET B-O
2505
+ pandemic NOUN B-O
2506
+ alert NOUN B-O
2507
+ phase NOUN B-O
2508
+ 6 NUM B-O
2509
+ , PUNCT B-O
2510
+ indicating VERB B-O
2511
+ that SCONJ B-O
2512
+ the DET B-O
2513
+ first ADJ B-O
2514
+ influenza NOUN B-O
2515
+ pandemic NOUN B-O
2516
+ of ADP B-O
2517
+ the DET B-O
2518
+ 21st ADJ B-O
2519
+ century NOUN B-O
2520
+ had AUX B-O
2521
+ begun VERB B-O
2522
+ [ X B-O
2523
+ 1]–[3 X B-O
2524
+ ] PUNCT B-O
2525
+ . PUNCT B-O
2526
+
2527
+ Between ADP B-O
2528
+ 1990 NUM B-O
2529
+ and CCONJ B-O
2530
+ 2014 NUM B-O
2531
+ the DET B-O
2532
+ world NOUN B-O
2533
+ prevalence NOUN B-O
2534
+ of ADP B-O
2535
+ cesarean ADJ B-LF
2536
+ section NOUN I-LF
2537
+ ( PUNCT B-O
2538
+ CS PROPN B-AC
2539
+ ) PUNCT B-O
2540
+ increased VERB B-O
2541
+ by ADP B-O
2542
+ 285 NUM B-O
2543
+ % NOUN B-O
2544
+ ( PUNCT B-O
2545
+ 6.7 NUM B-O
2546
+ % NOUN B-O
2547
+ versus ADP B-O
2548
+ 19.1 NUM B-O
2549
+ % NOUN B-O
2550
+ of ADP B-O
2551
+ all DET B-O
2552
+ births NOUN B-O
2553
+ ) PUNCT B-O
2554
+ [ PUNCT B-O
2555
+ 1 NUM B-O
2556
+ ] PUNCT B-O
2557
+ , PUNCT B-O
2558
+ albeit SCONJ B-O
2559
+ with ADP B-O
2560
+ large ADJ B-O
2561
+ regional ADJ B-O
2562
+ disparities NOUN B-O
2563
+ . PUNCT B-O
2564
+
2565
+ Note VERB B-O
2566
+ that SCONJ B-O
2567
+ as ADP B-O
2568
+ a DET B-O
2569
+ consequence NOUN B-O
2570
+ of ADP B-O
2571
+ standardization NOUN B-O
2572
+ of ADP B-O
2573
+ the DET B-O
2574
+ continuous ADJ B-O
2575
+ variables NOUN B-O
2576
+ ( PUNCT B-O
2577
+ age NOUN B-O
2578
+ , PUNCT B-O
2579
+ waist NOUN B-O
2580
+ circumference NOUN B-O
2581
+ , PUNCT B-O
2582
+ fasting VERB B-O
2583
+ plasma NOUN B-O
2584
+ glucose NOUN B-O
2585
+ , PUNCT B-O
2586
+ total ADJ B-O
2587
+ - PUNCT B-O
2588
+ to ADP B-O
2589
+ - PUNCT B-O
2590
+ HDL NOUN B-O
2591
+ cholesterol NOUN B-O
2592
+ , PUNCT B-O
2593
+ 24 NUM B-O
2594
+ - PUNCT B-O
2595
+ h NOUN B-O
2596
+ systolic ADJ B-O
2597
+ blood NOUN B-O
2598
+ pressure NOUN B-O
2599
+ ) PUNCT B-O
2600
+ the DET B-O
2601
+ regression NOUN B-O
2602
+ coefficient NOUN B-O
2603
+ ( PUNCT B-O
2604
+ B NOUN B-O
2605
+ ) PUNCT B-O
2606
+ for ADP B-O
2607
+ continuous ADJ B-O
2608
+ variables NOUN B-O
2609
+ equals VERB B-O
2610
+ the DET B-O
2611
+ standardized ADJ B-O
2612
+ beta NOUN B-O
2613
+ . PUNCT B-O
2614
+
2615
+ * PUNCT B-O
2616
+ P<0.05 NUM B-O
2617
+ , PUNCT B-O
2618
+ SD PROPN B-AC
2619
+ , PUNCT B-O
2620
+ standard ADJ B-LF
2621
+ deviation NOUN I-LF
2622
+ ; PUNCT B-O
2623
+ CI NOUN B-O
2624
+ , PUNCT B-O
2625
+ confidence NOUN B-O
2626
+ interval NOUN B-O
2627
+ ; PUNCT B-O
2628
+ HDL NOUN B-O
2629
+ , PUNCT B-O
2630
+ high ADJ B-O
2631
+ - PUNCT B-O
2632
+ density NOUN B-O
2633
+ lipoprotein NOUN B-O
2634
+ . PUNCT B-O
2635
+
2636
+ For ADP B-O
2637
+ this DET B-O
2638
+ interim ADJ B-O
2639
+ analysis NOUN B-O
2640
+ , PUNCT B-O
2641
+ we PRON B-O
2642
+ excluded VERB B-O
2643
+ patients NOUN B-O
2644
+ treated VERB B-O
2645
+ with ADP B-O
2646
+ different ADJ B-O
2647
+ therapies NOUN B-O
2648
+ other ADJ B-O
2649
+ than ADP B-O
2650
+ standard ADJ B-O
2651
+ chemotherapy NOUN B-O
2652
+ including VERB B-O
2653
+ anthracycline NOUN B-O
2654
+ and/or CCONJ B-O
2655
+ trastuzumab NOUN B-O
2656
+ ( PUNCT B-O
2657
+ n NOUN B-O
2658
+ = SYM B-O
2659
+ 2,929 NUM B-O
2660
+ ) PUNCT B-O
2661
+ , PUNCT B-O
2662
+ patients NOUN B-O
2663
+ with ADP B-O
2664
+ no DET B-O
2665
+ left ADJ B-LF
2666
+ ventricular ADJ I-LF
2667
+ ejection NOUN I-LF
2668
+ fraction NOUN I-LF
2669
+ ( PUNCT B-O
2670
+ LVEF PROPN B-AC
2671
+ ) PUNCT B-O
2672
+ measurement NOUN B-O
2673
+ at ADP B-O
2674
+ baseline NOUN B-O
2675
+ ( PUNCT B-O
2676
+ n NOUN B-O
2677
+ = SYM B-O
2678
+ 918)or NUM B-O
2679
+ no DET B-O
2680
+ available ADJ B-O
2681
+ follow VERB B-O
2682
+ - PUNCT B-O
2683
+ up ADP B-O
2684
+ measurements NOUN B-O
2685
+ ( PUNCT B-O
2686
+ n NOUN B-O
2687
+ = SYM B-O
2688
+ 799 NUM B-O
2689
+ ) PUNCT B-O
2690
+ , PUNCT B-O
2691
+ patients NOUN B-O
2692
+ with ADP B-O
2693
+ LVEF PROPN B-AC
2694
+ at ADP B-O
2695
+ baseline NOUN B-O
2696
+ < ADP B-O
2697
+ 50 NUM B-O
2698
+ % NOUN B-O
2699
+ ( PUNCT B-O
2700
+ n NOUN B-O
2701
+ = SYM B-O
2702
+ 13 NUM B-O
2703
+ ) PUNCT B-O
2704
+ , PUNCT B-O
2705
+ patients NOUN B-O
2706
+ with ADP B-O
2707
+ BMI PROPN B-AC
2708
+ < ADP B-O
2709
+ 18.5 NUM B-O
2710
+ kg NOUN B-O
2711
+ / SYM B-O
2712
+ m2 NOUN B-O
2713
+ ( PUNCT B-O
2714
+ n NOUN B-O
2715
+ = SYM B-O
2716
+ 32 NUM B-O
2717
+ ) PUNCT B-O
2718
+ , PUNCT B-O
2719
+ and CCONJ B-O
2720
+ patients NOUN B-O
2721
+ with ADP B-O
2722
+ evidence NOUN B-O
2723
+ of ADP B-O
2724
+ local ADJ B-O
2725
+ , PUNCT B-O
2726
+ regional ADJ B-O
2727
+ , PUNCT B-O
2728
+ or CCONJ B-O
2729
+ metastatic ADJ B-O
2730
+ recurrence NOUN B-O
2731
+ of ADP B-O
2732
+ BC PROPN B-AC
2733
+ ( PUNCT B-O
2734
+ n NOUN B-O
2735
+ = SYM B-O
2736
+ 181 NUM B-O
2737
+ ) PUNCT B-O
2738
+ . PUNCT B-O
2739
+
2740
+ Meanwhile ADV B-O
2741
+ , PUNCT B-O
2742
+ it PRON B-O
2743
+ lowered VERB B-O
2744
+ malondialdehyde NOUN B-LF
2745
+ ( PUNCT B-O
2746
+ MDA PROPN B-AC
2747
+ ) PUNCT B-O
2748
+ , PUNCT B-O
2749
+ nitric NOUN B-LF
2750
+ oxide NOUN I-LF
2751
+ ( PUNCT B-O
2752
+ NO PROPN B-AC
2753
+ ) PUNCT B-O
2754
+ and CCONJ B-O
2755
+ nuclear ADJ B-LF
2756
+ factor NOUN I-LF
2757
+ erythroid NOUN I-LF
2758
+ 2 NUM I-LF
2759
+ - PUNCT I-LF
2760
+ related VERB I-LF
2761
+ factor NOUN I-LF
2762
+ 2 NUM I-LF
2763
+ ( PUNCT B-O
2764
+ NRF-2 PROPN B-AC
2765
+ ) PUNCT B-O
2766
+ levels NOUN B-O
2767
+ with ADP B-O
2768
+ restoration NOUN B-O
2769
+ of ADP B-O
2770
+ glutathione NOUN B-LF
2771
+ ( PUNCT B-O
2772
+ GSH PROPN B-AC
2773
+ ) PUNCT B-O
2774
+ , PUNCT B-O
2775
+ and CCONJ B-O
2776
+ glutathione NOUN B-LF
2777
+ peroxidase NOUN I-LF
2778
+ ( PUNCT B-O
2779
+ GPx PROPN B-AC
2780
+ ) PUNCT B-O
2781
+ . PUNCT B-O
2782
+
2783
+ CD PROPN B-AC
2784
+ , PUNCT B-O
2785
+ change NOUN B-LF
2786
+ - PUNCT I-LF
2787
+ detection NOUN I-LF
2788
+ . PUNCT B-O
2789
+
2790
+ As SCONJ B-O
2791
+ the DET B-O
2792
+ transfer NOUN B-O
2793
+ of ADP B-O
2794
+ bacteria NOUN B-O
2795
+ to ADP B-O
2796
+ the DET B-O
2797
+ embryo NOUN B-O
2798
+ is AUX B-O
2799
+ being AUX B-O
2800
+ completed VERB B-O
2801
+ , PUNCT B-O
2802
+ expression NOUN B-O
2803
+ of ADP B-O
2804
+ the DET B-O
2805
+ Engrailed PROPN B-LF
2806
+ ( PUNCT B-O
2807
+ En PROPN B-AC
2808
+ ) PUNCT B-O
2809
+ protein NOUN B-O
2810
+ ( PUNCT B-O
2811
+ FBgn0000577 NOUN B-O
2812
+ ) PUNCT B-O
2813
+ ( PUNCT B-O
2814
+ Patel PROPN B-O
2815
+ et NOUN B-O
2816
+ al NOUN B-O
2817
+ . PUNCT B-O
2818
+
2819
+ 1989 NUM B-O
2820
+ ) PUNCT B-O
2821
+ is AUX B-O
2822
+ detected VERB B-O
2823
+ ( PUNCT B-O
2824
+ Figure NOUN B-O
2825
+ 1 NUM B-O
2826
+ G NOUN B-O
2827
+ ) PUNCT B-O
2828
+ . PUNCT B-O
2829
+
2830
+ Knowledge NOUN B-LF
2831
+ translation NOUN I-LF
2832
+ ( PUNCT B-O
2833
+ KT PROPN B-AC
2834
+ ) PUNCT B-O
2835
+ is AUX B-O
2836
+ one NUM B-O
2837
+ of ADP B-O
2838
+ a DET B-O
2839
+ host NOUN B-O
2840
+ of ADP B-O
2841
+ terms NOUN B-O
2842
+ ( PUNCT B-O
2843
+ e.g. X B-O
2844
+ , PUNCT B-O
2845
+ implementation NOUN B-O
2846
+ , PUNCT B-O
2847
+ knowledge NOUN B-O
2848
+ transfer NOUN B-O
2849
+ ) PUNCT B-O
2850
+ used VERB B-O
2851
+ to PART B-O
2852
+ describe VERB B-O
2853
+ “ PUNCT B-O
2854
+ a DET B-O
2855
+ dynamic ADJ B-O
2856
+ and CCONJ B-O
2857
+ iterative ADJ B-O
2858
+ process NOUN B-O
2859
+ that PRON B-O
2860
+ includes VERB B-O
2861
+ the DET B-O
2862
+ synthesis NOUN B-O
2863
+ , PUNCT B-O
2864
+ dissemination NOUN B-O
2865
+ , PUNCT B-O
2866
+ exchange NOUN B-O
2867
+ and CCONJ B-O
2868
+ ethically ADV B-O
2869
+ sound ADJ B-O
2870
+ application NOUN B-O
2871
+ of ADP B-O
2872
+ knowledge NOUN B-O
2873
+ to PART B-O
2874
+ improve VERB B-O
2875
+ health NOUN B-O
2876
+ , PUNCT B-O
2877
+ provide VERB B-O
2878
+ more ADV B-O
2879
+ effective ADJ B-O
2880
+ health NOUN B-O
2881
+ services NOUN B-O
2882
+ and CCONJ B-O
2883
+ products NOUN B-O
2884
+ , PUNCT B-O
2885
+ and CCONJ B-O
2886
+ strengthen VERB B-O
2887
+ the DET B-O
2888
+ healthcare NOUN B-O
2889
+ system NOUN B-O
2890
+ . PUNCT B-O
2891
+
2892
+ ”[6 X B-O
2893
+ ] X B-O
2894
+ This DET B-O
2895
+ value NOUN B-O
2896
+ is AUX B-O
2897
+ in ADP B-O
2898
+ excellent ADJ B-O
2899
+ agreement NOUN B-O
2900
+ with ADP B-O
2901
+ the DET B-O
2902
+ expected VERB B-O
2903
+ molecular ADJ B-O
2904
+ weight NOUN B-O
2905
+ of ADP B-O
2906
+ the DET B-O
2907
+ holoenzyme NOUN B-O
2908
+ , PUNCT B-O
2909
+ 28,705.88 NUM B-O
2910
+ Da PROPN B-AC
2911
+ . PUNCT B-O
2912
+
2913
+ As ADP B-O
2914
+ an DET B-O
2915
+ independent ADJ B-O
2916
+ confirmation NOUN B-O
2917
+ of ADP B-O
2918
+ these DET B-O
2919
+ results NOUN B-O
2920
+ , PUNCT B-O
2921
+ an DET B-O
2922
+ electrospray NOUN B-LF
2923
+ ionization NOUN I-LF
2924
+ ( PUNCT B-O
2925
+ ESI PROPN B-AC
2926
+ ) PUNCT B-O
2927
+ mass NOUN B-O
2928
+ spectrum NOUN B-O
2929
+ was AUX B-O
2930
+ acquired VERB B-O
2931
+ for ADP B-O
2932
+ APS PROPN B-AC
2933
+ reductase NOUN B-O
2934
+ . PUNCT B-O
2935
+
2936
+ Real ADJ B-O
2937
+ - PUNCT B-O
2938
+ time NOUN B-O
2939
+ reverse ADJ B-O
2940
+ transcription NOUN B-O
2941
+ PCR NOUN B-O
2942
+ ( PUNCT B-O
2943
+ qPCR NOUN B-O
2944
+ ) PUNCT B-O
2945
+ normalized VERB B-O
2946
+ to ADP B-O
2947
+ an DET B-O
2948
+ internal ADJ B-O
2949
+ reference NOUN B-LF
2950
+ gene NOUN I-LF
2951
+ ( PUNCT B-O
2952
+ RG PROPN B-AC
2953
+ ) PUNCT B-O
2954
+ , PUNCT B-O
2955
+ is AUX B-O
2956
+ a DET B-O
2957
+ frequently ADV B-O
2958
+ used VERB B-O
2959
+ method NOUN B-O
2960
+ for ADP B-O
2961
+ quantifying VERB B-O
2962
+ gene NOUN B-O
2963
+ expression NOUN B-O
2964
+ changes NOUN B-O
2965
+ in ADP B-O
2966
+ neuroscience NOUN B-O
2967
+ . PUNCT B-O
2968
+
2969
+ Consensus NOUN B-O
2970
+ documents NOUN B-O
2971
+ developed VERB B-O
2972
+ by ADP B-O
2973
+ professional ADJ B-O
2974
+ societies NOUN B-O
2975
+ from ADP B-O
2976
+ the DET B-O
2977
+ US PROPN B-O
2978
+ , PUNCT B-O
2979
+ Europe PROPN B-O
2980
+ , PUNCT B-O
2981
+ and CCONJ B-O
2982
+ Canada PROPN B-O
2983
+ [ X B-O
2984
+ 9–12 NUM B-O
2985
+ ] X B-O
2986
+ have AUX B-O
2987
+ cautioned VERB B-O
2988
+ against ADP B-O
2989
+ generic ADJ B-O
2990
+ immunosuppressant ADJ B-O
2991
+ use NOUN B-O
2992
+ , PUNCT B-O
2993
+ citing VERB B-O
2994
+ ( PUNCT B-O
2995
+ 1 X B-O
2996
+ ) PUNCT B-O
2997
+ the DET B-O
2998
+ lack NOUN B-O
2999
+ of ADP B-O
3000
+ data NOUN B-O
3001
+ in ADP B-O
3002
+ transplant NOUN B-O
3003
+ recipients NOUN B-O
3004
+ , PUNCT B-O
3005
+ especially ADV B-O
3006
+ “ PUNCT B-O
3007
+ high ADJ B-O
3008
+ risk NOUN B-O
3009
+ ” PUNCT B-O
3010
+ transplant NOUN B-O
3011
+ recipients NOUN B-O
3012
+ ; PUNCT B-O
3013
+ ( PUNCT B-O
3014
+ 2 X B-O
3015
+ ) PUNCT B-O
3016
+ the DET B-O
3017
+ need NOUN B-O
3018
+ to PART B-O
3019
+ implement VERB B-O
3020
+ stricter ADJ B-O
3021
+ bioequivalence NOUN B-O
3022
+ standards NOUN B-O
3023
+ , PUNCT B-O
3024
+ as SCONJ B-O
3025
+ tacrolimus PROPN B-O
3026
+ is AUX B-O
3027
+ a DET B-O
3028
+ narrow ADJ B-LF
3029
+ therapeutic ADJ I-LF
3030
+ index NOUN I-LF
3031
+ ( PUNCT B-O
3032
+ NTI PROPN B-AC
3033
+ ) PUNCT B-O
3034
+ drug NOUN B-O
3035
+ for ADP B-O
3036
+ which PRON B-O
3037
+ small ADJ B-O
3038
+ changes NOUN B-O
3039
+ in ADP B-O
3040
+ dose NOUN B-O
3041
+ or CCONJ B-O
3042
+ exposure NOUN B-O
3043
+ can AUX B-O
3044
+ result VERB B-O
3045
+ in ADP B-O
3046
+ therapeutic ADJ B-O
3047
+ failure NOUN B-O
3048
+ or CCONJ B-O
3049
+ toxicity NOUN B-O
3050
+ ; PUNCT B-O
3051
+ and CCONJ B-O
3052
+ ( PUNCT B-O
3053
+ 3 X B-O
3054
+ ) PUNCT B-O
3055
+ the DET B-O
3056
+ lack NOUN B-O
3057
+ of ADP B-O
3058
+ bioequivalence NOUN B-O
3059
+ data NOUN B-O
3060
+ between ADP B-O
3061
+ generics NOUN B-O
3062
+ . PUNCT B-O
3063
+
3064
+ Ductal ADJ B-LF
3065
+ carcinoma NOUN I-LF
3066
+ in ADP I-LF
3067
+ situ NOUN I-LF
3068
+ ( PUNCT B-O
3069
+ DCIS PROPN B-AC
3070
+ ) PUNCT B-O
3071
+ , PUNCT B-O
3072
+ a DET B-O
3073
+ noninvasive ADJ B-O
3074
+ nonobligate ADJ B-O
3075
+ precursor NOUN B-O
3076
+ of ADP B-O
3077
+ breast NOUN B-O
3078
+ cancer NOUN B-O
3079
+ , PUNCT B-O
3080
+ accounts VERB B-O
3081
+ for ADP B-O
3082
+ about ADV B-O
3083
+ 25 NUM B-O
3084
+ % NOUN B-O
3085
+ of ADP B-O
3086
+ all DET B-O
3087
+ breast NOUN B-O
3088
+ cancer NOUN B-O
3089
+ cases NOUN B-O
3090
+ [ PUNCT B-O
3091
+ 38 NUM B-O
3092
+ ] PUNCT B-O
3093
+ . PUNCT B-O
3094
+
3095
+ Indeed ADV B-O
3096
+ , PUNCT B-O
3097
+ as SCONJ B-O
3098
+ expected VERB B-O
3099
+ , PUNCT B-O
3100
+ pretreatment NOUN B-O
3101
+ of ADP B-O
3102
+ Hsp26 PROPN B-O
3103
+ for ADP B-O
3104
+ 10 NUM B-O
3105
+ min NOUN B-O
3106
+ at ADP B-O
3107
+ 45 NUM B-O
3108
+ ° NOUN B-O
3109
+ C NOUN B-O
3110
+ increased VERB B-O
3111
+ the DET B-O
3112
+ ability NOUN B-O
3113
+ of ADP B-O
3114
+ Hsp26 PROPN B-O
3115
+ to ADP B-O
3116
+ suppress VERB B-O
3117
+ aggregation NOUN B-O
3118
+ of ADP B-O
3119
+ glutamate NOUN B-LF
3120
+ dehydrogenase NOUN I-LF
3121
+ ( PUNCT B-O
3122
+ GDH PROPN B-AC
3123
+ ) PUNCT B-O
3124
+ ( PUNCT B-O
3125
+ Figure PROPN B-O
3126
+ 6D NUM B-O
3127
+ ) PUNCT B-O
3128
+ . PUNCT B-O
3129
+
3130
+ By ADP B-O
3131
+ contrast NOUN B-O
3132
+ , PUNCT B-O
3133
+ the DET B-O
3134
+ same ADJ B-O
3135
+ pretreatment NOUN B-O
3136
+ reduced VERB B-O
3137
+ the DET B-O
3138
+ ability NOUN B-O
3139
+ of ADP B-O
3140
+ Hsp26 PROPN B-O
3141
+ to ADP B-O
3142
+ inhibit VERB B-O
3143
+ spontaneous ADJ B-O
3144
+ NM NOUN B-O
3145
+ assembly NOUN B-O
3146
+ ( PUNCT B-O
3147
+ Figure PROPN B-O
3148
+ 6D NUM B-O
3149
+ ) PUNCT B-O
3150
+ . PUNCT B-O
3151
+
3152
+ Thus ADV B-O
3153
+ , PUNCT B-O
3154
+ at ADP B-O
3155
+ elevated VERB B-O
3156
+ temperatures NOUN B-O
3157
+ Hsp26 PROPN B-O
3158
+ might AUX B-O
3159
+ switch VERB B-O
3160
+ from ADP B-O
3161
+ inhibiting VERB B-O
3162
+ prion NOUN B-O
3163
+ assembly NOUN B-O
3164
+ to ADP B-O
3165
+ suppressing VERB B-O
3166
+ aggregation NOUN B-O
3167
+ of ADP B-O
3168
+ denatured VERB B-O
3169
+ substrates NOUN B-O
3170
+ . PUNCT B-O
3171
+
3172
+ The DET B-O
3173
+ results NOUN B-O
3174
+ demonstrated VERB B-O
3175
+ that SCONJ B-O
3176
+ this DET B-O
3177
+ human ADJ B-O
3178
+ LCM PROPN B-AC
3179
+ gene NOUN B-O
3180
+ set NOUN B-O
3181
+ was AUX B-O
3182
+ significantly ADV B-O
3183
+ decreased VERB B-O
3184
+ in ADP B-O
3185
+ the DET B-O
3186
+ STHdhQ111 NOUN B-O
3187
+ / SYM B-O
3188
+ Q111 NOUN B-O
3189
+ cells NOUN B-O
3190
+ ( PUNCT B-O
3191
+ enrichment NOUN B-LF
3192
+ score NOUN I-LF
3193
+ [ X B-O
3194
+ ES PROPN B-AC
3195
+ ] X B-O
3196
+ 0.51 NUM B-O
3197
+ , PUNCT B-O
3198
+ p NOUN B-O
3199
+ - NOUN B-O
3200
+ value NOUN B-O
3201
+ 0.000 NUM B-O
3202
+ , PUNCT B-O
3203
+ FDR PROPN B-AC
3204
+ q NOUN B-O
3205
+ - NOUN B-O
3206
+ value NOUN B-O
3207
+ 0.180 NUM B-O
3208
+ ) PUNCT B-O
3209
+ but CCONJ B-O
3210
+ was AUX B-O
3211
+ not PART B-O
3212
+ altered VERB B-O
3213
+ in ADP B-O
3214
+ the DET B-O
3215
+ 3 PROPN B-AC
3216
+ treated VERB B-O
3217
+ cells NOUN B-O
3218
+ ( PUNCT B-O
3219
+ -NPES PROPN B-AC
3220
+ 0.38 NUM B-O
3221
+ , PUNCT B-O
3222
+ p NOUN B-O
3223
+ - NOUN B-O
3224
+ value NOUN B-O
3225
+ 0.271 NUM B-O
3226
+ , PUNCT B-O
3227
+ FDR PROPN B-AC
3228
+ q NOUN B-O
3229
+ - NOUN B-O
3230
+ value NOUN B-O
3231
+ 0.713 NUM B-O
3232
+ ) PUNCT B-O
3233
+ . PUNCT B-O
3234
+
3235
+ BP PROPN B-AC
3236
+ : PUNCT B-O
3237
+ blood NOUN B-LF
3238
+ pressure NOUN I-LF
3239
+ . PUNCT B-O
3240
+
3241
+ In ADP B-O
3242
+ pemphigus NOUN B-LF
3243
+ vulgaris PROPN I-LF
3244
+ ( PUNCT B-O
3245
+ PV PROPN B-AC
3246
+ ) PUNCT B-O
3247
+ , PUNCT B-O
3248
+ the DET B-O
3249
+ most ADV B-O
3250
+ common ADJ B-O
3251
+ clinical ADJ B-O
3252
+ variant NOUN B-O
3253
+ of ADP B-O
3254
+ pemphigus NOUN B-O
3255
+ , PUNCT B-O
3256
+ several ADJ B-O
3257
+ in ADP B-O
3258
+ vitro ADJ B-O
3259
+ and CCONJ B-O
3260
+ in ADP B-O
3261
+ vivo ADJ B-O
3262
+ studies NOUN B-O
3263
+ demonstrated VERB B-O
3264
+ the DET B-O
3265
+ critical ADJ B-O
3266
+ role NOUN B-O
3267
+ of ADP B-O
3268
+ Dsg3 NOUN B-O
3269
+ - NOUN B-O
3270
+ specific ADJ B-O
3271
+ CD4 NOUN B-O
3272
+ + NOUN B-O
3273
+ T NOUN B-O
3274
+ cells NOUN B-O
3275
+ in ADP B-O
3276
+ the DET B-O
3277
+ generation NOUN B-O
3278
+ of ADP B-O
3279
+ Dsg3 NOUN B-O
3280
+ - NOUN B-O
3281
+ specific ADJ B-O
3282
+ auto-ab PROPN B-AC
3283
+ [ X B-O
3284
+ 4–9 NUM B-O
3285
+ ] PUNCT B-O
3286
+ . PUNCT B-O
3287
+
3288
+ I PRON B-O
3289
+ employed VERB B-O
3290
+ a DET B-O
3291
+ Z NOUN B-O
3292
+ - PUNCT B-O
3293
+ score NOUN B-O
3294
+ measure NOUN B-O
3295
+ of ADP B-O
3296
+ structural ADJ B-O
3297
+ proximity NOUN B-O
3298
+ as ADP B-O
3299
+ weight NOUN B-O
3300
+ for ADP B-O
3301
+ the DET B-O
3302
+ edges NOUN B-O
3303
+ to PART B-O
3304
+ create VERB B-O
3305
+ a DET B-O
3306
+ protein NOUN B-LF
3307
+ domains NOUN I-LF
3308
+ universe NOUN I-LF
3309
+ graph NOUN I-LF
3310
+ ( PUNCT B-O
3311
+ PDUG PROPN B-AC
3312
+ [ PUNCT B-O
3313
+ 19 NUM B-O
3314
+ ] PUNCT B-O
3315
+ ) PUNCT B-O
3316
+ . PUNCT B-O
3317
+
3318
+ The DET B-O
3319
+ VHL PROPN B-AC
3320
+ mutation NOUN B-O
3321
+ diminishes VERB B-O
3322
+ VHL PROPN B-AC
3323
+ 's PART B-O
3324
+ binding VERB B-O
3325
+ affinity NOUN B-O
3326
+ for ADP B-O
3327
+ hydroxylated VERB B-O
3328
+ HIF PROPN B-AC
3329
+ - PUNCT B-O
3330
+ α PUNCT B-O
3331
+ , PUNCT B-O
3332
+ thereby ADV B-O
3333
+ partially ADV B-O
3334
+ inhibiting VERB B-O
3335
+ HIF PROPN B-AC
3336
+ - PUNCT B-O
3337
+ α PUNCT B-O
3338
+ degradation NOUN B-O
3339
+ and CCONJ B-O
3340
+ pathologically ADV B-O
3341
+ up ADV B-O
3342
+ - PUNCT B-O
3343
+ regulating VERB B-O
3344
+ HIF PROPN B-AC
3345
+ target NOUN B-O
3346
+ genes NOUN B-O
3347
+ including VERB B-O
3348
+ erythropoietin NOUN B-LF
3349
+ ( PUNCT B-O
3350
+ EPO PROPN B-AC
3351
+ ) PUNCT B-O
3352
+ [ PUNCT B-O
3353
+ 8 NUM B-O
3354
+ ] PUNCT B-O
3355
+ . PUNCT B-O
3356
+
3357
+ Abbreviations NOUN B-O
3358
+ : PUNCT B-O
3359
+ BMI PROPN B-AC
3360
+ , PUNCT B-O
3361
+ body NOUN B-LF
3362
+ mass NOUN I-LF
3363
+ index NOUN I-LF
3364
+ ; PUNCT B-O
3365
+ HR NOUN B-O
3366
+ , PUNCT B-O
3367
+ hazard NOUN B-O
3368
+ ratio NOUN B-O
3369
+ ; PUNCT B-O
3370
+ ICS PROPN B-AC
3371
+ , PUNCT B-O
3372
+ inhaled VERB B-LF
3373
+ corticosteroid NOUN I-LF
3374
+ ; PUNCT B-O
3375
+ LABA PROPN B-AC
3376
+ , PUNCT B-O
3377
+ long ADV B-LF
3378
+ - PUNCT I-LF
3379
+ acting VERB I-LF
3380
+ beta NOUN I-LF
3381
+ - PUNCT I-LF
3382
+ agonist NOUN I-LF
3383
+ . PUNCT B-O
3384
+
3385
+ Information NOUN B-O
3386
+ is AUX B-O
3387
+ available ADJ B-O
3388
+ from ADP B-O
3389
+ Avert PROPN B-O
3390
+ , PUNCT B-O
3391
+ an DET B-O
3392
+ international ADJ B-O
3393
+ AIDS PROPN B-O
3394
+ charity NOUN B-O
3395
+ , PUNCT B-O
3396
+ on ADP B-O
3397
+ many ADJ B-O
3398
+ aspects NOUN B-O
3399
+ of ADP B-O
3400
+ HIV PROPN B-O
3401
+ / SYM B-O
3402
+ AIDS PROPN B-O
3403
+ , PUNCT B-O
3404
+ including VERB B-O
3405
+ information NOUN B-O
3406
+ on ADP B-O
3407
+ antiretroviral ADJ B-LF
3408
+ drugs NOUN B-O
3409
+ and CCONJ B-O
3410
+ on ADP B-O
3411
+ universal ADJ B-O
3412
+ access NOUN B-O
3413
+ to ADP B-O
3414
+ ARV PROPN B-AC
3415
+ therapy NOUN B-O
3416
+ ; PUNCT B-O
3417
+ Avert PROPN B-O
3418
+ also ADV B-O
3419
+ provides VERB B-O
3420
+ personal ADJ B-O
3421
+ stories NOUN B-O
3422
+ about ADP B-O
3423
+ living VERB B-O
3424
+ with ADP B-O
3425
+ HIV PROPN B-O
3426
+ / SYM B-O
3427
+ AIDS PROPN B-O
3428
+ The DET B-O
3429
+ efficiency NOUN B-O
3430
+ of ADP B-O
3431
+ siRNA NOUN B-O
3432
+ delivery NOUN B-O
3433
+ was AUX B-O
3434
+ checked VERB B-O
3435
+ with ADP B-O
3436
+ fluorescent ADJ B-O
3437
+ siGLO NOUN B-O
3438
+ . PUNCT B-O
3439
+
3440
+ Among ADP B-O
3441
+ these DET B-O
3442
+ siRNAs NOUN B-O
3443
+ , PUNCT B-O
3444
+ only ADV B-O
3445
+ those PRON B-O
3446
+ silencing VERB B-O
3447
+ the DET B-O
3448
+ Ca2 NOUN B-O
3449
+ + NOUN B-O
3450
+ -independent ADJ B-O
3451
+ Group PROPN B-LF
3452
+ VIIIA PROPN I-LF
3453
+ ( PUNCT B-O
3454
+ GVIIIA)-PLA2 PROPN B-AC
3455
+ inhibited VERB B-O
3456
+ VSVG PROPN B-AC
3457
+ transport NOUN B-O
3458
+ , PUNCT B-O
3459
+ resulting VERB B-O
3460
+ in ADP B-O
3461
+ accumulation NOUN B-O
3462
+ of ADP B-O
3463
+ cargo NOUN B-O
3464
+ within ADP B-O
3465
+ the DET B-O
3466
+ Golgi PROPN B-O
3467
+ complex NOUN B-O
3468
+ ( PUNCT B-O
3469
+ Figure NOUN B-O
3470
+ 8L NUM B-O
3471
+ and CCONJ B-O
3472
+ 8P NOUN B-O
3473
+ ) PUNCT B-O
3474
+ . PUNCT B-O
3475
+
3476
+ Strikingly ADV B-O
3477
+ , PUNCT B-O
3478
+ this DET B-O
3479
+ PLA2 PROPN B-AC
3480
+ isoform NOUN B-O
3481
+ has AUX B-O
3482
+ been AUX B-O
3483
+ detected VERB B-O
3484
+ by ADP B-O
3485
+ others NOUN B-O
3486
+ at ADP B-O
3487
+ the DET B-O
3488
+ Golgi PROPN B-O
3489
+ membranes NOUN B-O
3490
+ and CCONJ B-O
3491
+ appears VERB B-O
3492
+ to PART B-O
3493
+ be AUX B-O
3494
+ important ADJ B-O
3495
+ for ADP B-O
3496
+ maintenance NOUN B-O
3497
+ of ADP B-O
3498
+ the DET B-O
3499
+ tubular ADJ B-O
3500
+ elements NOUN B-O
3501
+ of ADP B-O
3502
+ the DET B-O
3503
+ Golgi PROPN B-O
3504
+ complex NOUN B-O
3505
+ ( PUNCT B-O
3506
+ W. PROPN B-O
3507
+ The DET B-O
3508
+ main ADJ B-O
3509
+ outcome NOUN B-O
3510
+ is AUX B-O
3511
+ whether SCONJ B-O
3512
+ baseline NOUN B-O
3513
+ participants NOUN B-O
3514
+ received VERB B-O
3515
+ RPC PROPN B-AC
3516
+ ( PUNCT B-O
3517
+ includes VERB B-O
3518
+ both CCONJ B-O
3519
+ pan ADJ B-O
3520
+ - PUNCT B-O
3521
+ retinal ADJ B-LF
3522
+ photocoagulation NOUN I-LF
3523
+ and CCONJ B-O
3524
+ focal ADJ B-O
3525
+ retinal ADJ B-O
3526
+ treatment NOUN B-O
3527
+ for ADP B-O
3528
+ macular ADJ B-O
3529
+ edema NOUN B-O
3530
+ ) PUNCT B-O
3531
+ during ADP B-O
3532
+ the DET B-O
3533
+ follow NOUN B-O
3534
+ - PUNCT B-O
3535
+ up ADP B-O
3536
+ period NOUN B-O
3537
+ , PUNCT B-O
3538
+ which PRON B-O
3539
+ is AUX B-O
3540
+ an DET B-O
3541
+ indicator NOUN B-O
3542
+ of ADP B-O
3543
+ progression NOUN B-O
3544
+ to ADP B-O
3545
+ sNPDR PROPN B-AC
3546
+ or CCONJ B-O
3547
+ PDR PROPN B-AC
3548
+ . PUNCT B-O
3549
+
3550
+ A DET B-O
3551
+ participant NOUN B-O
3552
+ who PRON B-O
3553
+ had AUX B-O
3554
+ at ADV B-O
3555
+ least ADV B-O
3556
+ one NUM B-O
3557
+ retinal ADJ B-O
3558
+ laser NOUN B-O
3559
+ treatment NOUN B-O
3560
+ record NOUN B-O
3561
+ in ADP B-O
3562
+ the DET B-O
3563
+ MBS PROPN B-AC
3564
+ database NOUN B-O
3565
+ ( PUNCT B-O
3566
+ MBS PROPN B-AC
3567
+ code NOUN B-O
3568
+ for ADP B-O
3569
+ RPC PROPN B-AC
3570
+ : PUNCT B-O
3571
+ 42809 NUM B-O
3572
+ ) PUNCT B-O
3573
+ were AUX B-O
3574
+ defined VERB B-O
3575
+ as SCONJ B-O
3576
+ had AUX B-O
3577
+ undergone VERB B-O
3578
+ RPC PROPN B-AC
3579
+ . PUNCT B-O
3580
+
3581
+ The DET B-O
3582
+ date NOUN B-O
3583
+ of ADP B-O
3584
+ first ADJ B-O
3585
+ laser NOUN B-O
3586
+ treatment NOUN B-O
3587
+ was AUX B-O
3588
+ utilized VERB B-O
3589
+ for ADP B-O
3590
+ analysis NOUN B-O
3591
+ if SCONJ B-O
3592
+ the DET B-O
3593
+ patient NOUN B-O
3594
+ underwent VERB B-O
3595
+ multiple ADJ B-O
3596
+ RPC PROPN B-AC
3597
+ treatments NOUN B-O
3598
+ . PUNCT B-O
3599
+
3600
+ Chronic ADJ B-O
3601
+ airflow NOUN B-O
3602
+ limitation NOUN B-O
3603
+ was AUX B-O
3604
+ defined VERB B-O
3605
+ as ADP B-O
3606
+ FEV1 PROPN B-AC
3607
+ / SYM B-O
3608
+ FVC PROPN B-AC
3609
+ below ADP B-O
3610
+ the DET B-O
3611
+ 5th ADJ B-O
3612
+ percentile NOUN B-O
3613
+ ( PUNCT B-O
3614
+ lower ADJ B-O
3615
+ limit NOUN B-O
3616
+ of ADP B-O
3617
+ normal ADJ B-O
3618
+ ; PUNCT B-O
3619
+ LLN PROPN B-AC
3620
+ ) PUNCT B-O
3621
+ . PUNCT B-O
3622
+
3623
+ Diffusing VERB B-LF
3624
+ lung NOUN I-LF
3625
+ capacity NOUN I-LF
3626
+ for ADP I-LF
3627
+ carbon NOUN I-LF
3628
+ monoxide NOUN I-LF
3629
+ ( PUNCT B-O
3630
+ DLCO PROPN B-AC
3631
+ ) PUNCT B-O
3632
+ and CCONJ B-O
3633
+ the DET B-O
3634
+ DLCO PROPN B-AC
3635
+ corrected VERB B-O
3636
+ for ADP B-O
3637
+ lung NOUN B-O
3638
+ volume NOUN B-O
3639
+ ( PUNCT B-O
3640
+ DLCO PROPN B-AC
3641
+ ) PUNCT B-O
3642
+ were AUX B-O
3643
+ measured VERB B-O
3644
+ using VERB B-O
3645
+ a DET B-O
3646
+ single ADJ B-O
3647
+ breath NOUN B-O
3648
+ carbon NOUN B-O
3649
+ monoxide NOUN B-O
3650
+ diffusion NOUN B-O
3651
+ test NOUN B-O
3652
+ and CCONJ B-O
3653
+ were AUX B-O
3654
+ adjusted VERB B-O
3655
+ for ADP B-O
3656
+ plasma NOUN B-O
3657
+ haemoglobin NOUN B-O
3658
+ level.[20 NOUN B-O
3659
+ ] X B-O
3660
+ Inspiratory ADJ B-LF
3661
+ capacity NOUN I-LF
3662
+ ( PUNCT B-O
3663
+ /VAIC PROPN B-AC
3664
+ ) PUNCT B-O
3665
+ was AUX B-O
3666
+ calculated VERB B-O
3667
+ as ADP B-O
3668
+ the DET B-O
3669
+ total ADJ B-LF
3670
+ lung NOUN I-LF
3671
+ capacity NOUN I-LF
3672
+ ( PUNCT B-O
3673
+ TLC PROPN B-AC
3674
+ ) PUNCT B-O
3675
+ minus CCONJ B-O
3676
+ the DET B-O
3677
+ functional ADJ B-LF
3678
+ residual ADJ I-LF
3679
+ capacity NOUN I-LF
3680
+ ( PUNCT B-O
3681
+ FRC PROPN B-AC
3682
+ ) PUNCT B-O
3683
+ . PUNCT B-O
3684
+
3685
+ All DET B-O
3686
+ lung NOUN B-O
3687
+ function NOUN B-O
3688
+ measures NOUN B-O
3689
+ were AUX B-O
3690
+ expressed VERB B-O
3691
+ as ADP B-O
3692
+ absolute ADJ B-O
3693
+ values NOUN B-O
3694
+ and CCONJ B-O
3695
+ relative ADJ B-O
3696
+ values NOUN B-O
3697
+ ( PUNCT B-O
3698
+ percentage NOUN B-O
3699
+ of ADP B-O
3700
+ predicted VERB B-O
3701
+ ; PUNCT B-O
3702
+ % NOUN B-O
3703
+ pred).[20–24 X B-O
3704
+ ] X B-O
3705
+ The DET B-O
3706
+ extent NOUN B-O
3707
+ of ADP B-O
3708
+ dysanapsis NOUN B-O
3709
+ was AUX B-O
3710
+ calculated VERB B-O
3711
+ using VERB B-O
3712
+ the DET B-O
3713
+ formula NOUN B-O
3714
+ of ADP B-O
3715
+ Mead PROPN B-O
3716
+ et PROPN B-O
3717
+ al.[8 X B-O
3718
+ , PUNCT B-O
3719
+ 9 NUM B-O
3720
+ , PUNCT B-O
3721
+ 25 NUM B-O
3722
+ ] X B-O
3723
+ Results NOUN B-O
3724
+ from ADP B-O
3725
+ the DET B-O
3726
+ PSA PROPN B-AC
3727
+ give VERB B-O
3728
+ slightly ADV B-O
3729
+ greater ADJ B-O
3730
+ mean ADJ B-O
3731
+ effects NOUN B-O
3732
+ for ADP B-O
3733
+ both CCONJ B-O
3734
+ the DET B-O
3735
+ routine ADJ B-O
3736
+ / SYM B-O
3737
+ manual ADJ B-O
3738
+ ( PUNCT B-O
3739
+ current ADJ B-O
3740
+ tax NOUN B-O
3741
+ increase NOUN B-O
3742
+ , NOUN B-O
3743
+ −3.6 NUM B-O
3744
+ % NOUN B-O
3745
+ [ PUNCT B-O
3746
+ 95 NUM B-O
3747
+ % NOUN B-O
3748
+ uncertainty NOUN B-LF
3749
+ interval NOUN I-LF
3750
+ ( PUNCT B-O
3751
+ UI PROPN B-AC
3752
+ ) PUNCT B-O
3753
+ −6.1 NUM B-O
3754
+ % NOUN B-O
3755
+ , NOUN B-O
3756
+ −0.6 NUM B-O
3757
+ % NOUN B-O
3758
+ ] PUNCT B-O
3759
+ ; PUNCT B-O
3760
+ value NOUN B-O
3761
+ - PUNCT B-O
3762
+ based VERB B-O
3763
+ tax NOUN B-O
3764
+ , NOUN B-O
3765
+ −3.3 NUM B-O
3766
+ % NOUN B-O
3767
+ [ PUNCT B-O
3768
+ UI PROPN B-AC
3769
+ −5.1 NUM B-O
3770
+ % NOUN B-O
3771
+ , NOUN B-O
3772
+ −1.7 NUM B-O
3773
+ % NOUN B-O
3774
+ ] PUNCT B-O
3775
+ ; PUNCT B-O
3776
+ strength NOUN B-O
3777
+ - PUNCT B-O
3778
+ based VERB B-O
3779
+ tax NOUN B-O
3780
+ , NOUN B-O
3781
+ −7.5 NUM B-O
3782
+ % NOUN B-O
3783
+ [ PUNCT B-O
3784
+ UI PROPN B-AC
3785
+ −13.7 NUM B-O
3786
+ % NOUN B-O
3787
+ , NOUN B-O
3788
+ −3.9 NUM B-O
3789
+ % NOUN B-O
3790
+ ] PUNCT B-O
3791
+ ; PUNCT B-O
3792
+ minimum ADJ B-O
3793
+ unit NOUN B-O
3794
+ pricing NOUN B-O
3795
+ , NOUN B-O
3796
+ −10.3 NUM B-O
3797
+ % NOUN B-O
3798
+ [ PUNCT B-O
3799
+ UI PROPN B-AC
3800
+ −10.3 NUM B-O
3801
+ % NOUN B-O
3802
+ , NOUN B-O
3803
+ −7.0 NUM B-O
3804
+ % NOUN B-O
3805
+ ] PUNCT B-O
3806
+ ) PUNCT B-O
3807
+ and CCONJ B-O
3808
+ professional ADJ B-O
3809
+ / SYM B-O
3810
+ managerial ADJ B-O
3811
+ occupation NOUN B-O
3812
+ groups NOUN B-O
3813
+ ( PUNCT B-O
3814
+ current ADJ B-O
3815
+ tax NOUN B-O
3816
+ increase NOUN B-O
3817
+ , NOUN B-O
3818
+ −1.8 NUM B-O
3819
+ % NOUN B-O
3820
+ [ PUNCT B-O
3821
+ UI PROPN B-AC
3822
+ −4.7 NUM B-O
3823
+ % NOUN B-O
3824
+ , NOUN B-O
3825
+ +1.6 NUM B-O
3826
+ % NOUN B-O
3827
+ ] PUNCT B-O
3828
+ ; PUNCT B-O
3829
+ value NOUN B-O
3830
+ - PUNCT B-O
3831
+ based VERB B-O
3832
+ tax NOUN B-O
3833
+ , NOUN B-O
3834
+ −1.9 NUM B-O
3835
+ % NOUN B-O
3836
+ [ PUNCT B-O
3837
+ UI PROPN B-AC
3838
+ −3.6 NUM B-O
3839
+ % NOUN B-O
3840
+ , NOUN B-O
3841
+ +0.4 NUM B-O
3842
+ % NOUN B-O
3843
+ ] PUNCT B-O
3844
+ ; PUNCT B-O
3845
+ strength NOUN B-O
3846
+ - PUNCT B-O
3847
+ based VERB B-O
3848
+ tax NOUN B-O
3849
+ , NOUN B-O
3850
+ −0.8 NUM B-O
3851
+ % NOUN B-O
3852
+ [ PUNCT B-O
3853
+ UI PROPN B-AC
3854
+ −6.9 NUM B-O
3855
+ % NOUN B-O
3856
+ , NOUN B-O
3857
+ +4.0 NUM B-O
3858
+ % NOUN B-O
3859
+ ] PUNCT B-O
3860
+ ; PUNCT B-O
3861
+ minimum ADJ B-O
3862
+ unit NOUN B-O
3863
+ pricing NOUN B-O
3864
+ , NOUN B-O
3865
+ −0.7 NUM B-O
3866
+ % NOUN B-O
3867
+ [ PUNCT B-O
3868
+ UI PROPN B-AC
3869
+ −5.6 NUM B-O
3870
+ % NOUN B-O
3871
+ , NOUN B-O
3872
+ +3.6 NUM B-O
3873
+ % NOUN B-O
3874
+ ] PUNCT B-O
3875
+ ) PUNCT B-O
3876
+ . PUNCT B-O
3877
+
3878
+ Chronic ADJ B-O
3879
+ hepatitis NOUN B-LF
3880
+ C PROPN I-LF
3881
+ virus NOUN I-LF
3882
+ ( PUNCT B-O
3883
+ HCV PROPN B-AC
3884
+ ) PUNCT B-O
3885
+ infection NOUN B-O
3886
+ is AUX B-O
3887
+ a DET B-O
3888
+ leading VERB B-O
3889
+ cause NOUN B-O
3890
+ of ADP B-O
3891
+ cirrhosis NOUN B-O
3892
+ , PUNCT B-O
3893
+ liver NOUN B-O
3894
+ failure NOUN B-O
3895
+ , PUNCT B-O
3896
+ and CCONJ B-O
3897
+ hepatocellular ADJ B-LF
3898
+ carcinoma NOUN I-LF
3899
+ ( PUNCT B-O
3900
+ HCC PROPN B-AC
3901
+ ) PUNCT B-O
3902
+ [ PUNCT B-O
3903
+ 1 NUM B-O
3904
+ , PUNCT B-O
3905
+ 2 NUM B-O
3906
+ ] PUNCT B-O
3907
+ . PUNCT B-O
3908
+
3909
+ DUSP1 PROPN B-AC
3910
+ has AUX B-O
3911
+ been AUX B-O
3912
+ shown VERB B-O
3913
+ to PART B-O
3914
+ attenuate VERB B-O
3915
+ MAPK PROPN B-AC
3916
+ signaling NOUN B-O
3917
+ , PUNCT B-O
3918
+ effectively ADV B-O
3919
+ reducing VERB B-O
3920
+ osteolysis NOUN B-O
3921
+ and CCONJ B-O
3922
+ cartilage NOUN B-O
3923
+ degeneration NOUN B-O
3924
+ in ADP B-O
3925
+ studies NOUN B-O
3926
+ utilizing VERB B-O
3927
+ mouse NOUN B-O
3928
+ models NOUN B-O
3929
+ of ADP B-O
3930
+ lipopolysaccharide NOUN B-O
3931
+ ( PUNCT B-O
3932
+ LPS PROPN B-AC
3933
+ ) PUNCT B-O
3934
+ induced VERB B-O
3935
+ inflammatory ADJ B-O
3936
+ bone NOUN B-O
3937
+ loss NOUN B-O
3938
+ and CCONJ B-O
3939
+ collagen NOUN B-LF
3940
+ induced VERB I-LF
3941
+ arthritis NOUN I-LF
3942
+ ( PUNCT B-O
3943
+ CIA PROPN B-AC
3944
+ ) PUNCT B-O
3945
+ [ PUNCT B-O
3946
+ 16,19,20 NUM B-O
3947
+ ] PUNCT B-O
3948
+ . PUNCT B-O
3949
+
3950
+ Genomic ADJ B-O
3951
+ DNA PROPN B-O
3952
+ was AUX B-O
3953
+ extracted VERB B-O
3954
+ from ADP B-O
3955
+ young ADJ B-O
3956
+ leaves NOUN B-O
3957
+ of ADP B-O
3958
+ these DET B-O
3959
+ above ADV B-O
3960
+ mentioned VERB B-O
3961
+ accessions NOUN B-O
3962
+ using VERB B-O
3963
+ a DET B-O
3964
+ modified VERB B-O
3965
+ cetyltrimethyl NOUN B-LF
3966
+ ammonium NOUN I-LF
3967
+ bromide NOUN I-LF
3968
+ ( PUNCT B-O
3969
+ CTAB PROPN B-AC
3970
+ ) PUNCT B-O
3971
+ method NOUN B-O
3972
+ . PUNCT B-O
3973
+
3974
+ The DET B-O
3975
+ median ADJ B-O
3976
+ age NOUN B-O
3977
+ at ADP B-O
3978
+ first ADJ B-O
3979
+ admission NOUN B-O
3980
+ was AUX B-O
3981
+ 6 NUM B-O
3982
+ months NOUN B-O
3983
+ ( PUNCT B-O
3984
+ interquartile ADJ B-LF
3985
+ range NOUN I-LF
3986
+ [ X B-O
3987
+ IQR PROPN B-AC
3988
+ ] X B-O
3989
+ 2–14 NUM B-O
3990
+ ) PUNCT B-O
3991
+ , PUNCT B-O
3992
+ and CCONJ B-O
3993
+ the DET B-O
3994
+ commonest ADJ B-O
3995
+ code NOUN B-O
3996
+ linked VERB B-O
3997
+ to ADP B-O
3998
+ the DET B-O
3999
+ first ADJ B-O
4000
+ and CCONJ B-O
4001
+ all DET B-O
4002
+ admissions NOUN B-O
4003
+ was AUX B-O
4004
+ urinary ADJ B-LF
4005
+ tract NOUN I-LF
4006
+ infection NOUN I-LF
4007
+ ( PUNCT B-O
4008
+ UTI PROPN B-AC
4009
+ ; PUNCT B-O
4010
+ ICD-10 PROPN B-AC
4011
+ codes NOUN B-O
4012
+ N39.0 NUM B-O
4013
+ , PUNCT B-O
4014
+ N39.1 NUM B-O
4015
+ , PUNCT B-O
4016
+ or CCONJ B-O
4017
+ P39.3 NUM B-O
4018
+ ) PUNCT B-O
4019
+ . PUNCT B-O
4020
+
4021
+ RS PROPN B-AC
4022
+ : PUNCT B-O
4023
+ retrospective ADJ B-LF
4024
+ . PUNCT B-O
4025
+
4026
+ These DET B-O
4027
+ two NUM B-O
4028
+ regions NOUN B-O
4029
+ of ADP B-O
4030
+ the DET B-O
4031
+ VE PROPN B-AC
4032
+ also ADV B-O
4033
+ show VERB B-O
4034
+ differences NOUN B-O
4035
+ in ADP B-O
4036
+ localisation NOUN B-O
4037
+ of ADP B-O
4038
+ the DET B-O
4039
+ molecular ADJ B-O
4040
+ motors NOUN B-O
4041
+ F PROPN B-O
4042
+ - NOUN B-O
4043
+ actin NOUN B-O
4044
+ and CCONJ B-O
4045
+ Myosin PROPN B-O
4046
+ IIA PROPN B-O
4047
+ , PUNCT B-O
4048
+ and CCONJ B-O
4049
+ the DET B-O
4050
+ Planar PROPN B-LF
4051
+ Cell PROPN I-LF
4052
+ Polarity PROPN I-LF
4053
+ ( PUNCT B-O
4054
+ PCP PROPN B-AC
4055
+ ) PUNCT B-O
4056
+ signalling NOUN B-O
4057
+ molecules NOUN B-O
4058
+ Dishevelled-2 PROPN B-LF
4059
+ ( PUNCT B-O
4060
+ Dvl-2 PROPN B-AC
4061
+ ) PUNCT B-O
4062
+ and CCONJ B-O
4063
+ Vangl2 PROPN B-O
4064
+ [ PUNCT B-O
4065
+ 20 NUM B-O
4066
+ ] PUNCT B-O
4067
+ . PUNCT B-O
4068
+
4069
+ Human ADJ B-O
4070
+ and CCONJ B-O
4071
+ mouse NOUN B-O
4072
+ B PROPN B-O
4073
+ cells NOUN B-O
4074
+ were AUX B-O
4075
+ activated VERB B-O
4076
+ with ADP B-O
4077
+ membrane NOUN B-O
4078
+ - PUNCT B-O
4079
+ tethered VERB B-O
4080
+ or CCONJ B-O
4081
+ soluble ADJ B-O
4082
+ mB PROPN B-O
4083
+ - PUNCT B-O
4084
+ Fab′–anti NOUN B-O
4085
+ - PUNCT B-O
4086
+ Ig NOUN B-O
4087
+ plus CCONJ B-O
4088
+ streptavidin NOUN B-O
4089
+ before ADP B-O
4090
+ staining VERB B-O
4091
+ for ADP B-O
4092
+ phosphorylated VERB B-LF
4093
+ WASP NOUN I-LF
4094
+ WASP PROPN B-AC
4095
+ ( PUNCT B-O
4096
+ pWASP PROPN B-AC
4097
+ ) PUNCT B-O
4098
+ and CCONJ B-O
4099
+ N-WASP PROPN B-AC
4100
+ ( PUNCT B-O
4101
+ pN PROPN B-AC
4102
+ ) PUNCT B-O
4103
+ . PUNCT B-O
4104
+
4105
+ Using VERB B-O
4106
+ total ADJ B-O
4107
+ internal ADJ B-O
4108
+ reflection NOUN B-O
4109
+ fluorescence NOUN B-O
4110
+ microscopy NOUN B-O
4111
+ ( PUNCT B-O
4112
+ TIRFM PROPN B-O
4113
+ ) PUNCT B-O
4114
+ , PUNCT B-O
4115
+ we PRON B-O
4116
+ analyzed VERB B-O
4117
+ the DET B-O
4118
+ distribution NOUN B-O
4119
+ and CCONJ B-O
4120
+ the DET B-O
4121
+ relative ADJ B-O
4122
+ levels NOUN B-O
4123
+ of ADP B-O
4124
+ -WASPpWASP PROPN B-AC
4125
+ and CCONJ B-O
4126
+ pN PROPN B-AC
4127
+ at ADP B-O
4128
+ the DET B-O
4129
+ surface NOUN B-O
4130
+ of ADP B-O
4131
+ B PROPN B-O
4132
+ cells NOUN B-O
4133
+ in ADP B-O
4134
+ contact NOUN B-O
4135
+ with ADP B-O
4136
+ the DET B-O
4137
+ mB PROPN B-O
4138
+ - PUNCT B-O
4139
+ Fab′–anti NOUN B-O
4140
+ - PUNCT B-O
4141
+ Ig NOUN B-O
4142
+ – PUNCT B-O
4143
+ tethered VERB B-O
4144
+ lipid NOUN B-O
4145
+ bilayer NOUN B-O
4146
+ ( PUNCT B-O
4147
+ B PROPN B-O
4148
+ - PUNCT B-O
4149
+ cell NOUN B-O
4150
+ contact NOUN B-O
4151
+ zone NOUN B-O
4152
+ ) PUNCT B-O
4153
+ . PUNCT B-O
4154
+
4155
+ This DET B-O
4156
+ study NOUN B-O
4157
+ is AUX B-O
4158
+ reported VERB B-O
4159
+ as ADP B-O
4160
+ per ADP B-O
4161
+ the DET B-O
4162
+ Strengthening VERB B-LF
4163
+ the DET I-LF
4164
+ Reporting PROPN I-LF
4165
+ of ADP I-LF
4166
+ Observational PROPN I-LF
4167
+ Studies PROPN I-LF
4168
+ in ADP I-LF
4169
+ Epidemiology PROPN I-LF
4170
+ ( PUNCT B-O
4171
+ STROBE PROPN B-AC
4172
+ ) PUNCT B-O
4173
+ guidelines NOUN B-O
4174
+ ( PUNCT B-O
4175
+ S1 PROPN B-O
4176
+ STROBE PROPN B-AC
4177
+ Checklist PROPN B-O
4178
+ ) PUNCT B-O
4179
+ . PUNCT B-O
4180
+
4181
+ SARS PROPN B-AC
4182
+ -CoV-2 PROPN B-AC
4183
+ entry NOUN B-O
4184
+ into ADP B-O
4185
+ cells NOUN B-O
4186
+ depends VERB B-O
4187
+ on ADP B-O
4188
+ the DET B-O
4189
+ binding NOUN B-O
4190
+ of ADP B-O
4191
+ the DET B-O
4192
+ viral ADJ B-O
4193
+ spike NOUN B-O
4194
+ ( PUNCT B-O
4195
+ S NOUN B-O
4196
+ ) PUNCT B-O
4197
+ protein NOUN B-O
4198
+ to ADP B-O
4199
+ its PRON B-O
4200
+ cognate NOUN B-O
4201
+ receptor NOUN B-O
4202
+ angiotensin NOUN B-LF
4203
+ converting VERB I-LF
4204
+ enzyme NOUN I-LF
4205
+ II NUM I-LF
4206
+ ( PUNCT B-O
4207
+ ACE2 PROPN B-AC
4208
+ ) PUNCT B-O
4209
+ on ADP B-O
4210
+ the DET B-O
4211
+ cell NOUN B-O
4212
+ surface NOUN B-O
4213
+ [ X B-O
4214
+ 6,10 NUM B-O
4215
+ ] PUNCT B-O
4216
+ . PUNCT B-O
4217
+
4218
+ This DET B-O
4219
+ study NOUN B-O
4220
+ is AUX B-O
4221
+ reported VERB B-O
4222
+ as ADP B-O
4223
+ per ADP B-O
4224
+ the DET B-O
4225
+ Strengthening VERB B-LF
4226
+ the DET I-LF
4227
+ Reporting PROPN I-LF
4228
+ of ADP I-LF
4229
+ Observational PROPN I-LF
4230
+ Studies PROPN I-LF
4231
+ in ADP I-LF
4232
+ Epidemiology PROPN I-LF
4233
+ ( PUNCT B-O
4234
+ STROBE PROPN B-AC
4235
+ ) PUNCT B-O
4236
+ guidelines NOUN B-O
4237
+ ( PUNCT B-O
4238
+ S1 PROPN B-O
4239
+ STROBE PROPN B-AC
4240
+ Checklist PROPN B-O
4241
+ ) PUNCT B-O
4242
+ [ PUNCT B-O
4243
+ 18 NUM B-O
4244
+ ] PUNCT B-O
4245
+ . PUNCT B-O
4246
+
4247
+ As ADP B-O
4248
+ a DET B-O
4249
+ first ADJ B-O
4250
+ line NOUN B-O
4251
+ , PUNCT B-O
4252
+ countries NOUN B-O
4253
+ should AUX B-O
4254
+ follow VERB B-O
4255
+ Food PROPN B-LF
4256
+ and CCONJ I-LF
4257
+ Agriculture PROPN I-LF
4258
+ Organization PROPN I-LF
4259
+ ( PUNCT B-O
4260
+ FAO PROPN B-AC
4261
+ ) PUNCT B-O
4262
+ advice NOUN B-O
4263
+ [ X B-O
4264
+ 6 X B-O
4265
+ ] X B-O
4266
+ and CCONJ B-O
4267
+ withdraw VERB B-O
4268
+ the DET B-O
4269
+ most ADV B-O
4270
+ toxic ADJ B-O
4271
+ WHO PROPN B-AC
4272
+ / SYM B-O
4273
+ US PROPN B-O
4274
+ Environmental PROPN B-LF
4275
+ Protection PROPN I-LF
4276
+ Agency PROPN I-LF
4277
+ ( PUNCT B-O
4278
+ EPA PROPN B-AC
4279
+ ) PUNCT B-O
4280
+ class NOUN B-O
4281
+ I NUM B-O
4282
+ pesticides NOUN B-O
4283
+ ( PUNCT B-O
4284
+ see VERB B-O
4285
+ Table NOUN B-O
4286
+ 1 NUM B-O
4287
+ for ADP B-O
4288
+ description NOUN B-O
4289
+ of ADP B-O
4290
+ toxicity NOUN B-O
4291
+ classifications NOUN B-O
4292
+ ) PUNCT B-O
4293
+ from ADP B-O
4294
+ agricultural ADJ B-O
4295
+ practice NOUN B-O
4296
+ . PUNCT B-O
4297
+
4298
+ Patients NOUN B-O
4299
+ underwent VERB B-O
4300
+ our PRON B-O
4301
+ standardized ADJ B-O
4302
+ diagnostic ADJ B-O
4303
+ protocol NOUN B-O
4304
+ encompassing VERB B-O
4305
+ clinical ADJ B-O
4306
+ evaluation NOUN B-O
4307
+ with ADP B-O
4308
+ assessment NOUN B-O
4309
+ of ADP B-O
4310
+ subjective ADJ B-O
4311
+ sleepiness NOUN B-O
4312
+ by ADP B-O
4313
+ means NOUN B-O
4314
+ of ADP B-O
4315
+ Epworth PROPN B-LF
4316
+ Sleepiness PROPN I-LF
4317
+ Scale PROPN I-LF
4318
+ ( PUNCT B-O
4319
+ ESS PROPN B-AC
4320
+ ) PUNCT B-O
4321
+ [ PUNCT B-O
4322
+ 24 NUM B-O
4323
+ ] PUNCT B-O
4324
+ , PUNCT B-O
4325
+ cerebral ADJ B-O
4326
+ magnetic ADJ B-O
4327
+ resonance NOUN B-O
4328
+ imaging NOUN B-O
4329
+ , PUNCT B-O
4330
+ hospitalization NOUN B-O
4331
+ with ADP B-O
4332
+ 48 NUM B-O
4333
+ - PUNCT B-O
4334
+ hr NOUN B-O
4335
+ continuous ADJ B-O
4336
+ polysomnographic ADJ B-O
4337
+ recording NOUN B-O
4338
+ , PUNCT B-O
4339
+ Multiple PROPN B-LF
4340
+ Sleep PROPN I-LF
4341
+ Latency PROPN I-LF
4342
+ Test PROPN I-LF
4343
+ ( PUNCT B-O
4344
+ MSLT PROPN B-AC
4345
+ ) PUNCT B-O
4346
+ , PUNCT B-O
4347
+ cataplexy NOUN B-O
4348
+ video NOUN B-O
4349
+ - PUNCT B-O
4350
+ documentation NOUN B-O
4351
+ , PUNCT B-O
4352
+ human ADJ B-LF
4353
+ leukocyte NOUN I-LF
4354
+ antigen NOUN I-LF
4355
+ ( PUNCT B-O
4356
+ HLA PROPN B-AC
4357
+ ) PUNCT B-O
4358
+ typing NOUN B-O
4359
+ and CCONJ B-O
4360
+ lumbar NOUN B-O
4361
+ puncture NOUN B-O
4362
+ for ADP B-O
4363
+ CSF PROPN B-O
4364
+ Hcrt-1 PROPN B-AC
4365
+ assay NOUN B-O
4366
+ [ PUNCT B-O
4367
+ 25 NUM B-O
4368
+ ] PUNCT B-O
4369
+ . PUNCT B-O
4370
+
4371
+ Although SCONJ B-O
4372
+ none NOUN B-O
4373
+ were AUX B-O
4374
+ capable ADJ B-O
4375
+ of ADP B-O
4376
+ complete ADJ B-O
4377
+ control NOUN B-O
4378
+ , PUNCT B-O
4379
+ all DET B-O
4380
+ policies NOUN B-O
4381
+ substantially ADV B-O
4382
+ reduced VERB B-O
4383
+ IAR PROPN B-AC
4384
+ . PUNCT B-O
4385
+
4386
+ The DET B-O
4387
+ baseline ADJ B-O
4388
+ IAR PROPN B-AC
4389
+ of ADP B-O
4390
+ 74 NUM B-O
4391
+ % NOUN B-O
4392
+ was AUX B-O
4393
+ reduced VERB B-O
4394
+ to ADP B-O
4395
+ 49 NUM B-O
4396
+ % NOUN B-O
4397
+ when SCONJ B-O
4398
+ voluntary ADJ B-LF
4399
+ household NOUN I-LF
4400
+ quarantine NOUN I-LF
4401
+ ( PUNCT B-O
4402
+ Q PROPN B-AC
4403
+ ) PUNCT B-O
4404
+ alone ADV B-O
4405
+ was AUX B-O
4406
+ in ADP B-O
4407
+ effect NOUN B-O
4408
+ . PUNCT B-O
4409
+
4410
+ Stevens PROPN B-LF
4411
+ - PUNCT I-LF
4412
+ Johnson PROPN I-LF
4413
+ syndrome NOUN I-LF
4414
+ ( PUNCT B-O
4415
+ SJS PROPN B-AC
4416
+ ) PUNCT B-O
4417
+ and CCONJ B-O
4418
+ its PRON B-O
4419
+ severe ADJ B-O
4420
+ variant NOUN B-O
4421
+ , PUNCT B-O
4422
+ toxic ADJ B-LF
4423
+ epidermal ADJ I-LF
4424
+ necrolysis NOUN I-LF
4425
+ ( PUNCT B-O
4426
+ TEN PROPN B-AC
4427
+ ) PUNCT B-O
4428
+ , PUNCT B-O
4429
+ are AUX B-O
4430
+ drug NOUN B-O
4431
+ - PUNCT B-O
4432
+ induced VERB B-O
4433
+ acute ADJ B-O
4434
+ inflammatory ADJ B-O
4435
+ vesiculobullous ADJ B-O
4436
+ reactions NOUN B-O
4437
+ of ADP B-O
4438
+ the DET B-O
4439
+ skin NOUN B-O
4440
+ and CCONJ B-O
4441
+ mucous ADJ B-O
4442
+ membranes NOUN B-O
4443
+ , PUNCT B-O
4444
+ including VERB B-O
4445
+ the DET B-O
4446
+ ocular ADJ B-O
4447
+ surface NOUN B-O
4448
+ . PUNCT B-O
4449
+
4450
+ Previous ADJ B-O
4451
+ analysis NOUN B-O
4452
+ has AUX B-O
4453
+ shown VERB B-O
4454
+ that PRON B-O
4455
+ neutrophils NOUN B-O
4456
+ from ADP B-O
4457
+ healthy ADJ B-LF
4458
+ controls NOUN I-LF
4459
+ ( PUNCT B-O
4460
+ HCs PROPN B-AC
4461
+ ) PUNCT B-O
4462
+ are AUX B-O
4463
+ capable ADJ B-O
4464
+ of ADP B-O
4465
+ efficiently ADV B-O
4466
+ binding VERB B-O
4467
+ Gal-9 PROPN B-AC
4468
+ ; PUNCT B-O
4469
+ however ADV B-O
4470
+ , PUNCT B-O
4471
+ the DET B-O
4472
+ receptor NOUN B-O
4473
+ that PRON B-O
4474
+ facilitate VERB B-O
4475
+ this DET B-O
4476
+ binding VERB B-O
4477
+ activity NOUN B-O
4478
+ was AUX B-O
4479
+ not PART B-O
4480
+ identified VERB B-O
4481
+ [ PUNCT B-O
4482
+ 50 NUM B-O
4483
+ ] PUNCT B-O
4484
+ . PUNCT B-O
4485
+
4486
+ Identification NOUN B-O
4487
+ of ADP B-O
4488
+ new ADJ B-O
4489
+ genes NOUN B-O
4490
+ from ADP B-O
4491
+ the DET B-O
4492
+ sequence NOUN B-O
4493
+ data NOUN B-O
4494
+ and CCONJ B-O
4495
+ placement NOUN B-O
4496
+ of ADP B-O
4497
+ all DET B-O
4498
+ genes NOUN B-O
4499
+ , PUNCT B-O
4500
+ along ADP B-O
4501
+ with ADP B-O
4502
+ genetic ADJ B-O
4503
+ markers NOUN B-O
4504
+ , PUNCT B-O
4505
+ on ADP B-O
4506
+ a DET B-O
4507
+ physical ADJ B-O
4508
+ assembly NOUN B-O
4509
+ has AUX B-O
4510
+ greatly ADV B-O
4511
+ aided VERB B-O
4512
+ in ADP B-O
4513
+ the DET B-O
4514
+ search NOUN B-O
4515
+ for ADP B-O
4516
+ phenotypically ADV B-O
4517
+ important ADJ B-O
4518
+ genes NOUN B-O
4519
+ in ADP B-O
4520
+ both CCONJ B-O
4521
+ quantitative ADJ B-LF
4522
+ trait NOUN I-LF
4523
+ loci NOUN I-LF
4524
+ ( PUNCT B-O
4525
+ QTL PROPN B-AC
4526
+ ) PUNCT B-O
4527
+ and CCONJ B-O
4528
+ mutagenesis NOUN B-O
4529
+ - PUNCT B-O
4530
+ based VERB B-O
4531
+ mapping NOUN B-O
4532
+ . PUNCT B-O
4533
+
4534
+ Individuals NOUN B-O
4535
+ can AUX B-O
4536
+ be AUX B-O
4537
+ diagnosed VERB B-O
4538
+ when SCONJ B-O
4539
+ they PRON B-O
4540
+ develop VERB B-O
4541
+ symptoms NOUN B-O
4542
+ and CCONJ B-O
4543
+ present VERB B-O
4544
+ at ADP B-O
4545
+ a DET B-O
4546
+ clinic NOUN B-O
4547
+ , PUNCT B-O
4548
+ or CCONJ B-O
4549
+ when SCONJ B-O
4550
+ they PRON B-O
4551
+ are AUX B-O
4552
+ referred VERB B-O
4553
+ from ADP B-O
4554
+ an DET B-O
4555
+ antenatal ADJ B-LF
4556
+ clinic NOUN I-LF
4557
+ ( PUNCT B-O
4558
+ ANC PROPN B-AC
4559
+ ) PUNCT B-O
4560
+ , PUNCT B-O
4561
+ or CCONJ B-O
4562
+ when SCONJ B-O
4563
+ they PRON B-O
4564
+ voluntarily ADV B-O
4565
+ get AUX B-O
4566
+ tested VERB B-O
4567
+ for ADP B-O
4568
+ HIV PROPN B-O
4569
+ ( PUNCT B-O
4570
+ voluntary ADJ B-LF
4571
+ counselling NOUN I-LF
4572
+ and CCONJ I-LF
4573
+ testing NOUN I-LF
4574
+ , PUNCT B-O
4575
+ VCT PROPN B-AC
4576
+ ) PUNCT B-O
4577
+ . PUNCT B-O
4578
+
4579
+ For ADP B-O
4580
+ simplicity NOUN B-O
4581
+ , PUNCT B-O
4582
+ we PRON B-O
4583
+ investigated VERB B-O
4584
+ circumstances NOUN B-O
4585
+ that PRON B-O
4586
+ range VERB B-O
4587
+ from ADP B-O
4588
+ the DET B-O
4589
+ worst ADJ B-O
4590
+ - PUNCT B-O
4591
+ case NOUN B-O
4592
+ to ADP B-O
4593
+ the DET B-O
4594
+ achievable ADJ B-O
4595
+ best ADJ B-O
4596
+ - PUNCT B-O
4597
+ case NOUN B-O
4598
+ scenario NOUN B-O
4599
+ . PUNCT B-O
4600
+
4601
+ TBC PROPN B-AC
4602
+ , PUNCT B-O
4603
+ Tre2 PROPN B-LF
4604
+ - PUNCT I-LF
4605
+ Bub2 PROPN I-LF
4606
+ - PUNCT I-LF
4607
+ Cdc16 PROPN I-LF
4608
+ . PUNCT B-O
4609
+
4610
+ * PUNCT B-O
4611
+ * PUNCT B-O
4612
+ * PUNCT B-O
4613
+ p NOUN B-O
4614
+ < SYM B-O
4615
+ 0.001 NUM B-O
4616
+ LAD PROPN B-AC
4617
+ , PUNCT B-O
4618
+ left ADJ B-LF
4619
+ atrial ADJ I-LF
4620
+ diameter NOUN I-LF
4621
+ ; PUNCT B-O
4622
+ LVDd PROPN B-AC
4623
+ , PUNCT B-O
4624
+ left ADJ B-LF
4625
+ ventricular ADJ I-LF
4626
+ end NOUN I-LF
4627
+ - PUNCT I-LF
4628
+ diastolic ADJ I-LF
4629
+ diameter NOUN I-LF
4630
+ ; PUNCT B-O
4631
+ LVDs PROPN B-AC
4632
+ , PUNCT B-O
4633
+ left ADJ B-LF
4634
+ ventricular ADJ I-LF
4635
+ end NOUN I-LF
4636
+ - PUNCT I-LF
4637
+ systolic ADJ I-LF
4638
+ diameter NOUN I-LF
4639
+ ; PUNCT B-O
4640
+ IVSth PROPN B-AC
4641
+ , PUNCT B-O
4642
+ intraventricular ADJ B-LF
4643
+ septum NOUN I-LF
4644
+ thickness NOUN I-LF
4645
+ ; PUNCT B-O
4646
+ PWth PROPN B-AC
4647
+ , PUNCT B-O
4648
+ posterior ADJ B-LF
4649
+ wall NOUN I-LF
4650
+ thickness NOUN I-LF
4651
+ ; PUNCT B-O
4652
+ LVEF PROPN B-AC
4653
+ , PUNCT B-O
4654
+ LV NOUN B-LF
4655
+ ejection NOUN I-LF
4656
+ LV PROPN B-AC
4657
+ fraction NOUN I-LF
4658
+ ; PUNCT B-O
4659
+ LVM PROPN B-AC
4660
+ , PUNCT B-O
4661
+ LV NOUN B-LF
4662
+ mass NOUN I-LF
4663
+ LV PROPN B-AC
4664
+ ; PUNCT B-O
4665
+ LVMI PROPN B-AC
4666
+ , PUNCT B-O
4667
+ LV NOUN B-LF
4668
+ mass NOUN I-LF
4669
+ LV PROPN B-AC
4670
+ index NOUN I-LF
4671
+ ; PUNCT B-O
4672
+ E PROPN B-AC
4673
+ / SYM B-O
4674
+ e NOUN B-O
4675
+ ’ PUNCT B-O
4676
+ , PUNCT B-O
4677
+ the DET B-O
4678
+ ratio NOUN B-O
4679
+ of ADP B-O
4680
+ early ADJ B-LF
4681
+ - PUNCT I-LF
4682
+ diastolic ADJ I-LF
4683
+ left ADJ I-LF
4684
+ ventricular ADJ I-LF
4685
+ inflow ADJ I-LF
4686
+ velocity NOUN I-LF
4687
+ ( PUNCT B-O
4688
+ E PROPN B-AC
4689
+ ) PUNCT B-O
4690
+ to ADP B-O
4691
+ early ADJ B-O
4692
+ - PUNCT B-O
4693
+ diastolic ADJ B-O
4694
+ mitral ADJ B-O
4695
+ annular ADJ B-O
4696
+ velocity NOUN B-O
4697
+ ( PUNCT B-O
4698
+ e′ NOUN B-O
4699
+ ): PUNCT B-O
4700
+ LAVI PROPN B-AC
4701
+ , PUNCT B-O
4702
+ left ADJ B-LF
4703
+ atrial ADJ I-LF
4704
+ mass NOUN I-LF
4705
+ index NOUN I-LF
4706
+ ; PUNCT B-O
4707
+ other ADJ B-O
4708
+ abbreviations NOUN B-O
4709
+ as ADP B-O
4710
+ in ADP B-O
4711
+ Table NOUN B-O
4712
+ 2 NUM B-O
4713
+ . PUNCT B-O
4714
+
4715
+ LDL PROPN B-AC
4716
+ , PUNCT B-O
4717
+ low ADJ B-LF
4718
+ - PUNCT I-LF
4719
+ density NOUN I-LF
4720
+ lipoprotein NOUN I-LF
4721
+ . PUNCT B-O
4722
+
4723
+ ( PUNCT B-O
4724
+ A X B-O
4725
+ ) PUNCT B-O
4726
+ Confocal ADJ B-O
4727
+ fluorescence NOUN B-O
4728
+ image NOUN B-O
4729
+ of ADP B-O
4730
+ miniSOG PROPN B-AC
4731
+ targeted VERB B-O
4732
+ to ADP B-O
4733
+ the DET B-O
4734
+ mitochondria NOUN B-O
4735
+ in ADP B-O
4736
+ body NOUN B-O
4737
+ wall NOUN B-O
4738
+ muscles NOUN B-O
4739
+ of ADP B-O
4740
+ C. NOUN B-O
4741
+ elegans NOUN B-O
4742
+ . PUNCT B-O
4743
+
4744
+ ( PUNCT B-O
4745
+ B X B-O
4746
+ – PUNCT B-O
4747
+ C NOUN B-O
4748
+ ) PUNCT B-O
4749
+ Thin ADJ B-O
4750
+ section NOUN B-O
4751
+ EM PROPN B-AC
4752
+ images NOUN B-O
4753
+ of ADP B-O
4754
+ a DET B-O
4755
+ portion NOUN B-O
4756
+ of ADP B-O
4757
+ C. NOUN B-O
4758
+ elegans NOUN B-O
4759
+ showing VERB B-O
4760
+ a DET B-O
4761
+ subset NOUN B-O
4762
+ of ADP B-O
4763
+ labeled VERB B-O
4764
+ mitochondria NOUN B-O
4765
+ in ADP B-O
4766
+ the DET B-O
4767
+ body NOUN B-O
4768
+ wall NOUN B-O
4769
+ muscle NOUN B-O
4770
+ ( PUNCT B-O
4771
+ arrow NOUN B-O
4772
+ ) PUNCT B-O
4773
+ and CCONJ B-O
4774
+ adjacent ADJ B-O
4775
+ unlabeled VERB B-O
4776
+ mitochondria NOUN B-O
4777
+ in ADP B-O
4778
+ a DET B-O
4779
+ different ADJ B-O
4780
+ cell NOUN B-O
4781
+ type NOUN B-O
4782
+ ( PUNCT B-O
4783
+ arrowheads NOUN B-O
4784
+ ) PUNCT B-O
4785
+ . PUNCT B-O
4786
+
4787
+ ( PUNCT B-O
4788
+ D X B-O
4789
+ – PUNCT B-O
4790
+ E X B-O
4791
+ ) PUNCT B-O
4792
+ Ultrastructural ADJ B-O
4793
+ localization NOUN B-O
4794
+ of ADP B-O
4795
+ miniSOG PROPN B-AC
4796
+ - PUNCT B-O
4797
+ labeled VERB B-O
4798
+ synaptic ADJ B-LF
4799
+ cell NOUN I-LF
4800
+ - PUNCT I-LF
4801
+ adhesion NOUN I-LF
4802
+ molecules NOUN I-LF
4803
+ ( PUNCT B-O
4804
+ SynCAMs PROPN B-AC
4805
+ ) PUNCT B-O
4806
+ in ADP B-O
4807
+ cultured VERB B-O
4808
+ cortical ADJ B-O
4809
+ neurons NOUN B-O
4810
+ . PUNCT B-O
4811
+
4812
+ ( PUNCT B-O
4813
+ D X B-O
4814
+ ) PUNCT B-O
4815
+ SynCAM1 PROPN B-O
4816
+ fusion NOUN B-O
4817
+ reveals VERB B-O
4818
+ uniform ADJ B-O
4819
+ membrane NOUN B-O
4820
+ labeling NOUN B-O
4821
+ at ADP B-O
4822
+ the DET B-O
4823
+ presynaptic ADJ B-O
4824
+ apposition NOUN B-O
4825
+ ( PUNCT B-O
4826
+ arrow NOUN B-O
4827
+ ) PUNCT B-O
4828
+ . PUNCT B-O
4829
+
4830
+ ( PUNCT B-O
4831
+ E X B-O
4832
+ ) PUNCT B-O
4833
+ SynCAM2 PROPN B-O
4834
+ fusion NOUN B-O
4835
+ shows VERB B-O
4836
+ postsynaptic ADJ B-O
4837
+ membrane NOUN B-O
4838
+ labeling NOUN B-O
4839
+ ( PUNCT B-O
4840
+ pointed VERB B-O
4841
+ by ADP B-O
4842
+ arrow NOUN B-O
4843
+ ) PUNCT B-O
4844
+ . PUNCT B-O
4845
+
4846
+ Att PROPN B-O
4847
+ , PUNCT B-O
4848
+ Attacin PROPN B-O
4849
+ A PROPN B-O
4850
+ ; PUNCT B-O
4851
+ Dpt PROPN B-O
4852
+ , PUNCT B-O
4853
+ Diptericin PROPN B-O
4854
+ ; PUNCT B-O
4855
+ Drs NOUN B-O
4856
+ , PUNCT B-O
4857
+ Drosomycin PROPN B-O
4858
+ ; PUNCT B-O
4859
+ IMD PROPN B-O
4860
+ / SYM B-O
4861
+ NFkB PROPN B-AC
4862
+ , PUNCT B-O
4863
+ immune ADJ B-O
4864
+ deficiency NOUN B-O
4865
+ / SYM B-O
4866
+ nuclear ADJ B-LF
4867
+ factor NOUN I-LF
4868
+ kappa NOUN I-LF
4869
+ B PROPN I-LF
4870
+ ; PUNCT B-O
4871
+ qRT PROPN B-AC
4872
+ , PUNCT B-O
4873
+ quantitative ADJ B-LF
4874
+ real ADJ I-LF
4875
+ - PUNCT I-LF
4876
+ time NOUN I-LF
4877
+ PCR NOUN I-LF
4878
+ ; PUNCT B-O
4879
+ -PCRRNAi PROPN B-AC
4880
+ , PUNCT B-O
4881
+ RNA NOUN B-LF
4882
+ interference NOUN I-LF
4883
+ . PUNCT B-O
4884
+
4885
+ We PRON B-O
4886
+ sought VERB B-O
4887
+ to ADP B-O
4888
+ develop VERB B-O
4889
+ and CCONJ B-O
4890
+ validate VERB B-O
4891
+ an DET B-O
4892
+ outcomes NOUN B-O
4893
+ model NOUN B-O
4894
+ for ADP B-O
4895
+ the DET B-O
4896
+ development NOUN B-O
4897
+ of ADP B-O
4898
+ diabetes NOUN B-O
4899
+ and CCONJ B-O
4900
+ related ADJ B-O
4901
+ complications NOUN B-O
4902
+ derived VERB B-O
4903
+ from ADP B-O
4904
+ Chinese ADJ B-O
4905
+ ( PUNCT B-O
4906
+ East ADJ B-O
4907
+ Asian ADJ B-O
4908
+ ) PUNCT B-O
4909
+ populations NOUN B-O
4910
+ and CCONJ B-O
4911
+ compare VERB B-O
4912
+ this DET B-O
4913
+ new ADJ B-O
4914
+ Chinese ADJ B-LF
4915
+ Hong PROPN I-LF
4916
+ Kong PROPN I-LF
4917
+ Integrated PROPN I-LF
4918
+ Modeling PROPN I-LF
4919
+ and CCONJ I-LF
4920
+ Evaluation PROPN I-LF
4921
+ ( PUNCT B-O
4922
+ CHIME PROPN B-AC
4923
+ ) PUNCT B-O
4924
+ model NOUN B-O
4925
+ to ADP B-O
4926
+ the DET B-O
4927
+ existing VERB B-O
4928
+ UKPDS PROPN B-AC
4929
+ and CCONJ B-O
4930
+ -OM2RECODe PROPN B-AC
4931
+ models NOUN B-O
4932
+ . PUNCT B-O
4933
+
4934
+ ( PUNCT B-O
4935
+ A X B-O
4936
+ ) PUNCT B-O
4937
+ Immunoblot NOUN B-O
4938
+ analysis NOUN B-O
4939
+ of ADP B-O
4940
+ acetylation NOUN B-O
4941
+ levels NOUN B-O
4942
+ of ADP B-O
4943
+ 7 NUM B-O
4944
+ lysine NOUN B-O
4945
+ residues NOUN B-O
4946
+ on ADP B-O
4947
+ histone NOUN B-O
4948
+ H3 NOUN B-O
4949
+ protein NOUN B-O
4950
+ in ADP B-O
4951
+ the DET B-O
4952
+ wild ADJ B-LF
4953
+ - PUNCT I-LF
4954
+ type NOUN I-LF
4955
+ ( PUNCT B-O
4956
+ WT PROPN B-AC
4957
+ ) PUNCT B-O
4958
+ strain NOUN B-O
4959
+ and CCONJ B-O
4960
+ the DET B-O
4961
+ mutants NOUN B-O
4962
+ ΔHdac1 NOUN B-O
4963
+ and CCONJ B-O
4964
+ ΔHat1 NOUN B-O
4965
+ . PUNCT B-O
4966
+
4967
+ Different ADJ B-O
4968
+ subtypes NOUN B-O
4969
+ of ADP B-O
4970
+ T NOUN B-LF
4971
+ helper NOUN I-LF
4972
+ ( PUNCT B-O
4973
+ Th PROPN B-AC
4974
+ ) PUNCT B-O
4975
+ cells NOUN B-O
4976
+ are AUX B-O
4977
+ activated VERB B-O
4978
+ in ADP B-O
4979
+ different ADJ B-O
4980
+ types NOUN B-O
4981
+ of ADP B-O
4982
+ chronic ADJ B-O
4983
+ intestinal ADJ B-O
4984
+ inflammation NOUN B-O
4985
+ . PUNCT B-O
4986
+
4987
+ For ADP B-O
4988
+ encoding NOUN B-O
4989
+ and CCONJ B-O
4990
+ consolidation NOUN B-O
4991
+ , PUNCT B-O
4992
+ we PRON B-O
4993
+ compared VERB B-O
4994
+ 30 NUM B-O
4995
+ min NOUN B-O
4996
+ and CCONJ B-O
4997
+ 5 NUM B-O
4998
+ h NOUN B-O
4999
+ after ADP B-O
5000
+ the DET B-O
5001
+ watermaze NOUN B-LF
5002
+ encoding NOUN B-O
5003
+ session NOUN B-O
5004
+ animals NOUN B-O
5005
+ that PRON B-O
5006
+ experienced VERB B-O
5007
+ the DET B-O
5008
+ watermaze NOUN B-LF
5009
+ ( PUNCT B-O
5010
+ WM PROPN B-AC
5011
+ ) PUNCT B-O
5012
+ directly ADV B-O
5013
+ with ADP B-O
5014
+ animals NOUN B-O
5015
+ that PRON B-O
5016
+ had AUX B-O
5017
+ not PART B-O
5018
+ experienced VERB B-O
5019
+ the DET B-O
5020
+ watermaze NOUN B-LF
5021
+ ( PUNCT B-O
5022
+ NoWM PROPN B-AC
5023
+ ) PUNCT B-O
5024
+ . PUNCT B-O
5025
+
5026
+ Thus ADV B-O
5027
+ , PUNCT B-O
5028
+ positive ADJ B-O
5029
+ values NOUN B-O
5030
+ on ADP B-O
5031
+ the DET B-O
5032
+ y NOUN B-O
5033
+ - NOUN B-O
5034
+ axis NOUN B-O
5035
+ show VERB B-O
5036
+ that PRON B-O
5037
+ animals NOUN B-O
5038
+ consolidating VERB B-O
5039
+ a DET B-O
5040
+ memory NOUN B-O
5041
+ ( PUNCT B-O
5042
+ WM PROPN B-AC
5043
+ ) PUNCT B-O
5044
+ show VERB B-O
5045
+ higher ADJ B-O
5046
+ gene NOUN B-O
5047
+ expression NOUN B-O
5048
+ than ADP B-O
5049
+ animals NOUN B-O
5050
+ that PRON B-O
5051
+ are AUX B-O
5052
+ not PART B-O
5053
+ consolidating VERB B-O
5054
+ a DET B-O
5055
+ memory NOUN B-O
5056
+ ( PUNCT B-O
5057
+ NoWM PROPN B-AC
5058
+ ) PUNCT B-O
5059
+ , PUNCT B-O
5060
+ independent ADJ B-O
5061
+ of ADP B-O
5062
+ what PRON B-O
5063
+ they PRON B-O
5064
+ are AUX B-O
5065
+ doing VERB B-O
5066
+ at ADP B-O
5067
+ the DET B-O
5068
+ moment NOUN B-O
5069
+ ( PUNCT B-O
5070
+ sleep NOUN B-O
5071
+ / SYM B-O
5072
+ N+SD PROPN B-AC
5073
+ ) PUNCT B-O
5074
+ . PUNCT B-O
5075
+
5076
+ Additionally ADV B-O
5077
+ , PUNCT B-O
5078
+ to PART B-O
5079
+ investigate VERB B-O
5080
+ the DET B-O
5081
+ differences NOUN B-O
5082
+ between ADP B-O
5083
+ sleep NOUN B-O
5084
+ and CCONJ B-O
5085
+ N PROPN B-AC
5086
+ animals NOUN B-O
5087
+ at ADP B-O
5088
+ retrieval NOUN B-O
5089
+ , PUNCT B-O
5090
+ we PRON B-O
5091
+ calculated VERB B-O
5092
+ percentage NOUN B-O
5093
+ change NOUN B-O
5094
+ ( PUNCT B-O
5095
+ sleep NOUN B-O
5096
+ > SYM B-O
5097
+ +SDN PROPN B-AC
5098
+ ) PUNCT B-O
5099
+ on ADP B-O
5100
+ each DET B-O
5101
+ plate NOUN B-O
5102
+ and CCONJ B-O
5103
+ then ADV B-O
5104
+ averaged VERB B-O
5105
+ the DET B-O
5106
+ data NOUN B-O
5107
+ ( PUNCT B-O
5108
+ see VERB B-O
5109
+ S7 PROPN B-O
5110
+ Fig PROPN B-O
5111
+ ) PUNCT B-O
5112
+ . PUNCT B-O
5113
+
5114
+ AOR PROPN B-AC
5115
+ = PUNCT B-O
5116
+ Adjusted ADJ B-O
5117
+ Adds NOUN B-O
5118
+ Ratio NOUN B-O
5119
+ , PUNCT B-O
5120
+ COR PROPN B-AC
5121
+ = PUNCT B-O
5122
+ Crude NOUN B-LF
5123
+ Odds NOUN I-LF
5124
+ Ratio NOUN I-LF
5125
+ . PUNCT B-O
5126
+
data/data_test.conll ADDED
@@ -0,0 +1,5152 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ Abbreviations NOUN B-O
2
+ : PUNCT B-O
3
+ GEMS PROPN B-AC
4
+ , PUNCT B-O
5
+ Global PROPN B-LF
6
+ Enteric PROPN I-LF
7
+ Multicenter PROPN I-LF
8
+ Study PROPN I-LF
9
+ ; PUNCT B-O
10
+ VIP PROPN B-AC
11
+ , PUNCT B-O
12
+ ventilated VERB B-LF
13
+ improved ADJ I-LF
14
+ pit NOUN I-LF
15
+ . PUNCT B-O
16
+
17
+ Fractions NOUN B-O
18
+ from ADP B-O
19
+ FPLC PROPN B-O
20
+ purification NOUN B-O
21
+ were AUX B-O
22
+ treated VERB B-O
23
+ with ADP B-O
24
+ Laemmli PROPN B-O
25
+ buffer NOUN B-O
26
+ [ X B-O
27
+ 82 X B-O
28
+ ] X B-O
29
+ with ADP B-O
30
+ 10 NUM B-O
31
+ mM NOUN B-O
32
+ 1,4 NUM B-O
33
+ - PUNCT B-O
34
+ dithiothreitol NOUN B-LF
35
+ ( PUNCT B-O
36
+ DTT PROPN B-AC
37
+ ) PUNCT B-O
38
+ and CCONJ B-O
39
+ heated VERB B-O
40
+ for ADP B-O
41
+ 5 NUM B-O
42
+ m NOUN B-O
43
+ at ADP B-O
44
+ 85 NUM B-O
45
+ ° NOUN B-O
46
+ C NOUN B-O
47
+ then ADV B-O
48
+ analyzed VERB B-O
49
+ on ADP B-O
50
+ a DET B-O
51
+ 4 NUM B-O
52
+ % NOUN B-O
53
+ to PART B-O
54
+ 15 NUM B-O
55
+ % NOUN B-O
56
+ discontinuous ADJ B-O
57
+ SDS PROPN B-AC
58
+ gel NOUN B-O
59
+ with ADP B-O
60
+ a DET B-O
61
+ 6 NUM B-O
62
+ % NOUN B-O
63
+ stacking NOUN B-O
64
+ gel NOUN B-O
65
+ run VERB B-O
66
+ at ADP B-O
67
+ ambient ADJ B-O
68
+ temperature NOUN B-O
69
+ at ADP B-O
70
+ a DET B-O
71
+ constant ADJ B-O
72
+ 100 NUM B-O
73
+ V. NOUN B-O
74
+ Two NUM B-O
75
+ epithelial ADJ B-O
76
+ cytokines NOUN B-O
77
+ other ADJ B-O
78
+ than ADP B-O
79
+ IL33 NOUN B-O
80
+ , PUNCT B-O
81
+ IL25 NOUN B-O
82
+ , PUNCT B-O
83
+ and CCONJ B-O
84
+ thymic ADJ B-LF
85
+ stromal ADJ I-LF
86
+ lymphopoietin NOUN I-LF
87
+ ( PUNCT B-O
88
+ TSLP PROPN B-AC
89
+ ) PUNCT B-O
90
+ are AUX B-O
91
+ known VERB B-O
92
+ to PART B-O
93
+ activate VERB B-O
94
+ ILC2 PROPN B-AC
95
+ in ADP B-O
96
+ the DET B-O
97
+ lung NOUN B-O
98
+ [ PUNCT B-O
99
+ 22,24 NUM B-O
100
+ ] PUNCT B-O
101
+ . PUNCT B-O
102
+
103
+ We PRON B-O
104
+ developed VERB B-O
105
+ a DET B-O
106
+ variant NOUN B-O
107
+ of ADP B-O
108
+ gene NOUN B-LF
109
+ set NOUN I-LF
110
+ enrichment NOUN I-LF
111
+ analysis NOUN I-LF
112
+ ( PUNCT B-O
113
+ GSEA PROPN B-AC
114
+ ) PUNCT B-O
115
+ to PART B-O
116
+ determine VERB B-O
117
+ whether SCONJ B-O
118
+ a DET B-O
119
+ genetic ADJ B-O
120
+ pathway NOUN B-O
121
+ shows VERB B-O
122
+ evidence NOUN B-O
123
+ for ADP B-O
124
+ age NOUN B-O
125
+ regulation NOUN B-O
126
+ [ PUNCT B-O
127
+ 23 NUM B-O
128
+ ] PUNCT B-O
129
+ . PUNCT B-O
130
+
131
+ Red NOUN B-O
132
+ represents VERB B-O
133
+ samples NOUN B-O
134
+ having VERB B-O
135
+ the DET B-O
136
+ normalized VERB B-O
137
+ pY232 PROPN B-AC
138
+ and/or CCONJ B-O
139
+ pY291 NOUN B-O
140
+ values NOUN B-O
141
+ in ADP B-O
142
+ cancer NOUN B-O
143
+ tissues NOUN B-O
144
+ ≥ PUNCT B-O
145
+ 1.1 NUM B-O
146
+ folds NOUN B-O
147
+ of ADP B-O
148
+ normal ADJ B-O
149
+ tissues NOUN B-O
150
+ ( PUNCT B-O
151
+ of ADP B-O
152
+ which PRON B-O
153
+ enhanced VERB B-O
154
+ pY232 PROPN B-AC
155
+ and/or CCONJ B-O
156
+ pY291 NOUN B-O
157
+ level NOUN B-O
158
+ may AUX B-O
159
+ be AUX B-O
160
+ indicative ADJ B-O
161
+ of ADP B-O
162
+ dominant ADJ B-O
163
+ survival NOUN B-O
164
+ mode NOUN B-O
165
+ of ADP B-O
166
+ Fas PROPN B-O
167
+ signaling NOUN B-O
168
+ ) PUNCT B-O
169
+ ; PUNCT B-O
170
+ blue NOUN B-O
171
+ represents VERB B-O
172
+ samples NOUN B-O
173
+ having VERB B-O
174
+ both CCONJ B-O
175
+ normalized VERB B-O
176
+ pY232 PROPN B-AC
177
+ and CCONJ B-O
178
+ pY291 NOUN B-O
179
+ values NOUN B-O
180
+ < ADP B-O
181
+ 1.1 NUM B-O
182
+ ( PUNCT B-O
183
+ of ADP B-O
184
+ which PRON B-O
185
+ pY232 PROPN B-AC
186
+ and CCONJ B-O
187
+ pY291 NOUN B-O
188
+ levels NOUN B-O
189
+ less ADJ B-O
190
+ than ADP B-O
191
+ or CCONJ B-O
192
+ equal ADJ B-O
193
+ to ADP B-O
194
+ normal ADJ B-O
195
+ may AUX B-O
196
+ be AUX B-O
197
+ indicative ADJ B-O
198
+ of ADP B-O
199
+ the DET B-O
200
+ apoptosis NOUN B-O
201
+ - NOUN B-O
202
+ ready ADJ B-O
203
+ mode NOUN B-O
204
+ of ADP B-O
205
+ Fas PROPN B-O
206
+ signaling NOUN B-O
207
+ ) PUNCT B-O
208
+ . PUNCT B-O
209
+
210
+ ( PUNCT B-O
211
+ D X B-O
212
+ ) PUNCT B-O
213
+ Lysates NOUN B-O
214
+ of ADP B-O
215
+ rectal ADJ B-O
216
+ cancer NOUN B-O
217
+ tissues NOUN B-O
218
+ before ADP B-O
219
+ and CCONJ B-O
220
+ after ADP B-O
221
+ radiotherapy NOUN B-LF
222
+ ( PUNCT B-O
223
+ RT PROPN B-AC
224
+ ) PUNCT B-O
225
+ from ADP B-O
226
+ each PRON B-O
227
+ of ADP B-O
228
+ the DET B-O
229
+ nine NUM B-O
230
+ patients NOUN B-O
231
+ were AUX B-O
232
+ subjected VERB B-O
233
+ to ADP B-O
234
+ SDS PROPN B-O
235
+ - NOUN B-O
236
+ PAGE PROPN B-O
237
+ and CCONJ B-O
238
+ immunoblotting NOUN B-O
239
+ with ADP B-O
240
+ antibodies NOUN B-O
241
+ against ADP B-O
242
+ pY232 PROPN B-AC
243
+ , PUNCT B-O
244
+ pY291 NOUN B-O
245
+ , PUNCT B-O
246
+ and CCONJ B-O
247
+ C NOUN B-O
248
+ - NOUN B-O
249
+ terminal ADJ B-O
250
+ ( PUNCT B-O
251
+ C NOUN B-O
252
+ - NOUN B-O
253
+ ter NOUN B-O
254
+ ) PUNCT B-O
255
+ of ADP B-O
256
+ Fas PROPN B-O
257
+ . PUNCT B-O
258
+
259
+ Relative ADJ B-LF
260
+ risks NOUN I-LF
261
+ ( PUNCT B-O
262
+ RRs PROPN B-AC
263
+ ) PUNCT B-O
264
+ with ADP B-O
265
+ 95 NUM B-O
266
+ % NOUN B-O
267
+ confidence NOUN B-LF
268
+ intervals NOUN I-LF
269
+ ( PUNCT B-O
270
+ CIs PROPN B-AC
271
+ ) PUNCT B-O
272
+ are AUX B-O
273
+ reported VERB B-O
274
+ . PUNCT B-O
275
+
276
+ Increasing VERB B-O
277
+ concentrations NOUN B-O
278
+ of ADP B-O
279
+ the DET B-O
280
+ p53 NOUN B-O
281
+ activators NOUN B-O
282
+ significantly ADV B-O
283
+ decrease NOUN B-O
284
+ the DET B-O
285
+ levels NOUN B-O
286
+ of ADP B-O
287
+ SOD1G85R PROPN B-O
288
+ but CCONJ B-O
289
+ not PART B-O
290
+ the DET B-O
291
+ endogenous ADJ B-O
292
+ WTSOD1 PROPN B-AC
293
+ proteins NOUN B-O
294
+ in ADP B-O
295
+ western ADJ B-O
296
+ blots NOUN B-O
297
+ of ADP B-O
298
+ both CCONJ B-O
299
+ supernatant NOUN B-O
300
+ and CCONJ B-O
301
+ pellet NOUN B-LF
302
+ fractions NOUN I-LF
303
+ . PUNCT B-O
304
+
305
+ ( PUNCT B-O
306
+ B X B-O
307
+ ) PUNCT B-O
308
+ A DET B-O
309
+ decrease NOUN B-O
310
+ in ADP B-O
311
+ p53 NOUN B-O
312
+ as SCONJ B-O
313
+ the DET B-O
314
+ result NOUN B-O
315
+ of ADP B-O
316
+ shRNA PROPN B-AC
317
+ knockdown NOUN B-O
318
+ increases VERB B-O
319
+ the DET B-O
320
+ levels NOUN B-O
321
+ of ADP B-O
322
+ SOD1G85R PROPN B-O
323
+ but CCONJ B-O
324
+ not PART B-O
325
+ WT PROPN B-AC
326
+ SOD1 PROPN B-AC
327
+ proteins NOUN B-O
328
+ in ADP B-O
329
+ the DET B-O
330
+ SOD1G85R PROPN B-O
331
+ aggregation NOUN B-O
332
+ assay NOUN B-O
333
+ , PUNCT B-O
334
+ as SCONJ B-O
335
+ shown VERB B-O
336
+ by ADP B-O
337
+ western ADJ B-O
338
+ blots NOUN B-O
339
+ of ADP B-O
340
+ both CCONJ B-O
341
+ supernatant NOUN B-O
342
+ ( PUNCT B-O
343
+ S PROPN B-AC
344
+ ) PUNCT B-O
345
+ ( PUNCT B-O
346
+ n NOUN B-O
347
+ = SYM B-O
348
+ 2 NUM B-O
349
+ ) PUNCT B-O
350
+ and CCONJ B-O
351
+ pellet NOUN B-O
352
+ ( PUNCT B-O
353
+ P PROPN B-AC
354
+ ) PUNCT B-O
355
+ ( PUNCT B-O
356
+ n NOUN B-O
357
+ = SYM B-O
358
+ 3 NUM B-O
359
+ ) PUNCT B-O
360
+ fractions NOUN B-O
361
+ . PUNCT B-O
362
+
363
+ ( PUNCT B-O
364
+ C X B-O
365
+ ) PUNCT B-O
366
+ A DET B-O
367
+ complete ADJ B-O
368
+ absence NOUN B-O
369
+ of ADP B-O
370
+ p53 NOUN B-O
371
+ increases VERB B-O
372
+ the DET B-O
373
+ accumulation NOUN B-O
374
+ of ADP B-O
375
+ SOD1G85R PROPN B-O
376
+ mutant ADJ B-O
377
+ proteins NOUN B-O
378
+ in ADP B-O
379
+ p53–/ NOUN B-O
380
+ – PUNCT B-O
381
+ HCT116 PROPN B-O
382
+ cells NOUN B-O
383
+ when SCONJ B-O
384
+ compared VERB B-O
385
+ with ADP B-O
386
+ controls NOUN B-O
387
+ . PUNCT B-O
388
+
389
+ Pravastatin ADJ B-LF
390
+ sodium NOUN I-LF
391
+ ( PUNCT B-O
392
+ PSS PROPN B-AC
393
+ , PUNCT B-O
394
+ Fig NOUN B-O
395
+ 2.9 NUM B-O
396
+ ) PUNCT B-O
397
+ is AUX B-O
398
+ the DET B-O
399
+ only ADJ B-O
400
+ included VERB B-O
401
+ NP PROPN B-AC
402
+ of ADP B-O
403
+ microbial ADJ B-O
404
+ origin NOUN B-O
405
+ . PUNCT B-O
406
+
407
+ I PRON B-O
408
+ have VERB B-O
409
+ read VERB B-O
410
+ the DET B-O
411
+ journal NOUN B-O
412
+ 's PART B-O
413
+ policy NOUN B-O
414
+ and CCONJ B-O
415
+ the DET B-O
416
+ authors NOUN B-O
417
+ of ADP B-O
418
+ this DET B-O
419
+ manuscript NOUN B-O
420
+ have VERB B-O
421
+ the DET B-O
422
+ following VERB B-O
423
+ competing VERB B-O
424
+ interests NOUN B-O
425
+ : PUNCT B-O
426
+ DF PROPN B-O
427
+ , PUNCT B-O
428
+ EJ PROPN B-O
429
+ , PUNCT B-O
430
+ and CCONJ B-O
431
+ NNL PROPN B-O
432
+ are AUX B-O
433
+ staff NOUN B-O
434
+ members NOUN B-O
435
+ of ADP B-O
436
+ the DET B-O
437
+ World PROPN B-LF
438
+ Health PROPN I-LF
439
+ Organization PROPN I-LF
440
+ ( PUNCT B-O
441
+ WHO PROPN B-AC
442
+ ) PUNCT B-O
443
+ . PUNCT B-O
444
+
445
+ Characteristics NOUN B-O
446
+ were AUX B-O
447
+ compared VERB B-O
448
+ across ADP B-O
449
+ the DET B-O
450
+ matched VERB B-O
451
+ groups NOUN B-O
452
+ using VERB B-O
453
+ standardized ADJ B-LF
454
+ mean ADJ I-LF
455
+ differences NOUN I-LF
456
+ ( PUNCT B-O
457
+ SMDs PROPN B-AC
458
+ ) PUNCT B-O
459
+ , PUNCT B-O
460
+ with ADP B-O
461
+ an DET B-O
462
+ SMD PROPN B-AC
463
+ > ADP B-O
464
+ 0.1 NUM B-O
465
+ indicating VERB B-O
466
+ a DET B-O
467
+ clinically ADV B-O
468
+ important ADJ B-O
469
+ difference NOUN B-O
470
+ . PUNCT B-O
471
+
472
+ Nutrients NOUN B-O
473
+ that PRON B-O
474
+ are AUX B-O
475
+ rich ADJ B-O
476
+ in ADP B-O
477
+ seafood NOUN B-O
478
+ were AUX B-O
479
+ selected VERB B-O
480
+ to PART B-O
481
+ be AUX B-O
482
+ included VERB B-O
483
+ this DET B-O
484
+ study NOUN B-O
485
+ : PUNCT B-O
486
+ protein NOUN B-O
487
+ , PUNCT B-O
488
+ eicosapentaenoic NOUN B-LF
489
+ acid NOUN I-LF
490
+ ( PUNCT B-O
491
+ EPA PROPN B-AC
492
+ ) PUNCT B-O
493
+ and CCONJ B-O
494
+ docosahexaenoic NOUN B-LF
495
+ acid NOUN I-LF
496
+ ( PUNCT B-O
497
+ DHA PROPN B-AC
498
+ ) PUNCT B-O
499
+ , PUNCT B-O
500
+ vitamins NOUN B-O
501
+ ( PUNCT B-O
502
+ A NOUN B-O
503
+ , PUNCT B-O
504
+ D NOUN B-O
505
+ , PUNCT B-O
506
+ B12 NOUN B-O
507
+ , PUNCT B-O
508
+ and CCONJ B-O
509
+ niacin NOUN B-O
510
+ ) PUNCT B-O
511
+ , PUNCT B-O
512
+ and CCONJ B-O
513
+ minerals NOUN B-O
514
+ ( PUNCT B-O
515
+ zinc NOUN B-O
516
+ and CCONJ B-O
517
+ selenium NOUN B-O
518
+ , PUNCT B-O
519
+ and CCONJ B-O
520
+ iron NOUN B-O
521
+ ) PUNCT B-O
522
+ . PUNCT B-O
523
+
524
+ To PART B-O
525
+ test VERB B-O
526
+ if SCONJ B-O
527
+ this DET B-O
528
+ polymorphism NOUN B-O
529
+ modulates VERB B-O
530
+ CD24 NOUN B-O
531
+ mRNA NOUN B-O
532
+ stability NOUN B-O
533
+ , PUNCT B-O
534
+ we PRON B-O
535
+ constructed VERB B-O
536
+ two NUM B-O
537
+ plasmids NOUN B-O
538
+ ( PUNCT B-O
539
+ pTracer PROPN B-O
540
+ CMV2 NOUN B-O
541
+ - PUNCT B-O
542
+ CD24TG NOUN B-O
543
+ and CCONJ B-O
544
+ pTracer PROPN B-O
545
+ CMV2 NOUN B-O
546
+ - PUNCT B-O
547
+ CD24del NOUN B-O
548
+ ; PUNCT B-O
549
+ Figure PROPN B-O
550
+ 5 NUM B-O
551
+ , PUNCT B-O
552
+ top ADJ B-O
553
+ panel NOUN B-O
554
+ ) PUNCT B-O
555
+ and CCONJ B-O
556
+ transfected VERB B-O
557
+ Chinese ADJ B-LF
558
+ hamster NOUN I-LF
559
+ ovary NOUN I-LF
560
+ ( PUNCT B-O
561
+ CHO PROPN B-AC
562
+ ) PUNCT B-O
563
+ cells NOUN B-O
564
+ with ADP B-O
565
+ the DET B-O
566
+ two NUM B-O
567
+ constructs NOUN B-O
568
+ . PUNCT B-O
569
+
570
+ Blood NOUN B-LF
571
+ pressure NOUN I-LF
572
+ ( PUNCT B-O
573
+ BP PROPN B-AC
574
+ ) PUNCT B-O
575
+ will AUX B-O
576
+ be AUX B-O
577
+ controlled VERB B-O
578
+ after ADP B-O
579
+ each DET B-O
580
+ visit NOUN B-O
581
+ . PUNCT B-O
582
+
583
+ Briefly ADV B-O
584
+ , PUNCT B-O
585
+ Phenotypic ADJ B-O
586
+ Age PROPN B-O
587
+ is AUX B-O
588
+ calculated VERB B-O
589
+ using VERB B-O
590
+ chronological ADJ B-O
591
+ age NOUN B-O
592
+ and CCONJ B-O
593
+ 9 NUM B-O
594
+ biomarkers NOUN B-O
595
+ ( PUNCT B-O
596
+ albumin NOUN B-O
597
+ , PUNCT B-O
598
+ creatinine NOUN B-O
599
+ , PUNCT B-O
600
+ glucose NOUN B-O
601
+ , PUNCT B-O
602
+ [ PUNCT B-O
603
+ log X B-O
604
+ ] PUNCT B-O
605
+ C NOUN B-LF
606
+ - NOUN I-LF
607
+ reactive ADJ I-LF
608
+ protein NOUN I-LF
609
+ [ PUNCT B-O
610
+ CRP PROPN B-AC
611
+ ] PUNCT B-O
612
+ , PUNCT B-O
613
+ lymphocyte NOUN B-O
614
+ percent NOUN B-O
615
+ , PUNCT B-O
616
+ mean ADJ B-O
617
+ cell NOUN B-O
618
+ volume NOUN B-O
619
+ , PUNCT B-O
620
+ red ADJ B-O
621
+ blood NOUN B-O
622
+ cell NOUN B-O
623
+ distribution NOUN B-O
624
+ width NOUN B-O
625
+ , PUNCT B-O
626
+ alkaline ADJ B-O
627
+ phosphatase NOUN B-O
628
+ , PUNCT B-O
629
+ and CCONJ B-O
630
+ white ADJ B-O
631
+ blood NOUN B-O
632
+ cell NOUN B-O
633
+ count NOUN B-O
634
+ ) PUNCT B-O
635
+ that PRON B-O
636
+ were AUX B-O
637
+ selected VERB B-O
638
+ using VERB B-O
639
+ a DET B-O
640
+ Cox PROPN B-O
641
+ proportional ADJ B-O
642
+ hazard NOUN B-O
643
+ elastic ADJ B-O
644
+ net NOUN B-O
645
+ model NOUN B-O
646
+ for ADP B-O
647
+ mortality NOUN B-O
648
+ based VERB B-O
649
+ on ADP B-O
650
+ 10 ADJ B-O
651
+ - NOUN B-O
652
+ fold ADJ B-O
653
+ cross NOUN B-O
654
+ - NOUN B-O
655
+ validation NOUN B-O
656
+ . PUNCT B-O
657
+
658
+ However ADV B-O
659
+ , PUNCT B-O
660
+ c NOUN B-O
661
+ - PUNCT B-O
662
+ Fos NOUN B-O
663
+ , PUNCT B-O
664
+ PStat3 PROPN B-O
665
+ , PUNCT B-O
666
+ and CCONJ B-O
667
+ PIP3 PROPN B-AC
668
+ formation NOUN B-O
669
+ were AUX B-O
670
+ not PART B-O
671
+ elevated VERB B-O
672
+ in ADP B-O
673
+ response NOUN B-O
674
+ to ADP B-O
675
+ leptin NOUN B-O
676
+ in ADP B-O
677
+ obese ADJ B-O
678
+ GSL PROPN B-O
679
+ - PUNCT B-O
680
+ deficient ADJ B-O
681
+ mice NOUN B-O
682
+ 6 NUM B-O
683
+ wk PROPN B-AC
684
+ p.i NOUN B-O
685
+ . PUNCT B-O
686
+
687
+ ( PUNCT B-O
688
+ Figures NOUN B-O
689
+ 7A NUM B-O
690
+ , PUNCT B-O
691
+ B NOUN B-O
692
+ and CCONJ B-O
693
+ S10A NOUN B-O
694
+ ) PUNCT B-O
695
+ . PUNCT B-O
696
+
697
+ No DET B-O
698
+ significant ADJ B-O
699
+ changes NOUN B-O
700
+ were AUX B-O
701
+ found VERB B-O
702
+ in ADP B-O
703
+ mediobasal ADJ B-LF
704
+ hypothalamus NOUN I-LF
705
+ ( PUNCT B-O
706
+ MBH PROPN B-AC
707
+ ) PUNCT B-O
708
+ baseline NOUN B-O
709
+ mRNA NOUN B-O
710
+ expression NOUN B-O
711
+ of ADP B-O
712
+ Pomc PROPN B-O
713
+ and CCONJ B-O
714
+ cocaine- NOUN B-O
715
+ and CCONJ B-O
716
+ amphetamine NOUN B-O
717
+ - PUNCT B-O
718
+ regulated VERB B-O
719
+ transcript NOUN B-O
720
+ ( PUNCT B-O
721
+ Cart PROPN B-O
722
+ ) PUNCT B-O
723
+ mRNA NOUN B-O
724
+ 6 NUM B-O
725
+ wk PROPN B-AC
726
+ p.i NOUN B-O
727
+ . PUNCT B-O
728
+
729
+ ( PUNCT B-O
730
+ Figure NOUN B-O
731
+ S10B NOUN B-O
732
+ ) PUNCT B-O
733
+ . PUNCT B-O
734
+
735
+ It PRON B-O
736
+ has AUX B-O
737
+ been AUX B-O
738
+ found VERB B-O
739
+ that SCONJ B-O
740
+ control NOUN B-O
741
+ has AUX B-O
742
+ been AUX B-O
743
+ centered VERB B-O
744
+ around ADP B-O
745
+ cyclin NOUN B-LF
746
+ - PUNCT I-LF
747
+ dependent ADJ I-LF
748
+ protein NOUN I-LF
749
+ kinases NOUN I-LF
750
+ ( PUNCT B-O
751
+ CDKs PROPN B-AC
752
+ ) PUNCT B-O
753
+ , PUNCT B-O
754
+ which PRON B-O
755
+ trigger VERB B-O
756
+ the DET B-O
757
+ major ADJ B-O
758
+ events NOUN B-O
759
+ of ADP B-O
760
+ the DET B-O
761
+ eukaryotic ADJ B-O
762
+ cell NOUN B-O
763
+ cycle NOUN B-O
764
+ . PUNCT B-O
765
+
766
+ The DET B-O
767
+ asparagine NOUN B-O
768
+ hydroxylase NOUN B-O
769
+ , PUNCT B-O
770
+ termed VERB B-O
771
+ factor NOUN B-LF
772
+ inhibiting VERB I-LF
773
+ HIF NOUN I-LF
774
+ HIF PROPN B-AC
775
+ ( PUNCT B-O
776
+ FIH PROPN B-AC
777
+ ) PUNCT B-O
778
+ ( PUNCT B-O
779
+ Uniprot ADJ B-O
780
+ accession NOUN B-O
781
+ number NOUN B-O
782
+ : PUNCT B-O
783
+ Q9NWT6 NOUN B-O
784
+ ) PUNCT B-O
785
+ , PUNCT B-O
786
+ hydroxylates VERB B-O
787
+ an DET B-O
788
+ asparagine NOUN B-O
789
+ residue NOUN B-O
790
+ within ADP B-O
791
+ HIFα NOUN B-O
792
+ subunits NOUN B-O
793
+ ( PUNCT B-O
794
+ N803 NUM B-O
795
+ on ADP B-O
796
+ HIF-1α PROPN B-AC
797
+ ) PUNCT B-O
798
+ , PUNCT B-O
799
+ resulting VERB B-O
800
+ in ADP B-O
801
+ steric ADJ B-O
802
+ inhibition NOUN B-O
803
+ of ADP B-O
804
+ its PRON B-O
805
+ interaction NOUN B-O
806
+ with ADP B-O
807
+ the DET B-O
808
+ transcriptional ADJ B-O
809
+ co NOUN B-O
810
+ - PUNCT B-O
811
+ activator NOUN B-O
812
+ p300 NOUN B-O
813
+ / SYM B-O
814
+ CBP PROPN B-O
815
+ , PUNCT B-O
816
+ thereby ADV B-O
817
+ inhibiting VERB B-O
818
+ HIF PROPN B-AC
819
+ - PUNCT B-O
820
+ dependent ADJ B-O
821
+ transcription NOUN B-O
822
+ [ PUNCT B-O
823
+ 2 NUM B-O
824
+ ] PUNCT B-O
825
+ . PUNCT B-O
826
+
827
+ The DET B-O
828
+ manuscript NOUN B-O
829
+ by ADP B-O
830
+ Varma PROPN B-O
831
+ et PROPN B-O
832
+ al NOUN B-O
833
+ explores VERB B-O
834
+ the DET B-O
835
+ relationships NOUN B-O
836
+ between ADP B-O
837
+ bile NOUN B-LF
838
+ acid NOUN I-LF
839
+ ( PUNCT B-O
840
+ BA PROPN B-AC
841
+ ) PUNCT B-O
842
+ levels NOUN B-O
843
+ / SYM B-O
844
+ synthesis NOUN B-O
845
+ and CCONJ B-O
846
+ dementia NOUN B-O
847
+ related VERB B-O
848
+ pathology NOUN B-O
849
+ , PUNCT B-O
850
+ such ADJ B-O
851
+ as ADP B-O
852
+ white ADJ B-LF
853
+ matter NOUN I-LF
854
+ lesions NOUN I-LF
855
+ ( PUNCT B-O
856
+ WML PROPN B-AC
857
+ ) PUNCT B-O
858
+ and CCONJ B-O
859
+ amyloid NOUN B-O
860
+ deposition NOUN B-O
861
+ , PUNCT B-O
862
+ as ADP B-O
863
+ well ADV B-O
864
+ as ADP B-O
865
+ vascular ADJ B-O
866
+ dementia NOUN B-O
867
+ risk NOUN B-O
868
+ and CCONJ B-O
869
+ sex NOUN B-O
870
+ related VERB B-O
871
+ differences NOUN B-O
872
+ . PUNCT B-O
873
+
874
+ However ADV B-O
875
+ , PUNCT B-O
876
+ current ADJ B-O
877
+ literature NOUN B-O
878
+ on ADP B-O
879
+ the DET B-O
880
+ stability NOUN B-O
881
+ of ADP B-O
882
+ the DET B-O
883
+ steroids NOUN B-O
884
+ in ADP B-O
885
+ DBS PROPN B-AC
886
+ is AUX B-O
887
+ very ADV B-O
888
+ limited ADJ B-O
889
+ , PUNCT B-O
890
+ dealing VERB B-O
891
+ exclusively ADV B-O
892
+ with ADP B-O
893
+ 17OHP PROPN B-AC
894
+ [ PUNCT B-O
895
+ 10–16 NUM B-O
896
+ ] PUNCT B-O
897
+ or CCONJ B-O
898
+ cortisol NOUN B-LF
899
+ ( PUNCT B-O
900
+ Cort PROPN B-AC
901
+ ) PUNCT B-O
902
+ [ PUNCT B-O
903
+ 17 NUM B-O
904
+ ] PUNCT B-O
905
+ . PUNCT B-O
906
+
907
+ CD PROPN B-AC
908
+ is AUX B-O
909
+ the DET B-O
910
+ most ADV B-O
911
+ common ADJ B-O
912
+ form NOUN B-O
913
+ of ADP B-O
914
+ inflammatory ADJ B-O
915
+ bowel NOUN B-O
916
+ disease NOUN B-O
917
+ , PUNCT B-O
918
+ the DET B-O
919
+ other ADJ B-O
920
+ being AUX B-O
921
+ ulcerative ADJ B-LF
922
+ colitis NOUN I-LF
923
+ ( PUNCT B-O
924
+ UC PROPN B-AC
925
+ ) PUNCT B-O
926
+ . PUNCT B-O
927
+
928
+ We PRON B-O
929
+ genotyped VERB B-O
930
+ a DET B-O
931
+ cohort NOUN B-O
932
+ of ADP B-O
933
+ 246 NUM B-O
934
+ Belgian ADJ B-O
935
+ UC PROPN B-AC
936
+ patients NOUN B-O
937
+ ( PUNCT B-O
938
+ Caucasians PROPN B-O
939
+ ) PUNCT B-O
940
+ for ADP B-O
941
+ IL23R NOUN B-O
942
+ ( PUNCT B-O
943
+ rs11209026 NUM B-O
944
+ ) PUNCT B-O
945
+ , PUNCT B-O
946
+ ATG16L1 NOUN B-O
947
+ ( PUNCT B-O
948
+ rs2241880 NUM B-O
949
+ ) PUNCT B-O
950
+ , PUNCT B-O
951
+ and CCONJ B-O
952
+ the DET B-O
953
+ novel ADJ B-O
954
+ 5p13.1 NOUN B-O
955
+ locus NOUN B-O
956
+ ( PUNCT B-O
957
+ rs4613763 NUM B-O
958
+ ) PUNCT B-O
959
+ . PUNCT B-O
960
+
961
+ Endophthalmitis NOUN B-O
962
+ after ADP B-O
963
+ vitreous ADJ B-O
964
+ surgery NOUN B-O
965
+ is AUX B-O
966
+ an DET B-O
967
+ uncommon ADJ B-O
968
+ but CCONJ B-O
969
+ a DET B-O
970
+ devastating ADJ B-O
971
+ complication.[1 NOUN B-O
972
+ ] PUNCT B-O
973
+ The DET B-O
974
+ reported VERB B-O
975
+ incidence NOUN B-O
976
+ of ADP B-O
977
+ endophthalmitis NOUN B-O
978
+ after ADP B-O
979
+ vitreous ADJ B-O
980
+ surgery NOUN B-O
981
+ ranges VERB B-O
982
+ from ADP B-O
983
+ 0.05 NUM B-O
984
+ % NOUN B-O
985
+ to ADP B-O
986
+ 0.02 NUM B-O
987
+ % NOUN B-O
988
+ with ADP B-O
989
+ 20 NUM B-O
990
+ - ADJ B-O
991
+ G NOUN B-O
992
+ vitrectomy.[2–10 NOUN B-O
993
+ ] PUNCT B-O
994
+ Initial ADJ B-O
995
+ reports NOUN B-O
996
+ showed VERB B-O
997
+ higher ADJ B-O
998
+ rates NOUN B-O
999
+ of ADP B-O
1000
+ post ADJ B-O
1001
+ - ADJ B-O
1002
+ minimally ADJ B-LF
1003
+ invasive ADJ I-LF
1004
+ vitreoretinal ADJ I-LF
1005
+ surgery NOUN I-LF
1006
+ ( PUNCT B-O
1007
+ MIVS PROPN B-AC
1008
+ ) PUNCT B-O
1009
+ endophthalmitis NOUN B-O
1010
+ , PUNCT B-O
1011
+ whereas SCONJ B-O
1012
+ recent ADJ B-O
1013
+ reports NOUN B-O
1014
+ have AUX B-O
1015
+ shown VERB B-O
1016
+ a DET B-O
1017
+ declining VERB B-O
1018
+ trend.[6,8,10,11 NUM B-O
1019
+ ] PUNCT B-O
1020
+ Body NOUN B-LF
1021
+ mass NOUN I-LF
1022
+ index NOUN I-LF
1023
+ ( PUNCT B-O
1024
+ BMI PROPN B-AC
1025
+ ) PUNCT B-O
1026
+ was AUX B-O
1027
+ calculated VERB B-O
1028
+ as ADP B-O
1029
+ the DET B-O
1030
+ weight NOUN B-O
1031
+ in ADP B-O
1032
+ kilograms NOUN B-O
1033
+ divided VERB B-O
1034
+ by ADP B-O
1035
+ the DET B-O
1036
+ square NOUN B-O
1037
+ of ADP B-O
1038
+ the DET B-O
1039
+ height NOUN B-O
1040
+ in ADP B-O
1041
+ meters NOUN B-O
1042
+ . PUNCT B-O
1043
+
1044
+ Source NOUN B-O
1045
+ data NOUN B-O
1046
+ are AUX B-O
1047
+ available ADJ B-O
1048
+ from ADP B-O
1049
+ https://figshare.com/s/b14c8e6cb1fc5135dd87 X B-O
1050
+ . PUNCT B-O
1051
+
1052
+ # PUNCT B-O
1053
+ Cells NOUN B-O
1054
+ , PUNCT B-O
1055
+ number NOUN B-O
1056
+ of ADP B-O
1057
+ cells NOUN B-O
1058
+ ; PUNCT B-O
1059
+ μ PUNCT B-O
1060
+ CA PROPN B-O
1061
+ , PUNCT B-O
1062
+ average ADJ B-O
1063
+ cell NOUN B-O
1064
+ area NOUN B-O
1065
+ ; PUNCT B-O
1066
+ LATE PROPN B-AC
1067
+ , PUNCT B-O
1068
+ a DET B-LF
1069
+ timing NOUN I-LF
1070
+ factor NOUN I-LF
1071
+ ; PUNCT B-O
1072
+ Leaf NOUN B-O
1073
+ A NOUN B-O
1074
+ , PUNCT B-O
1075
+ leaf NOUN B-O
1076
+ area NOUN B-O
1077
+ ; PUNCT B-O
1078
+ spch PROPN B-AC
1079
+ , PUNCT B-O
1080
+ speechless ADJ B-LF
1081
+ . PUNCT B-O
1082
+
1083
+ The DET B-O
1084
+ best ADJ B-LF
1085
+ linear ADJ I-LF
1086
+ unbiased ADJ I-LF
1087
+ estimates NOUN I-LF
1088
+ ( PUNCT B-O
1089
+ BLUEs PROPN B-AC
1090
+ ) PUNCT B-O
1091
+ of ADP B-O
1092
+ the DET B-O
1093
+ 481 NUM B-O
1094
+ BC1F3:4 NOUN B-O
1095
+ families NOUN B-O
1096
+ were AUX B-O
1097
+ estimated VERB B-O
1098
+ following VERB B-O
1099
+ the DET B-O
1100
+ model NOUN B-O
1101
+ : PUNCT B-O
1102
+ yijm NOUN B-O
1103
+ = SYM B-O
1104
+ μ+gi+ej+geij+δ(j)m+εijm X B-O
1105
+ , PUNCT B-O
1106
+ where SCONJ B-O
1107
+ yijm NOUN B-O
1108
+ is AUX B-O
1109
+ the DET B-O
1110
+ phenotype NOUN B-O
1111
+ of ADP B-O
1112
+ the DET B-O
1113
+ ith NOUN B-O
1114
+ ( PUNCT B-O
1115
+ i NOUN B-O
1116
+ = SYM B-O
1117
+ 1,2 NUM B-O
1118
+ … PUNCT B-O
1119
+ , PUNCT B-O
1120
+ 481 NUM B-O
1121
+ ) PUNCT B-O
1122
+ genotype NOUN B-O
1123
+ in ADP B-O
1124
+ the DET B-O
1125
+ jth NOUN B-O
1126
+ ( PUNCT B-O
1127
+ j NOUN B-O
1128
+ = SYM B-O
1129
+ 1,2,3,4 NUM B-O
1130
+ ) PUNCT B-O
1131
+ environment NOUN B-O
1132
+ , PUNCT B-O
1133
+ the DET B-O
1134
+ mth NOUN B-O
1135
+ ( PUNCT B-O
1136
+ m NOUN B-O
1137
+ = SYM B-O
1138
+ 1,2 NUM B-O
1139
+ ) PUNCT B-O
1140
+ replicate NOUN B-O
1141
+ effect NOUN B-O
1142
+ was AUX B-O
1143
+ nested VERB B-O
1144
+ in ADP B-O
1145
+ each DET B-O
1146
+ environment NOUN B-O
1147
+ . PUNCT B-O
1148
+
1149
+ μ PUNCT B-O
1150
+ is AUX B-O
1151
+ the DET B-O
1152
+ overall ADJ B-O
1153
+ mean NOUN B-O
1154
+ , PUNCT B-O
1155
+ gi NOUN B-O
1156
+ is AUX B-O
1157
+ the DET B-O
1158
+ genotype NOUN B-O
1159
+ effect NOUN B-O
1160
+ , PUNCT B-O
1161
+ ej NOUN B-O
1162
+ is AUX B-O
1163
+ the DET B-O
1164
+ environmental ADJ B-O
1165
+ effect NOUN B-O
1166
+ , PUNCT B-O
1167
+ geij NOUN B-O
1168
+ is AUX B-O
1169
+ the DET B-O
1170
+ G×E PROPN B-AC
1171
+ effect NOUN B-O
1172
+ , PUNCT B-O
1173
+ δ(j)m NOUN B-O
1174
+ is AUX B-O
1175
+ the DET B-O
1176
+ replicate NOUN B-O
1177
+ effect NOUN B-O
1178
+ , PUNCT B-O
1179
+ and CCONJ B-O
1180
+ εijm NOUN B-O
1181
+ ~ PUNCT B-O
1182
+ N NOUN B-O
1183
+ ( PUNCT B-O
1184
+ 0 NUM B-O
1185
+ , PUNCT B-O
1186
+ σε2 NUM B-O
1187
+ ) PUNCT B-O
1188
+ is AUX B-O
1189
+ the DET B-O
1190
+ error NOUN B-O
1191
+ term NOUN B-O
1192
+ . PUNCT B-O
1193
+
1194
+ KO PROPN B-AC
1195
+ , PUNCT B-O
1196
+ knockout NOUN B-LF
1197
+ ; PUNCT B-O
1198
+ PSD PROPN B-AC
1199
+ , PUNCT B-O
1200
+ postsynaptic ADJ B-LF
1201
+ density NOUN I-LF
1202
+ . PUNCT B-O
1203
+
1204
+ Small ADJ B-O
1205
+ RNA NOUN B-O
1206
+ sequencing NOUN B-O
1207
+ was AUX B-O
1208
+ performed VERB B-O
1209
+ to PART B-O
1210
+ profile VERB B-O
1211
+ miRNA PROPN B-AC
1212
+ expression NOUN B-O
1213
+ in ADP B-O
1214
+ SW480 NUM B-O
1215
+ and CCONJ B-O
1216
+ SW620 NUM B-O
1217
+ cell NOUN B-LF
1218
+ lysates NOUN I-LF
1219
+ ( PUNCT B-O
1220
+ CLs PROPN B-AC
1221
+ ) PUNCT B-O
1222
+ and CCONJ B-O
1223
+ their PRON B-O
1224
+ released VERB B-O
1225
+ EVs PROPN B-AC
1226
+ . PUNCT B-O
1227
+
1228
+ Initially ADV B-O
1229
+ , PUNCT B-O
1230
+ a DET B-O
1231
+ total NOUN B-O
1232
+ of ADP B-O
1233
+ 160.46 NUM B-O
1234
+ million NUM B-O
1235
+ raw ADJ B-O
1236
+ reads NOUN B-O
1237
+ were AUX B-O
1238
+ generated VERB B-O
1239
+ by ADP B-O
1240
+ an DET B-O
1241
+ Illumina PROPN B-O
1242
+ HiSeq-2000 PROPN B-O
1243
+ system NOUN B-O
1244
+ for ADP B-O
1245
+ all DET B-O
1246
+ the DET B-O
1247
+ samples NOUN B-O
1248
+ , PUNCT B-O
1249
+ yielding VERB B-O
1250
+ an DET B-O
1251
+ average ADJ B-O
1252
+ 12.77 NUM B-O
1253
+ million NUM B-O
1254
+ clean ADJ B-O
1255
+ reads NOUN B-O
1256
+ . PUNCT B-O
1257
+
1258
+ Inter- ADJ B-O
1259
+ and CCONJ B-O
1260
+ intra ADJ B-O
1261
+ - PUNCT B-O
1262
+ rater ADJ B-O
1263
+ reliability NOUN B-O
1264
+ was AUX B-O
1265
+ determined VERB B-O
1266
+ by ADP B-O
1267
+ means NOUN B-O
1268
+ of ADP B-O
1269
+ intraclass NOUN B-LF
1270
+ correlation NOUN I-LF
1271
+ coefficients NOUN I-LF
1272
+ ( PUNCT B-O
1273
+ ICC PROPN B-AC
1274
+ ) PUNCT B-O
1275
+ using VERB B-O
1276
+ R PROPN B-O
1277
+ Studio PROPN B-O
1278
+ ( PUNCT B-O
1279
+ Version PROPN B-O
1280
+ 1.1.456 NUM B-O
1281
+ ; PUNCT B-O
1282
+ RStudio PROPN B-O
1283
+ ) PUNCT B-O
1284
+ based VERB B-O
1285
+ on ADP B-O
1286
+ a DET B-O
1287
+ mean NOUN B-O
1288
+ of ADP B-O
1289
+ 2 NUM B-O
1290
+ raters NOUN B-O
1291
+ , PUNCT B-O
1292
+ consistency NOUN B-O
1293
+ , PUNCT B-O
1294
+ 2 NUM B-O
1295
+ - PUNCT B-O
1296
+ way NOUN B-O
1297
+ mixed VERB B-O
1298
+ - PUNCT B-O
1299
+ effects NOUN B-O
1300
+ model NOUN B-O
1301
+ for ADP B-O
1302
+ the DET B-O
1303
+ qualitative ADJ B-O
1304
+ analysis NOUN B-O
1305
+ [ PUNCT B-O
1306
+ 42 NUM B-O
1307
+ ] PUNCT B-O
1308
+ . PUNCT B-O
1309
+
1310
+ The DET B-O
1311
+ signaling NOUN B-O
1312
+ molecule NOUN B-O
1313
+ secreted VERB B-O
1314
+ by ADP B-O
1315
+ the DET B-O
1316
+ hypothalamus NOUN B-O
1317
+ is AUX B-O
1318
+ arginine NOUN B-LF
1319
+ vasopressin NOUN I-LF
1320
+ ( PUNCT B-O
1321
+ AVP PROPN B-AC
1322
+ ) PUNCT B-O
1323
+ , PUNCT B-O
1324
+ which PRON B-O
1325
+ binds VERB B-O
1326
+ to ADP B-O
1327
+ a DET B-O
1328
+ specific ADJ B-O
1329
+ protein NOUN B-O
1330
+ on ADP B-O
1331
+ the DET B-O
1332
+ surface NOUN B-O
1333
+ of ADP B-O
1334
+ kidney NOUN B-O
1335
+ cells NOUN B-O
1336
+ , PUNCT B-O
1337
+ AVP PROPN B-AC
1338
+ receptor NOUN B-O
1339
+ ( PUNCT B-O
1340
+ AVPR2 PROPN B-AC
1341
+ ) PUNCT B-O
1342
+ . PUNCT B-O
1343
+
1344
+ The DET B-O
1345
+ results NOUN B-O
1346
+ described VERB B-O
1347
+ above ADV B-O
1348
+ show VERB B-O
1349
+ that PRON B-O
1350
+ membrane NOUN B-O
1351
+ - PUNCT B-O
1352
+ tethered VERB B-O
1353
+ δ PUNCT B-O
1354
+ - PUNCT B-O
1355
+ ACTX NOUN B-O
1356
+ - PUNCT B-O
1357
+ Hv1a PROPN B-O
1358
+ expression NOUN B-O
1359
+ in ADP B-O
1360
+ PDF PROPN B-AC
1361
+ - PUNCT B-O
1362
+ secreting VERB B-O
1363
+ LNVs PROPN B-AC
1364
+ induces VERB B-O
1365
+ a DET B-O
1366
+ phase NOUN B-O
1367
+ - PUNCT B-O
1368
+ advance NOUN B-O
1369
+ of ADP B-O
1370
+ both CCONJ B-O
1371
+ sLNV PROPN B-AC
1372
+ PDF PROPN B-AC
1373
+ secretion NOUN B-O
1374
+ rhythms NOUN B-O
1375
+ and CCONJ B-O
1376
+ morning ADJ B-O
1377
+ anticipatory ADJ B-O
1378
+ locomotor ADJ B-O
1379
+ behavior NOUN B-O
1380
+ in ADP B-O
1381
+ LD PROPN B-AC
1382
+ , PUNCT B-O
1383
+ and CCONJ B-O
1384
+ disrupts VERB B-O
1385
+ free ADV B-O
1386
+ - PUNCT B-O
1387
+ running VERB B-O
1388
+ locomotor ADJ B-O
1389
+ rhythms NOUN B-O
1390
+ in ADP B-O
1391
+ DD PROPN B-AC
1392
+ . PUNCT B-O
1393
+
1394
+ In ADP B-O
1395
+ order NOUN B-O
1396
+ to PART B-O
1397
+ determine VERB B-O
1398
+ the DET B-O
1399
+ relationship NOUN B-O
1400
+ between ADP B-O
1401
+ these DET B-O
1402
+ phenotypes NOUN B-O
1403
+ and CCONJ B-O
1404
+ cellular ADJ B-O
1405
+ transcriptional ADJ B-O
1406
+ feedback NOUN B-O
1407
+ oscillation NOUN B-O
1408
+ , PUNCT B-O
1409
+ par PROPN B-LF
1410
+ domain NOUN I-LF
1411
+ protein NOUN I-LF
1412
+ 1 NUM I-LF
1413
+ ( PUNCT B-O
1414
+ PDP1 PROPN B-AC
1415
+ ) PUNCT B-O
1416
+ clock NOUN B-O
1417
+ protein NOUN B-O
1418
+ levels NOUN B-O
1419
+ were AUX B-O
1420
+ assayed VERB B-O
1421
+ in ADP B-O
1422
+ the DET B-O
1423
+ sLNV PROPN B-AC
1424
+ , PUNCT B-O
1425
+ dorsal ADJ B-LF
1426
+ lateral ADJ I-LF
1427
+ neuron NOUN I-LF
1428
+ ( PUNCT B-O
1429
+ LND PROPN B-AC
1430
+ ) PUNCT B-O
1431
+ , PUNCT B-O
1432
+ dorsal ADJ B-LF
1433
+ neuron NOUN I-LF
1434
+ ( PUNCT B-O
1435
+ DN)1 PROPN B-AC
1436
+ , PUNCT B-O
1437
+ and CCONJ B-O
1438
+ DN2 NOUN B-O
1439
+ neurons NOUN B-O
1440
+ of ADP B-O
1441
+ flies NOUN B-O
1442
+ expressing VERB B-O
1443
+ membrane NOUN B-O
1444
+ - PUNCT B-O
1445
+ tethered VERB B-O
1446
+ δ PUNCT B-O
1447
+ - PUNCT B-O
1448
+ ACTX NOUN B-O
1449
+ - PUNCT B-O
1450
+ Hv1a PROPN B-O
1451
+ in ADP B-O
1452
+ the DET B-O
1453
+ LNVs PROPN B-AC
1454
+ . PUNCT B-O
1455
+
1456
+ PDP1 PROPN B-AC
1457
+ is AUX B-O
1458
+ an DET B-O
1459
+ oscillating VERB B-O
1460
+ transcription NOUN B-O
1461
+ factor NOUN B-O
1462
+ that PRON B-O
1463
+ has AUX B-O
1464
+ been AUX B-O
1465
+ implicated VERB B-O
1466
+ in ADP B-O
1467
+ a DET B-O
1468
+ second ADJ B-O
1469
+ interlocking VERB B-O
1470
+ circadian ADJ B-O
1471
+ transcriptional ADJ B-O
1472
+ feedback NOUN B-O
1473
+ loop NOUN B-O
1474
+ [ PUNCT B-O
1475
+ 8 NUM B-O
1476
+ ] PUNCT B-O
1477
+ . PUNCT B-O
1478
+
1479
+ Mosquitoes NOUN B-O
1480
+ were AUX B-O
1481
+ allowed VERB B-O
1482
+ to ADP B-O
1483
+ feed VERB B-O
1484
+ on ADP B-O
1485
+ a DET B-O
1486
+ human NOUN B-O
1487
+ , PUNCT B-O
1488
+ then ADV B-O
1489
+ , PUNCT B-O
1490
+ 24 NUM B-O
1491
+ h NOUN B-O
1492
+ after ADP B-O
1493
+ the DET B-O
1494
+ blood NOUN B-O
1495
+ feeding NOUN B-O
1496
+ , PUNCT B-O
1497
+ gut NOUN B-O
1498
+ sections NOUN B-O
1499
+ were AUX B-O
1500
+ prepared VERB B-O
1501
+ for ADP B-O
1502
+ histology NOUN B-O
1503
+ and CCONJ B-O
1504
+ stained VERB B-O
1505
+ with ADP B-O
1506
+ hematoxylin NOUN B-LF
1507
+ and CCONJ I-LF
1508
+ eosin NOUN I-LF
1509
+ ( PUNCT B-O
1510
+ HE PROPN B-AC
1511
+ ) PUNCT B-O
1512
+ . PUNCT B-O
1513
+
1514
+ Compared VERB B-O
1515
+ to ADP B-O
1516
+ non ADJ B-O
1517
+ - PUNCT B-O
1518
+ transgenic ADJ B-O
1519
+ midguts NOUN B-O
1520
+ which PRON B-O
1521
+ were AUX B-O
1522
+ filled VERB B-O
1523
+ with ADP B-O
1524
+ intact ADJ B-O
1525
+ erythrocytes NOUN B-O
1526
+ ( PUNCT B-O
1527
+ Figure PROPN B-O
1528
+ 5A NUM B-O
1529
+ and CCONJ B-O
1530
+ 5C NUM B-O
1531
+ ) PUNCT B-O
1532
+ , PUNCT B-O
1533
+ erythrocytes NOUN B-O
1534
+ in ADP B-O
1535
+ the DET B-O
1536
+ midgut NOUN B-O
1537
+ of ADP B-O
1538
+ transgenic ADJ B-O
1539
+ mosquito NOUN B-O
1540
+ were AUX B-O
1541
+ extensively ADV B-O
1542
+ hemolyzed VERB B-O
1543
+ ( PUNCT B-O
1544
+ Figure PROPN B-O
1545
+ 5B NUM B-O
1546
+ and CCONJ B-O
1547
+ 5D NUM B-O
1548
+ ) PUNCT B-O
1549
+ . PUNCT B-O
1550
+
1551
+ Lymphocytes NOUN B-O
1552
+ were AUX B-O
1553
+ clearly ADV B-O
1554
+ contrasted VERB B-O
1555
+ in ADP B-O
1556
+ the DET B-O
1557
+ midgut NOUN B-O
1558
+ of ADP B-O
1559
+ transgenic ADJ B-O
1560
+ mosquito NOUN B-O
1561
+ ( PUNCT B-O
1562
+ Figure PROPN B-O
1563
+ 5D NUM B-O
1564
+ ) PUNCT B-O
1565
+ , PUNCT B-O
1566
+ but CCONJ B-O
1567
+ not PART B-O
1568
+ amongst ADP B-O
1569
+ the DET B-O
1570
+ intact ADJ B-O
1571
+ erythrocytes NOUN B-O
1572
+ in ADP B-O
1573
+ the DET B-O
1574
+ midgut NOUN B-O
1575
+ of ADP B-O
1576
+ non ADJ B-O
1577
+ - PUNCT B-O
1578
+ transgenic ADJ B-O
1579
+ mosquito NOUN B-O
1580
+ ( PUNCT B-O
1581
+ Figure PROPN B-O
1582
+ 5C NUM B-O
1583
+ ) PUNCT B-O
1584
+ . PUNCT B-O
1585
+
1586
+ These DET B-O
1587
+ results NOUN B-O
1588
+ are AUX B-O
1589
+ consistent ADJ B-O
1590
+ with ADP B-O
1591
+ the DET B-O
1592
+ data NOUN B-O
1593
+ shown VERB B-O
1594
+ in ADP B-O
1595
+ Figure PROPN B-O
1596
+ 3C NUM B-O
1597
+ , PUNCT B-O
1598
+ where SCONJ B-O
1599
+ the DET B-O
1600
+ secretion NOUN B-O
1601
+ of ADP B-O
1602
+ CEL NOUN B-O
1603
+ - PUNCT B-O
1604
+ III NUM B-O
1605
+ into ADP B-O
1606
+ the DET B-O
1607
+ midgut NOUN B-O
1608
+ lumen NOUN B-O
1609
+ caused VERB B-O
1610
+ effective ADJ B-O
1611
+ hemolysis NOUN B-O
1612
+ . PUNCT B-O
1613
+
1614
+ PM2.5 PROPN B-AC
1615
+ , PUNCT B-O
1616
+ fine ADJ B-LF
1617
+ particulate ADJ I-LF
1618
+ matter NOUN I-LF
1619
+ ( PUNCT B-O
1620
+ particulate ADJ B-O
1621
+ matter NOUN B-O
1622
+ with ADP B-O
1623
+ a DET B-O
1624
+ diameter NOUN B-O
1625
+ of ADP B-O
1626
+ < ADP B-O
1627
+ 2.5 NUM B-O
1628
+ μm NOUN B-O
1629
+ ) PUNCT B-O
1630
+ . PUNCT B-O
1631
+
1632
+ The DET B-O
1633
+ glycosphingolipid NOUN B-O
1634
+ isoglobotrihexosylceramide NOUN B-O
1635
+ , PUNCT B-O
1636
+ or CCONJ B-O
1637
+ isogloboside NOUN B-LF
1638
+ 3 NUM I-LF
1639
+ ( PUNCT B-O
1640
+ iGb3 PROPN B-AC
1641
+ ) PUNCT B-O
1642
+ , PUNCT B-O
1643
+ is AUX B-O
1644
+ believed VERB B-O
1645
+ to PART B-O
1646
+ be AUX B-O
1647
+ critical ADJ B-O
1648
+ for ADP B-O
1649
+ natural ADJ B-LF
1650
+ killer NOUN I-LF
1651
+ T PROPN I-LF
1652
+ ( PUNCT B-O
1653
+ NKT PROPN B-AC
1654
+ ) PUNCT B-O
1655
+ cell NOUN B-O
1656
+ development NOUN B-O
1657
+ and CCONJ B-O
1658
+ self NOUN B-O
1659
+ - PUNCT B-O
1660
+ recognition NOUN B-O
1661
+ in ADP B-O
1662
+ mice NOUN B-O
1663
+ and CCONJ B-O
1664
+ humans NOUN B-O
1665
+ . PUNCT B-O
1666
+
1667
+ Other ADJ B-O
1668
+ authors NOUN B-O
1669
+ [ X B-O
1670
+ 16,17 X B-O
1671
+ ] X B-O
1672
+ have AUX B-O
1673
+ proposed VERB B-O
1674
+ different ADJ B-O
1675
+ methods NOUN B-O
1676
+ for ADP B-O
1677
+ continuous ADJ B-O
1678
+ nICP PROPN B-AC
1679
+ monitoring NOUN B-O
1680
+ based VERB B-O
1681
+ on ADP B-O
1682
+ the DET B-O
1683
+ waveform NOUN B-O
1684
+ analysis NOUN B-O
1685
+ of ADP B-O
1686
+ cerebral ADJ B-O
1687
+ blood NOUN B-O
1688
+ flow NOUN B-O
1689
+ velocity NOUN B-O
1690
+ from ADP B-O
1691
+ the DET B-O
1692
+ middle ADJ B-LF
1693
+ cerebral ADJ I-LF
1694
+ artery NOUN I-LF
1695
+ ( PUNCT B-O
1696
+ MCA PROPN B-AC
1697
+ ) PUNCT B-O
1698
+ and CCONJ B-O
1699
+ arterial ADJ B-O
1700
+ pressure NOUN B-O
1701
+ . PUNCT B-O
1702
+
1703
+ The DET B-O
1704
+ median ADJ B-O
1705
+ age NOUN B-O
1706
+ of ADP B-O
1707
+ women NOUN B-O
1708
+ screened VERB B-O
1709
+ was AUX B-O
1710
+ 25 NUM B-O
1711
+ years NOUN B-O
1712
+ ( PUNCT B-O
1713
+ interquartile ADJ B-LF
1714
+ range NOUN I-LF
1715
+ [ PUNCT B-O
1716
+ IQR PROPN B-AC
1717
+ ] PUNCT B-O
1718
+ : PUNCT B-O
1719
+ 22–29 NUM B-O
1720
+ ) PUNCT B-O
1721
+ , PUNCT B-O
1722
+ 8 NUM B-O
1723
+ % NOUN B-O
1724
+ ( PUNCT B-O
1725
+ 105/1,271 NUM B-O
1726
+ ) PUNCT B-O
1727
+ were AUX B-O
1728
+ < ADP B-O
1729
+ 20 NUM B-O
1730
+ years NOUN B-O
1731
+ old ADJ B-O
1732
+ , PUNCT B-O
1733
+ and CCONJ B-O
1734
+ 49 NUM B-O
1735
+ % NOUN B-O
1736
+ ( PUNCT B-O
1737
+ 627/1,271 NUM B-O
1738
+ ) PUNCT B-O
1739
+ were AUX B-O
1740
+ < ADP B-O
1741
+ 24 NUM B-O
1742
+ years NOUN B-O
1743
+ old ADJ B-O
1744
+ ; PUNCT B-O
1745
+ 82 NUM B-O
1746
+ % NOUN B-O
1747
+ ( PUNCT B-O
1748
+ 1,026/1,271 NUM B-O
1749
+ ) PUNCT B-O
1750
+ were AUX B-O
1751
+ married ADJ B-O
1752
+ , PUNCT B-O
1753
+ and CCONJ B-O
1754
+ more ADJ B-O
1755
+ than ADP B-O
1756
+ a DET B-O
1757
+ third ADJ B-O
1758
+ ( PUNCT B-O
1759
+ 427/1,271 NUM B-O
1760
+ ) PUNCT B-O
1761
+ of ADP B-O
1762
+ the DET B-O
1763
+ women NOUN B-O
1764
+ did AUX B-O
1765
+ not PART B-O
1766
+ know VERB B-O
1767
+ their PRON B-O
1768
+ male ADJ B-O
1769
+ partners NOUN B-O
1770
+ ’ PUNCT B-O
1771
+ HIV PROPN B-O
1772
+ status NOUN B-O
1773
+ ( PUNCT B-O
1774
+ Table PROPN B-O
1775
+ 1 NUM B-O
1776
+ ) PUNCT B-O
1777
+ . PUNCT B-O
1778
+
1779
+ In ADP B-O
1780
+ a DET B-O
1781
+ ' PUNCT B-O
1782
+ status X B-O
1783
+ quo X B-O
1784
+ ' PUNCT B-O
1785
+ setting NOUN B-O
1786
+ , PUNCT B-O
1787
+ the DET B-O
1788
+ VMMC PROPN B-AC
1789
+ program NOUN B-O
1790
+ could AUX B-O
1791
+ be AUX B-O
1792
+ accompanied VERB B-O
1793
+ by ADP B-O
1794
+ continuations NOUN B-O
1795
+ of ADP B-O
1796
+ recent ADJ B-O
1797
+ trends NOUN B-O
1798
+ in ADP B-O
1799
+ antiretroviral ADJ B-LF
1800
+ therapy NOUN I-LF
1801
+ ( PUNCT B-O
1802
+ ART PROPN B-AC
1803
+ ) PUNCT B-O
1804
+ scale NOUN B-O
1805
+ - ADJ B-O
1806
+ up NOUN B-O
1807
+ , PUNCT B-O
1808
+ with ADP B-O
1809
+ constant ADJ B-O
1810
+ coverage NOUN B-O
1811
+ of ADP B-O
1812
+ prevention NOUN B-O
1813
+ interventions NOUN B-O
1814
+ and CCONJ B-O
1815
+ constant ADJ B-O
1816
+ rates NOUN B-O
1817
+ of ADP B-O
1818
+ risk NOUN B-O
1819
+ and CCONJ B-O
1820
+ ( PUNCT B-O
1821
+ non ADJ B-O
1822
+ - ADJ B-O
1823
+ VMMC PROPN B-AC
1824
+ ) PUNCT B-O
1825
+ protective ADJ B-O
1826
+ behaviors NOUN B-O
1827
+ . PUNCT B-O
1828
+
1829
+ This DET B-O
1830
+ study NOUN B-O
1831
+ included VERB B-O
1832
+ 31 NUM B-O
1833
+ women NOUN B-O
1834
+ who PRON B-O
1835
+ delivered VERB B-O
1836
+ small ADJ B-LF
1837
+ for ADP I-LF
1838
+ gestational ADJ I-LF
1839
+ age NOUN I-LF
1840
+ ( PUNCT B-O
1841
+ SGA PROPN B-AC
1842
+ ) PUNCT B-O
1843
+ babies NOUN B-O
1844
+ ( PUNCT B-O
1845
+ SGA PROPN B-AC
1846
+ , PUNCT B-O
1847
+ ≤10th ADJ B-O
1848
+ percentile NOUN B-O
1849
+ ) PUNCT B-O
1850
+ , PUNCT B-O
1851
+ 28 NUM B-O
1852
+ who PRON B-O
1853
+ delivered VERB B-O
1854
+ large ADJ B-LF
1855
+ for ADP I-LF
1856
+ gestational ADJ I-LF
1857
+ age NOUN I-LF
1858
+ ( PUNCT B-O
1859
+ LGA PROPN B-AC
1860
+ ) PUNCT B-O
1861
+ babies NOUN B-O
1862
+ ( PUNCT B-O
1863
+ ≥90th ADJ B-O
1864
+ percentile NOUN B-O
1865
+ ) PUNCT B-O
1866
+ , PUNCT B-O
1867
+ and CCONJ B-O
1868
+ 31 NUM B-O
1869
+ who PRON B-O
1870
+ delivered VERB B-O
1871
+ appropriate ADJ B-LF
1872
+ for ADP I-LF
1873
+ gestational ADJ I-LF
1874
+ age NOUN I-LF
1875
+ ( PUNCT B-O
1876
+ AGA PROPN B-AC
1877
+ ) PUNCT B-O
1878
+ babies NOUN B-O
1879
+ ( PUNCT B-O
1880
+ controls NOUN B-O
1881
+ , PUNCT B-O
1882
+ > NUM B-O
1883
+ 10th ADJ B-O
1884
+ to PART B-O
1885
+ < NUM B-O
1886
+ 90th NUM B-O
1887
+ percentile NOUN B-O
1888
+ ) PUNCT B-O
1889
+ . PUNCT B-O
1890
+
1891
+ Most ADV B-O
1892
+ strikingly ADV B-O
1893
+ , PUNCT B-O
1894
+ the DET B-O
1895
+ strongly ADV B-O
1896
+ conserved VERB B-O
1897
+ proline NOUN B-LF
1898
+ ( PUNCT B-O
1899
+ Pro PROPN B-AC
1900
+ ) PUNCT B-O
1901
+ residue NOUN B-O
1902
+ at ADP B-O
1903
+ site NOUN B-O
1904
+ 283 NUM B-O
1905
+ in ADP B-O
1906
+ NP PROPN B-AC
1907
+ is AUX B-O
1908
+ rendered VERB B-O
1909
+ highly ADV B-O
1910
+ unfit ADJ B-O
1911
+ by ADP B-O
1912
+ HSF1 PROPN B-AC
1913
+ inhibition NOUN B-O
1914
+ at ADP B-O
1915
+ febrile ADJ B-O
1916
+ temperatures NOUN B-O
1917
+ . PUNCT B-O
1918
+
1919
+ The DET B-O
1920
+ microRNA NOUN B-LF
1921
+ ( PUNCT B-O
1922
+ miRNA PROPN B-AC
1923
+ ) PUNCT B-O
1924
+ miR-148a NOUN B-O
1925
+ is AUX B-O
1926
+ a DET B-O
1927
+ 17- NUM B-O
1928
+ to ADP B-O
1929
+ 25 NUM B-O
1930
+ - ADJ B-O
1931
+ nucleotide NOUN B-O
1932
+ ( PUNCT B-O
1933
+ nt)-long ADJ B-O
1934
+ highly ADV B-O
1935
+ conserved ADJ B-O
1936
+ single ADJ B-O
1937
+ - ADJ B-O
1938
+ stranded ADJ B-O
1939
+ non ADJ B-O
1940
+ - ADJ B-O
1941
+ coding ADJ B-O
1942
+ RNA NOUN B-O
1943
+ regulating VERB B-O
1944
+ the DET B-O
1945
+ expression NOUN B-O
1946
+ of ADP B-O
1947
+ target NOUN B-O
1948
+ genes NOUN B-O
1949
+ at ADP B-O
1950
+ the DET B-O
1951
+ post ADJ B-O
1952
+ - ADJ B-O
1953
+ transcriptional ADJ B-O
1954
+ level NOUN B-O
1955
+ by ADP B-O
1956
+ binding VERB B-O
1957
+ to ADP B-O
1958
+ the DET B-O
1959
+ complementary ADJ B-O
1960
+ sites NOUN B-O
1961
+ of ADP B-O
1962
+ the DET B-O
1963
+ mRNA NOUN B-O
1964
+ of ADP B-O
1965
+ specific ADJ B-O
1966
+ target NOUN B-O
1967
+ genes NOUN B-O
1968
+ [ PUNCT B-O
1969
+ 4 NUM B-O
1970
+ ] PUNCT B-O
1971
+ . PUNCT B-O
1972
+
1973
+ While SCONJ B-O
1974
+ FGF PROPN B-AC
1975
+ primarily ADV B-O
1976
+ induces VERB B-O
1977
+ the DET B-O
1978
+ Ras PROPN B-O
1979
+ – PUNCT B-O
1980
+ Mitogen PROPN B-LF
1981
+ - PUNCT I-LF
1982
+ Activated PROPN I-LF
1983
+ Protein PROPN I-LF
1984
+ Kinase PROPN I-LF
1985
+ ( PUNCT B-O
1986
+ MAPK PROPN B-AC
1987
+ ) PUNCT B-O
1988
+ axis NOUN B-O
1989
+ to PART B-O
1990
+ promote VERB B-O
1991
+ lens NOUN B-O
1992
+ cell NOUN B-O
1993
+ differentiation NOUN B-O
1994
+ , PUNCT B-O
1995
+ PDGF PROPN B-AC
1996
+ preferentially ADV B-O
1997
+ stimulates VERB B-O
1998
+ Phosphoinositide NOUN B-LF
1999
+ 3 NUM I-LF
2000
+ - PUNCT I-LF
2001
+ kinase NOUN I-LF
2002
+ ( PUNCT B-O
2003
+ PI3 PROPN B-AC
2004
+ ) PUNCT B-O
2005
+ to PART B-O
2006
+ enhance VERB B-O
2007
+ Notch NOUN B-O
2008
+ signaling NOUN B-O
2009
+ , PUNCT B-O
2010
+ which PRON B-O
2011
+ is AUX B-O
2012
+ necessary ADJ B-O
2013
+ for ADP B-O
2014
+ maintaining VERB B-O
2015
+ the DET B-O
2016
+ lens NOUN B-O
2017
+ progenitor NOUN B-O
2018
+ cell NOUN B-O
2019
+ pool NOUN B-O
2020
+ . PUNCT B-O
2021
+
2022
+ To PART B-O
2023
+ begin VERB B-O
2024
+ to PART B-O
2025
+ establish VERB B-O
2026
+ such ADJ B-O
2027
+ links NOUN B-O
2028
+ between ADP B-O
2029
+ genotype NOUN B-O
2030
+ and CCONJ B-O
2031
+ growth NOUN B-O
2032
+ phenotype NOUN B-O
2033
+ , PUNCT B-O
2034
+ we PRON B-O
2035
+ developed VERB B-O
2036
+ a DET B-O
2037
+ computer NOUN B-O
2038
+ model NOUN B-O
2039
+ for ADP B-O
2040
+ the DET B-O
2041
+ intracellular ADJ B-O
2042
+ growth NOUN B-O
2043
+ of ADP B-O
2044
+ vesicular NOUN B-LF
2045
+ stomatitis NOUN I-LF
2046
+ virus NOUN I-LF
2047
+ ( PUNCT B-O
2048
+ VSV PROPN B-AC
2049
+ ) PUNCT B-O
2050
+ , PUNCT B-O
2051
+ a DET B-O
2052
+ well ADV B-O
2053
+ - PUNCT B-O
2054
+ studied VERB B-O
2055
+ , PUNCT B-O
2056
+ nonsegmented ADJ B-O
2057
+ , PUNCT B-O
2058
+ negative ADJ B-O
2059
+ - PUNCT B-O
2060
+ stranded ADJ B-O
2061
+ RNA NOUN B-O
2062
+ virus NOUN B-O
2063
+ . PUNCT B-O
2064
+
2065
+ Legend NOUN B-O
2066
+ : PUNCT B-O
2067
+ HCV PROPN B-AC
2068
+ : PUNCT B-O
2069
+ Chronic ADJ B-O
2070
+ hepatitis NOUN B-O
2071
+ C NOUN B-O
2072
+ ; PUNCT B-O
2073
+ DAA PROPN B-AC
2074
+ : PUNCT B-O
2075
+ Direct ADV B-LF
2076
+ - PUNCT I-LF
2077
+ acting VERB I-LF
2078
+ antivirals NOUN I-LF
2079
+ ; PUNCT B-O
2080
+ N NOUN B-O
2081
+ : PUNCT B-O
2082
+ Sample NOUN B-O
2083
+ size NOUN B-O
2084
+ ; PUNCT B-O
2085
+ comorbidities NOUN B-O
2086
+ : PUNCT B-O
2087
+ Comorbidity NOUN B-O
2088
+ ; PUNCT B-O
2089
+ comedications NOUN B-O
2090
+ : PUNCT B-O
2091
+ Comedication NOUN B-O
2092
+ . PUNCT B-O
2093
+
2094
+ Time NOUN B-O
2095
+ to ADP B-O
2096
+ ART PROPN B-AC
2097
+ initiation NOUN B-O
2098
+ was AUX B-O
2099
+ estimated VERB B-O
2100
+ using VERB B-O
2101
+ cumulative ADJ B-LF
2102
+ incidence NOUN I-LF
2103
+ functions NOUN I-LF
2104
+ ( PUNCT B-O
2105
+ CIFs PROPN B-AC
2106
+ ): PUNCT B-O
2107
+ mortality NOUN B-O
2108
+ and CCONJ B-O
2109
+ LTFU PROPN B-AC
2110
+ were AUX B-O
2111
+ considered VERB B-O
2112
+ competing VERB B-O
2113
+ events NOUN B-O
2114
+ to ADP B-O
2115
+ ART PROPN B-AC
2116
+ initiation NOUN B-O
2117
+ [ PUNCT B-O
2118
+ 9 NUM B-O
2119
+ ] PUNCT B-O
2120
+ , PUNCT B-O
2121
+ while SCONJ B-O
2122
+ those PRON B-O
2123
+ transferred VERB B-O
2124
+ out ADV B-O
2125
+ were AUX B-O
2126
+ right ADV B-O
2127
+ - PUNCT B-O
2128
+ censored VERB B-O
2129
+ , PUNCT B-O
2130
+ with ADP B-O
2131
+ the DET B-O
2132
+ assumption NOUN B-O
2133
+ that SCONJ B-O
2134
+ they PRON B-O
2135
+ remained VERB B-O
2136
+ in ADP B-O
2137
+ HIV PROPN B-O
2138
+ care NOUN B-O
2139
+ and CCONJ B-O
2140
+ had VERB B-O
2141
+ similar ADJ B-O
2142
+ outcomes NOUN B-O
2143
+ as ADP B-O
2144
+ patients NOUN B-O
2145
+ still ADV B-O
2146
+ in ADP B-O
2147
+ observation NOUN B-O
2148
+ . PUNCT B-O
2149
+
2150
+ FISH PROPN B-AC
2151
+ , PUNCT B-O
2152
+ fluorescence NOUN B-LF
2153
+ in ADP I-LF
2154
+ situ NOUN I-LF
2155
+ hybridization NOUN I-LF
2156
+ . PUNCT B-O
2157
+
2158
+ We PRON B-O
2159
+ included VERB B-O
2160
+ those PRON B-O
2161
+ with ADP B-O
2162
+ follow VERB B-O
2163
+ - PUNCT B-O
2164
+ up ADP B-O
2165
+ visits NOUN B-O
2166
+ and CCONJ B-O
2167
+ pulmonary ADJ B-LF
2168
+ function NOUN I-LF
2169
+ tests NOUN I-LF
2170
+ ( PUNCT B-O
2171
+ PFTs PROPN B-AC
2172
+ ) PUNCT B-O
2173
+ available ADJ B-O
2174
+ after ADP B-O
2175
+ hospitalization NOUN B-O
2176
+ . PUNCT B-O
2177
+
2178
+ WT PROPN B-O
2179
+ , PUNCT B-O
2180
+ wild ADJ B-O
2181
+ type NOUN B-O
2182
+ ; PUNCT B-O
2183
+ TG PROPN B-AC
2184
+ , PUNCT B-O
2185
+ transgenic ADJ B-O
2186
+ ; PUNCT B-O
2187
+ TSA PROPN B-AC
2188
+ , PUNCT B-O
2189
+ total ADJ B-LF
2190
+ salvianolic ADJ I-LF
2191
+ acid NOUN I-LF
2192
+ ; PUNCT B-O
2193
+ n NOUN B-O
2194
+ = SYM B-O
2195
+ 20 NUM B-O
2196
+ , PUNCT B-O
2197
+ error NOUN B-O
2198
+ bars NOUN B-O
2199
+ represent VERB B-O
2200
+ SEM NOUN B-O
2201
+ . PUNCT B-O
2202
+
2203
+ * NOUN B-O
2204
+ p<0.05 NUM B-O
2205
+ , PUNCT B-O
2206
+ * NOUN B-O
2207
+ * NOUN B-O
2208
+ p<0.01 NUM B-O
2209
+ versus ADP B-O
2210
+ WT PROPN B-O
2211
+ control NOUN B-O
2212
+ group NOUN B-O
2213
+ ; PUNCT B-O
2214
+ # SYM B-O
2215
+ p<0.05 NUM B-O
2216
+ , PUNCT B-O
2217
+ # SYM B-O
2218
+ # SYM B-O
2219
+ p<0.01 NUM B-O
2220
+ versus ADP B-O
2221
+ vehicle NOUN B-O
2222
+ - PUNCT B-O
2223
+ treated VERB B-O
2224
+ APPswe PROPN B-O
2225
+ / SYM B-O
2226
+ PS1dE9 PROPN B-O
2227
+ transgenic ADJ B-O
2228
+ group NOUN B-O
2229
+ . PUNCT B-O
2230
+
2231
+ M PROPN B-O
2232
+ , PUNCT B-O
2233
+ mirror NOUN B-O
2234
+ ; PUNCT B-O
2235
+ P NOUN B-O
2236
+ , PUNCT B-O
2237
+ pinhole NOUN B-O
2238
+ ; PUNCT B-O
2239
+ λ/2 NUM B-O
2240
+ , PUNCT B-O
2241
+ λ/2 NUM B-O
2242
+ plate NOUN B-O
2243
+ ; PUNCT B-O
2244
+ PBS PROPN B-AC
2245
+ , PUNCT B-O
2246
+ polarizing VERB B-LF
2247
+ beam NOUN I-LF
2248
+ splitter NOUN I-LF
2249
+ ; PUNCT B-O
2250
+ EOM PROPN B-O
2251
+ , PUNCT B-O
2252
+ electro ADJ B-O
2253
+ optical ADJ B-O
2254
+ modulator NOUN B-O
2255
+ ; PUNCT B-O
2256
+ S NOUN B-O
2257
+ , PUNCT B-O
2258
+ shutter NOUN B-O
2259
+ ; PUNCT B-O
2260
+ F NOUN B-O
2261
+ , PUNCT B-O
2262
+ filter NOUN B-O
2263
+ ; PUNCT B-O
2264
+ Pol PROPN B-O
2265
+ , PUNCT B-O
2266
+ polarizer NOUN B-O
2267
+ ; PUNCT B-O
2268
+ DC NOUN B-O
2269
+ , PUNCT B-O
2270
+ dichroic ADJ B-O
2271
+ mirror NOUN B-O
2272
+ . PUNCT B-O
2273
+
2274
+ In ADP B-O
2275
+ the DET B-O
2276
+ third ADJ B-O
2277
+ group NOUN B-O
2278
+ , PUNCT B-O
2279
+ the DET B-O
2280
+ variables NOUN B-O
2281
+ related VERB B-O
2282
+ to ADP B-O
2283
+ resuming VERB B-O
2284
+ dialysis NOUN B-O
2285
+ were AUX B-O
2286
+ : PUNCT B-O
2287
+ Charlson PROPN B-O
2288
+ comorbidity NOUN B-O
2289
+ index NOUN B-O
2290
+ [ PUNCT B-O
2291
+ 18 NUM B-O
2292
+ ] PUNCT B-O
2293
+ ; PUNCT B-O
2294
+ dialysis NOUN B-O
2295
+ modality NOUN B-O
2296
+ and CCONJ B-O
2297
+ access NOUN B-O
2298
+ , PUNCT B-O
2299
+ such ADJ B-O
2300
+ as ADP B-O
2301
+ arterio ADJ B-O
2302
+ - PUNCT B-O
2303
+ venous ADJ B-O
2304
+ ( PUNCT B-O
2305
+ AV PROPN B-AC
2306
+ ) PUNCT B-O
2307
+ fistula NOUN B-O
2308
+ as ADP B-O
2309
+ access NOUN B-O
2310
+ for ADP B-O
2311
+ hemodialysis NOUN B-O
2312
+ , PUNCT B-O
2313
+ venous ADJ B-O
2314
+ catheters NOUN B-O
2315
+ , PUNCT B-O
2316
+ or CCONJ B-O
2317
+ peritoneal ADJ B-O
2318
+ catheters NOUN B-O
2319
+ for ADP B-O
2320
+ peritoneal ADJ B-O
2321
+ dialysis NOUN B-O
2322
+ ; PUNCT B-O
2323
+ and CCONJ B-O
2324
+ biochemical ADJ B-O
2325
+ parameters NOUN B-O
2326
+ such ADJ B-O
2327
+ as ADP B-O
2328
+ creatinine NOUN B-O
2329
+ , PUNCT B-O
2330
+ hemoglobin NOUN B-O
2331
+ , PUNCT B-O
2332
+ urea NOUN B-O
2333
+ , PUNCT B-O
2334
+ potassium NOUN B-O
2335
+ , PUNCT B-O
2336
+ ionic ADJ B-O
2337
+ calcium NOUN B-O
2338
+ , PUNCT B-O
2339
+ phosphorus NOUN B-O
2340
+ , PUNCT B-O
2341
+ parathormone NOUN B-LF
2342
+ ( PUNCT B-O
2343
+ PTH PROPN B-AC
2344
+ ) PUNCT B-O
2345
+ , PUNCT B-O
2346
+ serum NOUN B-O
2347
+ albumin NOUN B-O
2348
+ and CCONJ B-O
2349
+ C NOUN B-O
2350
+ - PUNCT B-O
2351
+ reactive ADJ B-O
2352
+ protein NOUN B-O
2353
+ . PUNCT B-O
2354
+
2355
+ HPD PROPN B-AC
2356
+ , PUNCT B-O
2357
+ human ADJ B-LF
2358
+ population NOUN I-LF
2359
+ density NOUN I-LF
2360
+ . PUNCT B-O
2361
+
2362
+ PD PROPN B-AC
2363
+ ; PUNCT B-O
2364
+ the DET B-O
2365
+ ERK PROPN B-O
2366
+ inhibitor NOUN B-O
2367
+ PD98059 PROPN B-LF
2368
+ . PUNCT B-O
2369
+
2370
+ β PUNCT B-O
2371
+ - PUNCT B-O
2372
+ Actin PROPN B-O
2373
+ served VERB B-O
2374
+ as ADP B-O
2375
+ an DET B-O
2376
+ input NOUN B-O
2377
+ control NOUN B-O
2378
+ . PUNCT B-O
2379
+
2380
+ ( PUNCT B-O
2381
+ G NOUN B-O
2382
+ ) PUNCT B-O
2383
+ Levels NOUN B-O
2384
+ of ADP B-O
2385
+ inflammatory ADJ B-O
2386
+ response NOUN B-O
2387
+ markers NOUN B-O
2388
+ ( PUNCT B-O
2389
+ NF NOUN B-O
2390
+ - PUNCT B-O
2391
+ κB NOUN B-O
2392
+ p65 NOUN B-O
2393
+ activity NOUN B-O
2394
+ and CCONJ B-O
2395
+ TNFα PROPN B-O
2396
+ and CCONJ B-O
2397
+ IL-8 PROPN B-AC
2398
+ production NOUN B-O
2399
+ , PUNCT B-O
2400
+ by ADP B-O
2401
+ ELISA PROPN B-O
2402
+ ) PUNCT B-O
2403
+ in ADP B-O
2404
+ control NOUN B-O
2405
+ medium NOUN B-O
2406
+ - PUNCT B-O
2407
+ treated VERB B-O
2408
+ or CCONJ B-O
2409
+ CSE PROPN B-AC
2410
+ - PUNCT B-O
2411
+ exposed VERB B-O
2412
+ H292 PROPN B-O
2413
+ cells NOUN B-O
2414
+ , PUNCT B-O
2415
+ pretreated VERB B-O
2416
+ with ADP B-O
2417
+ either CCONJ B-O
2418
+ Csn-B PROPN B-AC
2419
+ ( PUNCT B-O
2420
+ 10 NUM B-O
2421
+ μM NOUN B-O
2422
+ ) PUNCT B-O
2423
+ or CCONJ B-O
2424
+ Veh PROPN B-AC
2425
+ . PUNCT B-O
2426
+
2427
+ ( PUNCT B-O
2428
+ left ADJ B-O
2429
+ panel NOUN B-O
2430
+ ) PUNCT B-O
2431
+ Spectrophotometric ADJ B-O
2432
+ reading NOUN B-O
2433
+ value NOUN B-O
2434
+ ( PUNCT B-O
2435
+ A450 NOUN B-O
2436
+ ) PUNCT B-O
2437
+ represents VERB B-O
2438
+ NF NOUN B-O
2439
+ - PUNCT B-O
2440
+ κB NOUN B-O
2441
+ p65 NOUN B-O
2442
+ activity NOUN B-O
2443
+ . PUNCT B-O
2444
+
2445
+ ( PUNCT B-O
2446
+ middle ADJ B-O
2447
+ and CCONJ B-O
2448
+ right ADJ B-O
2449
+ panels NOUN B-O
2450
+ ) PUNCT B-O
2451
+ The DET B-O
2452
+ levels NOUN B-O
2453
+ of ADP B-O
2454
+ cytokine NOUN B-O
2455
+ and CCONJ B-O
2456
+ chemokine NOUN B-O
2457
+ are AUX B-O
2458
+ shown VERB B-O
2459
+ as ADP B-O
2460
+ protein NOUN B-O
2461
+ concentrations NOUN B-O
2462
+ ( PUNCT B-O
2463
+ pg NOUN B-O
2464
+ ) PUNCT B-O
2465
+ in ADP B-O
2466
+ ml NOUN B-O
2467
+ of ADP B-O
2468
+ cell NOUN B-O
2469
+ culture NOUN B-O
2470
+ medium NOUN B-O
2471
+ . PUNCT B-O
2472
+
2473
+ The DET B-O
2474
+ EP3 NOUN B-O
2475
+ receptor NOUN B-O
2476
+ as ADP B-O
2477
+ a DET B-O
2478
+ PGE2 PROPN B-AC
2479
+ receptor NOUN B-O
2480
+ , PUNCT B-O
2481
+ same ADJ B-O
2482
+ as ADP B-O
2483
+ the DET B-O
2484
+ other ADJ B-O
2485
+ types NOUN B-O
2486
+ of ADP B-O
2487
+ EP PROPN B-O
2488
+ receptor NOUN B-O
2489
+ ( PUNCT B-O
2490
+ EP1 NOUN B-O
2491
+ - PUNCT B-O
2492
+ 2 NUM B-O
2493
+ and CCONJ B-O
2494
+ EP4 PROPN B-O
2495
+ ) PUNCT B-O
2496
+ , PUNCT B-O
2497
+ is AUX B-O
2498
+ a DET B-O
2499
+ G PROPN B-LF
2500
+ - PUNCT I-LF
2501
+ protein NOUN I-LF
2502
+ - PUNCT I-LF
2503
+ coupled VERB I-LF
2504
+ receptor NOUN I-LF
2505
+ ( PUNCT B-O
2506
+ GPCR PROPN B-AC
2507
+ ) PUNCT B-O
2508
+ [ X B-O
2509
+ 23 NUM B-O
2510
+ ] PUNCT B-O
2511
+ and CCONJ B-O
2512
+ specifically ADV B-O
2513
+ contributes VERB B-O
2514
+ to ADP B-O
2515
+ the DET B-O
2516
+ cough NOUN B-O
2517
+ through ADP B-O
2518
+ activating VERB B-O
2519
+ airway NOUN B-O
2520
+ sensory ADJ B-O
2521
+ nerves NOUN B-O
2522
+ [ X B-O
2523
+ 24 NUM B-O
2524
+ , PUNCT B-O
2525
+ 25 NUM B-O
2526
+ ] PUNCT B-O
2527
+ . PUNCT B-O
2528
+
2529
+ G6PD PROPN B-AC
2530
+ , PUNCT B-O
2531
+ glucose-6 NOUN B-LF
2532
+ - PUNCT I-LF
2533
+ phosphate NOUN I-LF
2534
+ dehydrogenase NOUN I-LF
2535
+ . PUNCT B-O
2536
+
2537
+ Partial ADJ B-LF
2538
+ least ADJ I-LF
2539
+ squares NOUN I-LF
2540
+ regression NOUN I-LF
2541
+ ( PUNCT B-O
2542
+ PLSR PROPN B-AC
2543
+ ) PUNCT B-O
2544
+ , PUNCT B-O
2545
+ a DET B-O
2546
+ technique NOUN B-O
2547
+ previously ADV B-O
2548
+ shown VERB B-O
2549
+ to ADP B-O
2550
+ be AUX B-O
2551
+ useful ADJ B-O
2552
+ for ADP B-O
2553
+ the DET B-O
2554
+ creation NOUN B-O
2555
+ of ADP B-O
2556
+ signal NOUN B-O
2557
+ – PUNCT B-O
2558
+ response NOUN B-O
2559
+ models NOUN B-O
2560
+ based VERB B-O
2561
+ on ADP B-O
2562
+ highly ADV B-O
2563
+ dimensional ADJ B-O
2564
+ datasets NOUN B-O
2565
+ , PUNCT B-O
2566
+ was AUX B-O
2567
+ used VERB B-O
2568
+ to ADP B-O
2569
+ correlate VERB B-O
2570
+ phosphorylation NOUN B-O
2571
+ events NOUN B-O
2572
+ to ADP B-O
2573
+ both CCONJ B-O
2574
+ migration NOUN B-O
2575
+ and CCONJ B-O
2576
+ proliferation NOUN B-O
2577
+ [ PUNCT B-O
2578
+ 10 NUM B-O
2579
+ ] PUNCT B-O
2580
+ . PUNCT B-O
2581
+
2582
+ Copper NOUN B-LF
2583
+ ( PUNCT B-O
2584
+ Cu PROPN B-AC
2585
+ ) PUNCT B-O
2586
+ and CCONJ B-O
2587
+ zinc NOUN B-LF
2588
+ ( PUNCT B-O
2589
+ Zn PROPN B-AC
2590
+ ) PUNCT B-O
2591
+ are AUX B-O
2592
+ essential ADJ B-O
2593
+ nutritional ADJ B-O
2594
+ metals NOUN B-O
2595
+ required VERB B-O
2596
+ for ADP B-O
2597
+ the DET B-O
2598
+ function NOUN B-O
2599
+ of ADP B-O
2600
+ numerous ADJ B-O
2601
+ enzymatic ADJ B-O
2602
+ molecules NOUN B-O
2603
+ active ADJ B-O
2604
+ in ADP B-O
2605
+ human ADJ B-O
2606
+ cell NOUN B-O
2607
+ metabolic ADJ B-O
2608
+ pathways NOUN B-O
2609
+ . PUNCT B-O
2610
+
2611
+ RNase NOUN B-O
2612
+ T NOUN B-O
2613
+ showed VERB B-O
2614
+ in ADP B-O
2615
+ in ADP B-O
2616
+ vitro ADJ B-O
2617
+ experiments NOUN B-O
2618
+ that SCONJ B-O
2619
+ it PRON B-O
2620
+ can AUX B-O
2621
+ serve VERB B-O
2622
+ as ADP B-O
2623
+ a DET B-O
2624
+ downstream ADJ B-O
2625
+ exonuclease NOUN B-O
2626
+ of ADP B-O
2627
+ Endonuclease NOUN B-LF
2628
+ V NOUN I-LF
2629
+ ( PUNCT B-O
2630
+ alternative ADJ B-LF
2631
+ EndoV)–mediated PROPN B-AC
2632
+ base NOUN I-LF
2633
+ excision NOUN I-LF
2634
+ repair NOUN I-LF
2635
+ ( PUNCT B-O
2636
+ AER PROPN B-AC
2637
+ ) PUNCT B-O
2638
+ [ PUNCT B-O
2639
+ 33 NUM B-O
2640
+ ] PUNCT B-O
2641
+ . PUNCT B-O
2642
+
2643
+ Interestingly ADV B-O
2644
+ , PUNCT B-O
2645
+ incubation NOUN B-O
2646
+ of ADP B-O
2647
+ parasites NOUN B-O
2648
+ in ADP B-O
2649
+ the DET B-O
2650
+ presence NOUN B-O
2651
+ of ADP B-O
2652
+ 0.5 NUM B-O
2653
+ μM NOUN B-O
2654
+ Cytochalasin NOUN B-LF
2655
+ D PROPN I-LF
2656
+ ( PUNCT B-O
2657
+ CD PROPN B-AC
2658
+ ; PUNCT B-O
2659
+ a DET B-O
2660
+ drug NOUN B-O
2661
+ used VERB B-O
2662
+ to PART B-O
2663
+ disrupt VERB B-O
2664
+ F NOUN B-O
2665
+ - ADJ B-O
2666
+ actin NOUN B-O
2667
+ ) PUNCT B-O
2668
+ did AUX B-O
2669
+ not PART B-O
2670
+ result VERB B-O
2671
+ in ADP B-O
2672
+ significant ADJ B-O
2673
+ reduction NOUN B-O
2674
+ of ADP B-O
2675
+ bead NOUN B-O
2676
+ translocation NOUN B-O
2677
+ ( PUNCT B-O
2678
+ Fig NOUN B-O
2679
+ 1 NUM B-O
2680
+ G NOUN B-O
2681
+ ) PUNCT B-O
2682
+ , PUNCT B-O
2683
+ confirming VERB B-O
2684
+ that SCONJ B-O
2685
+ retrograde ADJ B-O
2686
+ membrane NOUN B-O
2687
+ flow NOUN B-O
2688
+ can AUX B-O
2689
+ occur VERB B-O
2690
+ in ADP B-O
2691
+ the DET B-O
2692
+ absence NOUN B-O
2693
+ of ADP B-O
2694
+ a DET B-O
2695
+ functional ADJ B-O
2696
+ acto NOUN B-O
2697
+ - ADJ B-O
2698
+ myosin NOUN B-O
2699
+ system NOUN B-O
2700
+ , PUNCT B-O
2701
+ as SCONJ B-O
2702
+ reported VERB B-O
2703
+ previously ADV B-O
2704
+ [ X B-O
2705
+ 5 NUM B-O
2706
+ ] PUNCT B-O
2707
+ . PUNCT B-O
2708
+
2709
+ Focal ADJ B-O
2710
+ increases NOUN B-O
2711
+ in ADP B-O
2712
+ fMRI PROPN B-AC
2713
+ - PUNCT B-O
2714
+ activity NOUN B-O
2715
+ were AUX B-O
2716
+ observed VERB B-O
2717
+ in ADP B-O
2718
+ area NOUN B-O
2719
+ AIP PROPN B-AC
2720
+ , PUNCT B-O
2721
+ consisting VERB B-O
2722
+ of ADP B-O
2723
+ both DET B-O
2724
+ aAIP PROPN B-AC
2725
+ and CCONJ B-O
2726
+ pAIP PROPN B-AC
2727
+ ( PUNCT B-O
2728
+ Fig NOUN B-O
2729
+ . PUNCT B-O
2730
+
2731
+ 2A NUM B-O
2732
+ , PUNCT B-O
2733
+ left ADJ B-O
2734
+ column NOUN B-O
2735
+ , PUNCT B-O
2736
+ first ADJ B-O
2737
+ and CCONJ B-O
2738
+ second ADJ B-O
2739
+ row NOUN B-O
2740
+ ) PUNCT B-O
2741
+ , PUNCT B-O
2742
+ in ADP B-O
2743
+ the DET B-O
2744
+ anterior ADJ B-O
2745
+ lateral ADJ B-O
2746
+ bank NOUN B-O
2747
+ of ADP B-O
2748
+ the DET B-O
2749
+ IPS PROPN B-AC
2750
+ . PUNCT B-O
2751
+
2752
+ Furthermore ADV B-O
2753
+ , PUNCT B-O
2754
+ aAIP PROPN B-AC
2755
+ - PUNCT B-O
2756
+ EM PROPN B-AC
2757
+ elicited VERB B-O
2758
+ significant ADJ B-O
2759
+ fMRI PROPN B-AC
2760
+ activations NOUN B-O
2761
+ in ADP B-O
2762
+ the DET B-O
2763
+ medial ADJ B-O
2764
+ bank NOUN B-O
2765
+ of ADP B-O
2766
+ the DET B-O
2767
+ IPS PROPN B-AC
2768
+ ( PUNCT B-O
2769
+ area NOUN B-O
2770
+ MIP PROPN B-AC
2771
+ ) PUNCT B-O
2772
+ , PUNCT B-O
2773
+ in ADP B-O
2774
+ area NOUN B-O
2775
+ PFG PROPN B-AC
2776
+ in ADP B-O
2777
+ the DET B-O
2778
+ rostral ADJ B-O
2779
+ portion NOUN B-O
2780
+ of ADP B-O
2781
+ the DET B-O
2782
+ inferior ADJ B-O
2783
+ parietal ADJ B-O
2784
+ lobule NOUN B-O
2785
+ , PUNCT B-O
2786
+ in ADP B-O
2787
+ the DET B-O
2788
+ most ADV B-O
2789
+ anterior ADJ B-O
2790
+ sector NOUN B-O
2791
+ of ADP B-O
2792
+ somatosensory ADJ B-O
2793
+ area NOUN B-O
2794
+ S2 PROPN B-O
2795
+ and CCONJ B-O
2796
+ in ADP B-O
2797
+ ventral ADJ B-LF
2798
+ premotor ADJ I-LF
2799
+ cortex NOUN I-LF
2800
+ ( PUNCT B-O
2801
+ PMv PROPN B-AC
2802
+ , PUNCT B-O
2803
+ or CCONJ B-O
2804
+ area NOUN B-O
2805
+ F5 NUM B-O
2806
+ ; PUNCT B-O
2807
+ Fig NOUN B-O
2808
+ . PUNCT B-O
2809
+
2810
+ 2A NUM B-O
2811
+ , PUNCT B-O
2812
+ left ADJ B-O
2813
+ column NOUN B-O
2814
+ , PUNCT B-O
2815
+ rows NOUN B-O
2816
+ 2–5 NUM B-O
2817
+ ) PUNCT B-O
2818
+ . PUNCT B-O
2819
+
2820
+ Here ADV B-O
2821
+ , PUNCT B-O
2822
+ the DET B-O
2823
+ high ADJ B-O
2824
+ level NOUN B-O
2825
+ of ADP B-O
2826
+ HR PROPN B-AC
2827
+ is AUX B-O
2828
+ due ADJ B-O
2829
+ to ADP B-O
2830
+ the DET B-O
2831
+ programmed VERB B-O
2832
+ formation NOUN B-O
2833
+ of ADP B-O
2834
+ a DET B-O
2835
+ large ADJ B-O
2836
+ number NOUN B-O
2837
+ of ADP B-O
2838
+ DNA NOUN B-O
2839
+ double ADJ B-LF
2840
+ - PUNCT I-LF
2841
+ strand NOUN I-LF
2842
+ breaks NOUN I-LF
2843
+ ( PUNCT B-O
2844
+ DSBs PROPN B-AC
2845
+ ) PUNCT B-O
2846
+ [ PUNCT B-O
2847
+ 4 NUM B-O
2848
+ ] PUNCT B-O
2849
+ . PUNCT B-O
2850
+
2851
+ Natural ADJ B-LF
2852
+ killer NOUN I-LF
2853
+ T PROPN I-LF
2854
+ ( PUNCT B-O
2855
+ NKT PROPN B-AC
2856
+ ) PUNCT B-O
2857
+ cell NOUN B-O
2858
+ development NOUN B-O
2859
+ depends VERB B-O
2860
+ on ADP B-O
2861
+ recognition NOUN B-O
2862
+ of ADP B-O
2863
+ self NOUN B-O
2864
+ - PUNCT B-O
2865
+ glycolipids NOUN B-O
2866
+ via ADP B-O
2867
+ their PRON B-O
2868
+ semi ADJ B-O
2869
+ - PUNCT B-O
2870
+ invariant ADJ B-O
2871
+ Vα14i NOUN B-O
2872
+ - PUNCT B-O
2873
+ TCR PROPN B-O
2874
+ . PUNCT B-O
2875
+
2876
+ However ADV B-O
2877
+ , PUNCT B-O
2878
+ to PART B-O
2879
+ what DET B-O
2880
+ extent NOUN B-O
2881
+ TCR PROPN B-O
2882
+ - PUNCT B-O
2883
+ mediated VERB B-O
2884
+ signals NOUN B-O
2885
+ determine VERB B-O
2886
+ identity NOUN B-O
2887
+ and CCONJ B-O
2888
+ function NOUN B-O
2889
+ of ADP B-O
2890
+ mature ADJ B-O
2891
+ NKT PROPN B-AC
2892
+ cells NOUN B-O
2893
+ remains AUX B-O
2894
+ incompletely ADV B-O
2895
+ understood VERB B-O
2896
+ . PUNCT B-O
2897
+
2898
+ Inhalation NOUN B-O
2899
+ injury NOUN B-O
2900
+ predisposes VERB B-O
2901
+ these DET B-O
2902
+ patients NOUN B-O
2903
+ to ADP B-O
2904
+ respiratory ADJ B-O
2905
+ failure NOUN B-O
2906
+ , PUNCT B-O
2907
+ acute ADJ B-LF
2908
+ respiratory ADJ I-LF
2909
+ distress NOUN I-LF
2910
+ syndrome NOUN I-LF
2911
+ ( PUNCT B-O
2912
+ ARDS PROPN B-AC
2913
+ ) PUNCT B-O
2914
+ , PUNCT B-O
2915
+ and CCONJ B-O
2916
+ pneumonia NOUN B-O
2917
+ . PUNCT B-O
2918
+
2919
+ In ADP B-O
2920
+ support NOUN B-O
2921
+ of ADP B-O
2922
+ this DET B-O
2923
+ idea NOUN B-O
2924
+ we PRON B-O
2925
+ found VERB B-O
2926
+ that SCONJ B-O
2927
+ a DET B-O
2928
+ bacterially ADV B-O
2929
+ expressed VERB B-O
2930
+ p180 NOUN B-O
2931
+ lysine NOUN B-O
2932
+ - PUNCT B-O
2933
+ rich ADJ B-O
2934
+ region NOUN B-O
2935
+ , PUNCT B-O
2936
+ fused VERB B-O
2937
+ to ADP B-O
2938
+ glutathione NOUN B-LF
2939
+ s NOUN I-LF
2940
+ - PUNCT I-LF
2941
+ transferase NOUN I-LF
2942
+ ( PUNCT B-O
2943
+ GST PROPN B-AC
2944
+ - PUNCT B-O
2945
+ p180 NOUN B-O
2946
+ - PUNCT B-O
2947
+ Lys PROPN B-O
2948
+ ; PUNCT B-O
2949
+ Figure PROPN B-O
2950
+ 7A NUM B-O
2951
+ ) PUNCT B-O
2952
+ , PUNCT B-O
2953
+ could AUX B-O
2954
+ form VERB B-O
2955
+ a DET B-O
2956
+ complex NOUN B-O
2957
+ with ADP B-O
2958
+ a DET B-O
2959
+ 32P NOUN B-O
2960
+ - PUNCT B-O
2961
+ labeled VERB B-O
2962
+ RNA NOUN B-O
2963
+ derived VERB B-O
2964
+ from ADP B-O
2965
+ the DET B-O
2966
+ human ADJ B-O
2967
+ insulin NOUN B-O
2968
+ SSCR PROPN B-AC
2969
+ ( PUNCT B-O
2970
+ Figure PROPN B-O
2971
+ 7B NUM B-O
2972
+ ) PUNCT B-O
2973
+ . PUNCT B-O
2974
+
2975
+ In ADP B-O
2976
+ contrast NOUN B-O
2977
+ , PUNCT B-O
2978
+ no DET B-O
2979
+ complex NOUN B-O
2980
+ was AUX B-O
2981
+ formed VERB B-O
2982
+ between ADP B-O
2983
+ this DET B-O
2984
+ RNA NOUN B-O
2985
+ and CCONJ B-O
2986
+ a DET B-O
2987
+ control NOUN B-O
2988
+ protein NOUN B-O
2989
+ , PUNCT B-O
2990
+ GST PROPN B-AC
2991
+ - PUNCT B-O
2992
+ Ran PROPN B-O
2993
+ ( PUNCT B-O
2994
+ Figure PROPN B-O
2995
+ 7A NUM B-O
2996
+ – PUNCT B-O
2997
+ B NOUN B-O
2998
+ ) PUNCT B-O
2999
+ . PUNCT B-O
3000
+
3001
+ By ADP B-O
3002
+ varying VERB B-O
3003
+ the DET B-O
3004
+ amount NOUN B-O
3005
+ of ADP B-O
3006
+ protein NOUN B-O
3007
+ in ADP B-O
3008
+ our PRON B-O
3009
+ binding VERB B-O
3010
+ assay NOUN B-O
3011
+ , PUNCT B-O
3012
+ we PRON B-O
3013
+ estimate VERB B-O
3014
+ that SCONJ B-O
3015
+ the DET B-O
3016
+ GST PROPN B-AC
3017
+ - PUNCT B-O
3018
+ p180 NOUN B-O
3019
+ - PUNCT B-O
3020
+ Lys PROPN B-O
3021
+ binds VERB B-O
3022
+ to ADP B-O
3023
+ RNA NOUN B-O
3024
+ with ADP B-O
3025
+ an DET B-O
3026
+ affinity NOUN B-O
3027
+ of ADP B-O
3028
+ about ADP B-O
3029
+ 0.8 NUM B-O
3030
+ µM. NOUN B-O
3031
+ Here ADV B-O
3032
+ we PRON B-O
3033
+ report VERB B-O
3034
+ the DET B-O
3035
+ modulation NOUN B-O
3036
+ of ADP B-O
3037
+ the DET B-O
3038
+ structure NOUN B-O
3039
+ / SYM B-O
3040
+ function NOUN B-O
3041
+ of ADP B-O
3042
+ recombinant ADJ B-O
3043
+ Ace PROPN B-AC
3044
+ by ADP B-O
3045
+ small ADJ B-O
3046
+ molecule NOUN B-O
3047
+ calcium NOUN B-LF
3048
+ - PUNCT I-LF
3049
+ activated VERB I-LF
3050
+ chloride NOUN I-LF
3051
+ channel NOUN I-LF
3052
+ ( PUNCT B-O
3053
+ CaCC PROPN B-AC
3054
+ ) PUNCT B-O
3055
+ inhibitors NOUN B-O
3056
+ , PUNCT B-O
3057
+ namely ADV B-O
3058
+ CaCCinh PROPN B-O
3059
+ - PUNCT B-O
3060
+ A01 PROPN B-O
3061
+ , PUNCT B-O
3062
+ digallic ADJ B-LF
3063
+ acid NOUN I-LF
3064
+ ( PUNCT B-O
3065
+ DGA PROPN B-AC
3066
+ ) PUNCT B-O
3067
+ and CCONJ B-O
3068
+ tannic NOUN B-O
3069
+ acid NOUN B-O
3070
+ . PUNCT B-O
3071
+
3072
+ IMD PROPN B-O
3073
+ , PUNCT B-O
3074
+ Index PROPN B-O
3075
+ of ADP B-O
3076
+ Multiple ADJ B-O
3077
+ Deprivation NOUN B-O
3078
+ , PUNCT B-O
3079
+ derived VERB B-O
3080
+ from ADP B-O
3081
+ the DET B-O
3082
+ Lower PROPN B-O
3083
+ Super PROPN B-O
3084
+ Output PROPN B-O
3085
+ Area PROPN B-O
3086
+ of ADP B-O
3087
+ the DET B-O
3088
+ patient NOUN B-O
3089
+ ’s PART B-O
3090
+ home NOUN B-O
3091
+ address NOUN B-O
3092
+ ; PUNCT B-O
3093
+ IQR PROPN B-AC
3094
+ , PUNCT B-O
3095
+ interquartile ADJ B-LF
3096
+ range NOUN I-LF
3097
+ . PUNCT B-O
3098
+
3099
+ Analyzed VERB B-O
3100
+ parameter NOUN B-O
3101
+ were AUX B-O
3102
+ immunoreactive ADJ B-LF
3103
+ area NOUN B-O
3104
+ ( PUNCT B-O
3105
+ IR PROPN B-AC
3106
+ ) PUNCT B-O
3107
+ in ADP B-O
3108
+ percent NOUN B-O
3109
+ of ADP B-O
3110
+ the DET B-O
3111
+ ROI NOUN B-O
3112
+ area NOUN B-O
3113
+ and CCONJ B-O
3114
+ summarized VERB B-O
3115
+ object NOUN B-O
3116
+ intensity NOUN B-O
3117
+ in ADP B-O
3118
+ a.u./mm2 X B-O
3119
+ . PUNCT B-O
3120
+
3121
+ Bovine ADJ B-LF
3122
+ serum NOUN I-LF
3123
+ albumin NOUN I-LF
3124
+ ( PUNCT B-O
3125
+ BSA PROPN B-AC
3126
+ ) PUNCT B-O
3127
+ medium NOUN B-O
3128
+ , PUNCT B-O
3129
+ containing VERB B-O
3130
+ no DET B-O
3131
+ peptides NOUN B-O
3132
+ , PUNCT B-O
3133
+ was AUX B-O
3134
+ used VERB B-O
3135
+ as ADP B-O
3136
+ a DET B-O
3137
+ negative ADJ B-O
3138
+ control NOUN B-O
3139
+ . PUNCT B-O
3140
+
3141
+ Recently ADV B-O
3142
+ , PUNCT B-O
3143
+ it PRON B-O
3144
+ has AUX B-O
3145
+ been AUX B-O
3146
+ shown VERB B-O
3147
+ that PRON B-O
3148
+ PD-L1 PROPN B-AC
3149
+ intracytoplasmic ADJ B-O
3150
+ tail NOUN B-O
3151
+ can AUX B-O
3152
+ trigger VERB B-O
3153
+ a DET B-O
3154
+ signal NOUN B-O
3155
+ cascade NOUN B-O
3156
+ that PRON B-O
3157
+ make VERB B-O
3158
+ cancer NOUN B-O
3159
+ cells NOUN B-O
3160
+ resistant ADJ B-O
3161
+ to ADP B-O
3162
+ interferon NOUN B-LF
3163
+ ( PUNCT B-O
3164
+ IFN)-mediated PROPN B-AC
3165
+ cytotoxicity NOUN B-O
3166
+ through ADP B-O
3167
+ a DET B-O
3168
+ STAT3 NOUN B-O
3169
+ / SYM B-O
3170
+ caspase-7 NOUN B-O
3171
+ - PUNCT B-O
3172
+ dependent ADJ B-O
3173
+ pathway NOUN B-O
3174
+ [ PUNCT B-O
3175
+ 16 NUM B-O
3176
+ ] PUNCT B-O
3177
+ . PUNCT B-O
3178
+
3179
+ Their PRON B-O
3180
+ transcripts NOUN B-O
3181
+ were AUX B-O
3182
+ generally ADV B-O
3183
+ classified VERB B-O
3184
+ into ADP B-O
3185
+ two NUM B-O
3186
+ groups NOUN B-O
3187
+ including VERB B-O
3188
+ long ADJ B-O
3189
+ non ADJ B-O
3190
+ - ADJ B-O
3191
+ coding ADJ B-O
3192
+ RNAs NOUN B-O
3193
+ ( PUNCT B-O
3194
+ longer ADJ B-O
3195
+ than ADP B-O
3196
+ 200 NUM B-O
3197
+ nt NOUN B-O
3198
+ ) PUNCT B-O
3199
+ and CCONJ B-O
3200
+ small ADJ B-LF
3201
+ RNAs NOUN I-LF
3202
+ ( PUNCT B-O
3203
+ sRNAs PROPN B-AC
3204
+ , PUNCT B-O
3205
+ shorter ADJ B-O
3206
+ than ADP B-O
3207
+ 200 NUM B-O
3208
+ nt NOUN B-O
3209
+ ) PUNCT B-O
3210
+ . PUNCT B-O
3211
+
3212
+ The DET B-O
3213
+ underlying VERB B-O
3214
+ data NOUN B-O
3215
+ can AUX B-O
3216
+ be AUX B-O
3217
+ found VERB B-O
3218
+ in ADP B-O
3219
+ S1 PROPN B-O
3220
+ Data PROPN B-O
3221
+ . PUNCT B-O
3222
+
3223
+ ; PUNCT B-O
3224
+ eFSGM PROPN B-AC
3225
+ , PUNCT B-O
3226
+ extended ADJ B-LF
3227
+ FSGM PROPN I-LF
3228
+ FSGM PROPN B-AC
3229
+ ; PUNCT B-O
3230
+ FBA PROPN B-AC
3231
+ , PUNCT B-O
3232
+ feature NOUN B-LF
3233
+ - PUNCT I-LF
3234
+ based VERB I-LF
3235
+ attention NOUN I-LF
3236
+ ; PUNCT B-O
3237
+ HR PROPN B-AC
3238
+ , PUNCT B-O
3239
+ hit NOUN B-LF
3240
+ rate NOUN I-LF
3241
+ ; PUNCT B-O
3242
+ RT PROPN B-AC
3243
+ , PUNCT B-O
3244
+ reaction NOUN B-LF
3245
+ time NOUN I-LF
3246
+ . PUNCT B-O
3247
+
3248
+ Results NOUN B-O
3249
+ of ADP B-O
3250
+ logistic ADJ B-O
3251
+ regression NOUN B-O
3252
+ models NOUN B-O
3253
+ are AUX B-O
3254
+ presented VERB B-O
3255
+ using VERB B-O
3256
+ adjusted ADJ B-LF
3257
+ Odds NOUN I-LF
3258
+ Ratio PROPN I-LF
3259
+ ( PUNCT B-O
3260
+ aOR PROPN B-AC
3261
+ ) PUNCT B-O
3262
+ and CCONJ B-O
3263
+ 95 NUM B-LF
3264
+ % NOUN I-LF
3265
+ Confidence PROPN I-LF
3266
+ Interval NOUN I-LF
3267
+ ( PUNCT B-O
3268
+ 95 PROPN B-AC
3269
+ ) PUNCT B-O
3270
+ . PUNCT B-O
3271
+
3272
+ To PART B-O
3273
+ handle VERB B-O
3274
+ missing VERB B-O
3275
+ data NOUN B-O
3276
+ of ADP B-O
3277
+ two NUM B-O
3278
+ covariates NOUN B-O
3279
+ , PUNCT B-O
3280
+ multivariate ADJ B-O
3281
+ logistic ADJ B-O
3282
+ regression NOUN B-O
3283
+ models NOUN B-O
3284
+ were AUX B-O
3285
+ performed VERB B-O
3286
+ using VERB B-O
3287
+ multiple ADJ B-O
3288
+ imputation NOUN B-O
3289
+ [ X B-O
3290
+ 45,46 NUM B-O
3291
+ ] PUNCT B-O
3292
+ . PUNCT B-O
3293
+
3294
+ F NOUN B-O
3295
+ - PUNCT B-O
3296
+ actin NOUN B-O
3297
+ induction NOUN B-O
3298
+ was AUX B-O
3299
+ plotted VERB B-O
3300
+ as ADP B-O
3301
+ mean NOUN B-O
3302
+ ± SYM B-O
3303
+ standard ADJ B-O
3304
+ error NOUN B-O
3305
+ of ADP B-O
3306
+ the DET B-O
3307
+ mean NOUN B-O
3308
+ ( PUNCT B-O
3309
+ SEM PROPN B-O
3310
+ ) PUNCT B-O
3311
+ . PUNCT B-O
3312
+
3313
+ n NOUN B-O
3314
+ = SYM B-O
3315
+ 3 NUM B-O
3316
+ . PUNCT B-O
3317
+
3318
+ * PUNCT B-O
3319
+ p NOUN B-O
3320
+ ≤ PUNCT B-O
3321
+ 0.05 NUM B-O
3322
+ , PUNCT B-O
3323
+ * PUNCT B-O
3324
+ * PUNCT B-O
3325
+ * PUNCT B-O
3326
+ p NOUN B-O
3327
+ ≤ PUNCT B-O
3328
+ 0.001 NUM B-O
3329
+ . PUNCT B-O
3330
+
3331
+ ( PUNCT B-O
3332
+ D X B-O
3333
+ ) PUNCT B-O
3334
+ Time NOUN B-O
3335
+ - PUNCT B-O
3336
+ lapse NOUN B-O
3337
+ total ADJ B-LF
3338
+ internal ADJ I-LF
3339
+ reflection NOUN I-LF
3340
+ fluorescence NOUN I-LF
3341
+ microscopy NOUN I-LF
3342
+ ( PUNCT B-O
3343
+ TIRFM PROPN B-AC
3344
+ ) PUNCT B-O
3345
+ of ADP B-O
3346
+ speckle NOUN B-O
3347
+ mCherry NOUN B-O
3348
+ - PUNCT B-O
3349
+ β PUNCT B-O
3350
+ - PUNCT B-O
3351
+ actin NOUN B-O
3352
+ in ADP B-O
3353
+ eNOS PROPN B-AC
3354
+ and CCONJ B-O
3355
+ G2A NOUN B-O
3356
+ T NOUN B-O
3357
+ cells NOUN B-O
3358
+ , PUNCT B-O
3359
+ stimulated VERB B-O
3360
+ on ADP B-O
3361
+ CD3 PROPN B-O
3362
+ Ab PROPN B-O
3363
+ - PUNCT B-O
3364
+ coated VERB B-O
3365
+ chambers NOUN B-O
3366
+ . PUNCT B-O
3367
+
3368
+ Free ADJ B-O
3369
+ fatty ADJ B-LF
3370
+ acid NOUN I-LF
3371
+ ( PUNCT B-O
3372
+ FA PROPN B-AC
3373
+ ) PUNCT B-O
3374
+ and CCONJ B-O
3375
+ polar ADJ B-O
3376
+ lipid NOUN B-O
3377
+ species NOUN B-O
3378
+ were AUX B-O
3379
+ determined VERB B-O
3380
+ in ADP B-O
3381
+ flowers NOUN B-O
3382
+ and CCONJ B-O
3383
+ caulinary ADJ B-O
3384
+ leaves NOUN B-O
3385
+ of ADP B-O
3386
+ 7 NUM B-O
3387
+ - PUNCT B-O
3388
+ week NOUN B-O
3389
+ - PUNCT B-O
3390
+ old ADJ B-O
3391
+ , PUNCT B-O
3392
+ mature ADJ B-O
3393
+ flowering VERB B-O
3394
+ plants NOUN B-O
3395
+ . PUNCT B-O
3396
+
3397
+ The DET B-O
3398
+ substances NOUN B-O
3399
+ which PRON B-O
3400
+ mainly ADV B-O
3401
+ contributed VERB B-O
3402
+ to ADP B-O
3403
+ Ozone PROPN B-LF
3404
+ layer NOUN I-LF
3405
+ depletion NOUN I-LF
3406
+ ( PUNCT B-O
3407
+ OLD PROPN B-AC
3408
+ ) PUNCT B-O
3409
+ were AUX B-O
3410
+ Methane PROPN B-O
3411
+ , PUNCT B-O
3412
+ bromotrifluoro- NOUN B-O
3413
+ , PUNCT B-O
3414
+ Halon PROPN B-O
3415
+ 1301 NUM B-O
3416
+ ( PUNCT B-O
3417
+ 7.16E-06 NUM B-O
3418
+ kg NOUN B-O
3419
+ CFC-11 NOUN B-O
3420
+ eq NOUN B-O
3421
+ ) PUNCT B-O
3422
+ and CCONJ B-O
3423
+ Methane PROPN B-O
3424
+ , PUNCT B-O
3425
+ trichlorofluoro NOUN B-O
3426
+ CFC-11 NOUN B-O
3427
+ ( PUNCT B-O
3428
+ 7.28559E-11 NUM B-O
3429
+ kg NOUN B-O
3430
+ CFC-11 NOUN B-O
3431
+ eq NOUN B-O
3432
+ ) PUNCT B-O
3433
+ . PUNCT B-O
3434
+
3435
+ There PRON B-O
3436
+ is VERB B-O
3437
+ an DET B-O
3438
+ increasing VERB B-O
3439
+ expectation NOUN B-O
3440
+ that SCONJ B-O
3441
+ CHWs PROPN B-AC
3442
+ will AUX B-O
3443
+ participate VERB B-O
3444
+ in ADP B-O
3445
+ disease NOUN B-O
3446
+ surveillance NOUN B-O
3447
+ and CCONJ B-O
3448
+ data NOUN B-O
3449
+ collection NOUN B-O
3450
+ , PUNCT B-O
3451
+ diagnosis NOUN B-O
3452
+ and CCONJ B-O
3453
+ referral NOUN B-O
3454
+ for ADP B-O
3455
+ care NOUN B-O
3456
+ , PUNCT B-O
3457
+ and CCONJ B-O
3458
+ antiretroviral ADJ B-LF
3459
+ therapy NOUN I-LF
3460
+ ( PUNCT B-O
3461
+ ART PROPN B-AC
3462
+ ) PUNCT B-O
3463
+ provision NOUN B-O
3464
+ [ PUNCT B-O
3465
+ 10 NUM B-O
3466
+ ] PUNCT B-O
3467
+ . PUNCT B-O
3468
+
3469
+ ( PUNCT B-O
3470
+ A X B-O
3471
+ ) PUNCT B-O
3472
+ Trimethoprim NOUN B-O
3473
+ + SYM B-O
3474
+ sulfamethizole NOUN B-O
3475
+ . PUNCT B-O
3476
+
3477
+ ( PUNCT B-O
3478
+ B X B-O
3479
+ ) PUNCT B-O
3480
+ Trimethoprim NOUN B-O
3481
+ + SYM B-O
3482
+ AZT PROPN B-AC
3483
+ . PUNCT B-O
3484
+
3485
+ Synergistic ADJ B-O
3486
+ fractional ADJ B-LF
3487
+ inhibitory ADJ I-LF
3488
+ concentration NOUN I-LF
3489
+ index NOUN I-LF
3490
+ ( PUNCT B-O
3491
+ FICI PROPN B-AC
3492
+ ) PUNCT B-O
3493
+ values NOUN B-O
3494
+ ( PUNCT B-O
3495
+ ≤0.5 NUM B-O
3496
+ ) PUNCT B-O
3497
+ are AUX B-O
3498
+ marked VERB B-O
3499
+ with ADP B-O
3500
+ yellow ADJ B-O
3501
+ bars NOUN B-O
3502
+ , PUNCT B-O
3503
+ and CCONJ B-O
3504
+ nonsynergistic ADJ B-O
3505
+ ( PUNCT B-O
3506
+ FICI PROPN B-AC
3507
+ > SYM B-O
3508
+ 0.5 NUM B-O
3509
+ ) PUNCT B-O
3510
+ FICI PROPN B-AC
3511
+ values NOUN B-O
3512
+ are AUX B-O
3513
+ marked VERB B-O
3514
+ with ADP B-O
3515
+ blue ADJ B-O
3516
+ bars NOUN B-O
3517
+ . PUNCT B-O
3518
+
3519
+ However ADV B-O
3520
+ , PUNCT B-O
3521
+ Zbtb7a NOUN B-O
3522
+ is AUX B-O
3523
+ not PART B-O
3524
+ restricted VERB B-O
3525
+ to PART B-O
3526
+ NFκB PROPN B-AC
3527
+ target NOUN B-O
3528
+ promoters NOUN B-O
3529
+ , PUNCT B-O
3530
+ and CCONJ B-O
3531
+ indeed ADV B-O
3532
+ , PUNCT B-O
3533
+ a DET B-O
3534
+ large ADJ B-O
3535
+ fraction NOUN B-O
3536
+ of ADP B-O
3537
+ all DET B-O
3538
+ genomic ADJ B-O
3539
+ promoters NOUN B-O
3540
+ are AUX B-O
3541
+ associated VERB B-O
3542
+ with ADP B-O
3543
+ overlapping VERB B-O
3544
+ — PUNCT B-O
3545
+ or CCONJ B-O
3546
+ nearby ADJ B-O
3547
+ — PUNCT B-O
3548
+ Zbtb7a NOUN B-O
3549
+ binding NOUN B-O
3550
+ ( PUNCT B-O
3551
+ up ADP B-O
3552
+ to PART B-O
3553
+ 17 NUM B-O
3554
+ % PUNCT B-O
3555
+ or CCONJ B-O
3556
+ 41 NUM B-O
3557
+ % PUNCT B-O
3558
+ , PUNCT B-O
3559
+ respectively ADV B-O
3560
+ , PUNCT B-O
3561
+ of ADP B-O
3562
+ all DET B-O
3563
+ promoters NOUN B-O
3564
+ in ADP B-O
3565
+ fibroblasts NOUN B-O
3566
+ ; PUNCT B-O
3567
+ Fig PROPN B-O
3568
+ 2D NUM B-O
3569
+ ) PUNCT B-O
3570
+ , PUNCT B-O
3571
+ with ADP B-O
3572
+ a DET B-O
3573
+ preference NOUN B-O
3574
+ for ADP B-O
3575
+ guanine NOUN B-LF
3576
+ - PUNCT I-LF
3577
+ cytosine NOUN I-LF
3578
+ ( PUNCT B-O
3579
+ GC)-rich PROPN B-AC
3580
+ and CCONJ B-O
3581
+ CpG NOUN B-LF
3582
+ island NOUN I-LF
3583
+ ( PUNCT B-O
3584
+ CGI)-containing PROPN B-AC
3585
+ promoters NOUN B-O
3586
+ ( PUNCT B-O
3587
+ S2H PROPN B-O
3588
+ and CCONJ B-O
3589
+ S2I PROPN B-O
3590
+ Fig PROPN B-O
3591
+ ) PUNCT B-O
3592
+ . PUNCT B-O
3593
+
3594
+ LUSC PROPN B-AC
3595
+ ( PUNCT B-O
3596
+ lung NOUN B-LF
3597
+ squamous ADJ I-LF
3598
+ cell NOUN I-LF
3599
+ carcinoma NOUN I-LF
3600
+ ) PUNCT B-O
3601
+ Based VERB B-O
3602
+ on ADP B-O
3603
+ observations NOUN B-O
3604
+ in ADP B-O
3605
+ Drosophila PROPN B-O
3606
+ [ PUNCT B-O
3607
+ 5 NUM B-O
3608
+ ] PUNCT B-O
3609
+ , PUNCT B-O
3610
+ we PRON B-O
3611
+ set VERB B-O
3612
+ out ADP B-O
3613
+ to PART B-O
3614
+ assess VERB B-O
3615
+ the DET B-O
3616
+ role NOUN B-O
3617
+ of ADP B-O
3618
+ stress NOUN B-O
3619
+ - PUNCT B-O
3620
+ response NOUN B-O
3621
+ pathways NOUN B-O
3622
+ , PUNCT B-O
3623
+ particularly ADV B-O
3624
+ of ADP B-O
3625
+ heat NOUN B-LF
3626
+ shock NOUN I-LF
3627
+ protein NOUN I-LF
3628
+ 90 NUM I-LF
3629
+ ( PUNCT B-O
3630
+ Hsp90 PROPN B-AC
3631
+ ) PUNCT B-O
3632
+ function NOUN B-O
3633
+ , PUNCT B-O
3634
+ in ADP B-O
3635
+ phenotype NOUN B-O
3636
+ modification NOUN B-O
3637
+ , PUNCT B-O
3638
+ using VERB B-O
3639
+ zebrafish NOUN B-O
3640
+ as ADP B-O
3641
+ a DET B-O
3642
+ vertebrate ADJ B-O
3643
+ model NOUN B-O
3644
+ . PUNCT B-O
3645
+
3646
+ Driving VERB B-LF
3647
+ simulator NOUN I-LF
3648
+ ( PUNCT B-O
3649
+ DS PROPN B-AC
3650
+ ) PUNCT B-O
3651
+ systems NOUN B-O
3652
+ have VERB B-O
3653
+ advantages NOUN B-O
3654
+ in ADP B-O
3655
+ controlling VERB B-O
3656
+ traffic- NOUN B-O
3657
+ and CCONJ B-O
3658
+ automobile NOUN B-O
3659
+ - PUNCT B-O
3660
+ related VERB B-O
3661
+ conditions NOUN B-O
3662
+ [ PUNCT B-O
3663
+ 1,13,14 NUM B-O
3664
+ ] PUNCT B-O
3665
+ . PUNCT B-O
3666
+
3667
+ We PRON B-O
3668
+ assumed VERB B-O
3669
+ a DET B-O
3670
+ 50 NUM B-O
3671
+ % NOUN B-O
3672
+ proportion NOUN B-O
3673
+ , PUNCT B-O
3674
+ 80 NUM B-O
3675
+ % NOUN B-O
3676
+ power NOUN B-O
3677
+ , PUNCT B-O
3678
+ 95 NUM B-O
3679
+ % NOUN B-O
3680
+ confidence NOUN B-LF
3681
+ interval NOUN I-LF
3682
+ ( PUNCT B-O
3683
+ CI PROPN B-AC
3684
+ ) PUNCT B-O
3685
+ and CCONJ B-O
3686
+ 5 NUM B-O
3687
+ % NOUN B-O
3688
+ precision NOUN B-O
3689
+ . PUNCT B-O
3690
+
3691
+ All DET B-O
3692
+ known VERB B-O
3693
+ AP PROPN B-AC
3694
+ endonucleases NOUN B-O
3695
+ are AUX B-O
3696
+ grouped VERB B-O
3697
+ in ADP B-O
3698
+ two NUM B-O
3699
+ distinct ADJ B-O
3700
+ superfamilies NOUN B-O
3701
+ based VERB B-O
3702
+ on ADP B-O
3703
+ their PRON B-O
3704
+ structural ADJ B-O
3705
+ and CCONJ B-O
3706
+ sequence NOUN B-O
3707
+ similarity NOUN B-O
3708
+ to ADP B-O
3709
+ either CCONJ B-O
3710
+ Escherichia PROPN B-LF
3711
+ coli PROPN I-LF
3712
+ exonuclease NOUN I-LF
3713
+ III NUM I-LF
3714
+ ( PUNCT B-O
3715
+ Xth PROPN B-AC
3716
+ ; PUNCT B-O
3717
+ Endonuclease NOUN B-LF
3718
+ — PUNCT I-LF
3719
+ Exonuclease NOUN I-LF
3720
+ — PUNCT I-LF
3721
+ Phosphatase NOUN I-LF
3722
+ superfamily NOUN B-O
3723
+ , PUNCT B-O
3724
+ or CCONJ B-O
3725
+ EEP PROPN B-AC
3726
+ ) PUNCT B-O
3727
+ or CCONJ B-O
3728
+ endonuclease NOUN B-O
3729
+ IV NUM B-O
3730
+ ( PUNCT B-O
3731
+ Nfo PROPN B-O
3732
+ ) PUNCT B-O
3733
+ [ PUNCT B-O
3734
+ 10 NUM B-O
3735
+ ] PUNCT B-O
3736
+ . PUNCT B-O
3737
+
3738
+ Arm PROPN B-AC
3739
+ , PUNCT B-O
3740
+ Armadillo PROPN B-LF
3741
+ ; PUNCT B-O
3742
+ bGal PROPN B-AC
3743
+ , PUNCT B-O
3744
+ beta NOUN B-LF
3745
+ - PUNCT I-LF
3746
+ galactosidase NOUN I-LF
3747
+ ; PUNCT B-O
3748
+ Cyt PROPN B-AC
3749
+ -Arm PROPN B-AC
3750
+ , PUNCT B-O
3751
+ Cytoplasm NOUN B-O
3752
+ - PUNCT B-O
3753
+ Armadillo PROPN B-LF
3754
+ ; PUNCT B-O
3755
+ GBSC PROPN B-AC
3756
+ , PUNCT B-O
3757
+ glioblastoma NOUN B-LF
3758
+ multiforme ADJ I-LF
3759
+ stem NOUN I-LF
3760
+ - PUNCT I-LF
3761
+ like ADJ I-LF
3762
+ cell NOUN I-LF
3763
+ ; PUNCT B-O
3764
+ GFP PROPN B-AC
3765
+ , PUNCT B-O
3766
+ green ADJ B-LF
3767
+ fluorescent ADJ I-LF
3768
+ protein NOUN I-LF
3769
+ ; PUNCT B-O
3770
+ igl PROPN B-AC
3771
+ , PUNCT B-O
3772
+ igloo NOUN B-LF
3773
+ ; PUNCT B-O
3774
+ myrRFP PROPN B-O
3775
+ , PUNCT B-O
3776
+ myristoilated PROPN B-O
3777
+ Red PROPN B-O
3778
+ Fluorescent PROPN B-O
3779
+ Protein PROPN B-O
3780
+ ; PUNCT B-O
3781
+ nkd PROPN B-AC
3782
+ , PUNCT B-O
3783
+ -lacZnkd PROPN B-AC
3784
+ , PUNCT B-O
3785
+ transcriptional ADJ B-O
3786
+ beta NOUN B-LF
3787
+ - PUNCT I-LF
3788
+ galactosidase NOUN I-LF
3789
+ reporter NOUN B-O
3790
+ of ADP B-O
3791
+ naked ADJ B-O
3792
+ gene NOUN B-O
3793
+ NLGN3 PROPN B-O
3794
+ ; PUNCT B-O
3795
+ NMRI PROPN B-O
3796
+ , PUNCT B-O
3797
+ Naval PROPN B-O
3798
+ Medical PROPN B-O
3799
+ Research PROPN B-O
3800
+ Institute PROPN B-O
3801
+ . PUNCT B-O
3802
+
3803
+ Very ADV B-LF
3804
+ - PUNCT I-LF
3805
+ long ADV I-LF
3806
+ - PUNCT I-LF
3807
+ chain NOUN I-LF
3808
+ fatty ADJ I-LF
3809
+ acid NOUN I-LF
3810
+ ( PUNCT B-O
3811
+ VLCFA PROPN B-AC
3812
+ ) PUNCT B-O
3813
+ accumulation NOUN B-O
3814
+ has AUX B-O
3815
+ long ADV B-O
3816
+ been AUX B-O
3817
+ suggested VERB B-O
3818
+ as ADP B-O
3819
+ a DET B-O
3820
+ major ADJ B-O
3821
+ disease NOUN B-O
3822
+ - PUNCT B-O
3823
+ mediating VERB B-O
3824
+ factor NOUN B-O
3825
+ , PUNCT B-O
3826
+ although SCONJ B-O
3827
+ the DET B-O
3828
+ exact ADJ B-O
3829
+ pathological ADJ B-O
3830
+ consequences NOUN B-O
3831
+ are AUX B-O
3832
+ unclear ADJ B-O
3833
+ . PUNCT B-O
3834
+
3835
+ Unexpectedly ADV B-O
3836
+ , PUNCT B-O
3837
+ we PRON B-O
3838
+ found VERB B-O
3839
+ that SCONJ B-O
3840
+ Notch1 NOUN B-O
3841
+ - PUNCT B-O
3842
+ expressing VERB B-O
3843
+ cells NOUN B-O
3844
+ invariably ADV B-O
3845
+ lacked VERB B-O
3846
+ the DET B-O
3847
+ expression NOUN B-O
3848
+ of ADP B-O
3849
+ ERα PROPN B-AC
3850
+ and CCONJ B-O
3851
+ PR PROPN B-AC
3852
+ ( PUNCT B-O
3853
+ Fig PROPN B-O
3854
+ . PUNCT B-O
3855
+
3856
+ 2F NUM B-O
3857
+ , PUNCT B-O
3858
+ G NOUN B-O
3859
+ ) PUNCT B-O
3860
+ , PUNCT B-O
3861
+ and CCONJ B-O
3862
+ we PRON B-O
3863
+ confirmed VERB B-O
3864
+ these DET B-O
3865
+ results NOUN B-O
3866
+ by ADP B-O
3867
+ quantitative ADJ B-LF
3868
+ Real ADJ I-LF
3869
+ Time NOUN I-LF
3870
+ Polymerase PROPN I-LF
3871
+ Chain PROPN I-LF
3872
+ Reaction PROPN I-LF
3873
+ ( PUNCT B-O
3874
+ qRT PROPN B-AC
3875
+ ) PUNCT B-O
3876
+ in ADP B-O
3877
+ sorted ADJ B-O
3878
+ -PCRGFP PROPN B-AC
3879
+ - PUNCT B-O
3880
+ labeled VERB B-O
3881
+ cells NOUN B-O
3882
+ ( PUNCT B-O
3883
+ S3B PROPN B-O
3884
+ , PUNCT B-O
3885
+ C PROPN B-O
3886
+ Fig PROPN B-O
3887
+ . PUNCT B-O
3888
+
3889
+ ) PUNCT B-O
3890
+ . PUNCT B-O
3891
+
3892
+ In ADP B-O
3893
+ RSV PROPN B-AC
3894
+ infected VERB B-O
3895
+ animals NOUN B-O
3896
+ treated VERB B-O
3897
+ with ADP B-O
3898
+ EGY-2 PROPN B-AC
3899
+ , PUNCT B-O
3900
+ alveolar ADJ B-LF
3901
+ macrophages NOUN I-LF
3902
+ ( PUNCT B-O
3903
+ AM PROPN B-AC
3904
+ ) PUNCT B-O
3905
+ in ADP B-O
3906
+ the DET B-O
3907
+ high ADJ B-O
3908
+ dose NOUN B-O
3909
+ group NOUN B-O
3910
+ showed VERB B-O
3911
+ a DET B-O
3912
+ markedly ADV B-O
3913
+ enhanced VERB B-O
3914
+ phagocytic ADJ B-O
3915
+ function NOUN B-O
3916
+ at ADP B-O
3917
+ the DET B-O
3918
+ early ADJ B-O
3919
+ phase NOUN B-O
3920
+ of ADP B-O
3921
+ infection NOUN B-O
3922
+ , PUNCT B-O
3923
+ as ADP B-O
3924
+ both CCONJ B-O
3925
+ the DET B-O
3926
+ number NOUN B-O
3927
+ of ADP B-O
3928
+ phagocytic ADJ B-O
3929
+ AM PROPN B-AC
3930
+ as ADP B-O
3931
+ well ADV B-O
3932
+ as ADP B-O
3933
+ their PRON B-O
3934
+ phagocytic ADJ B-O
3935
+ activity NOUN B-O
3936
+ was AUX B-O
3937
+ significantly ADV B-O
3938
+ enhanced VERB B-O
3939
+ compared VERB B-O
3940
+ to ADP B-O
3941
+ untreated ADJ B-O
3942
+ animals NOUN B-O
3943
+ on ADP B-O
3944
+ day NOUN B-O
3945
+ 1 NUM B-O
3946
+ p.i PROPN B-AC
3947
+ . PUNCT B-O
3948
+
3949
+ ( PUNCT B-O
3950
+ Fig NOUN B-O
3951
+ 4A NUM B-O
3952
+ and CCONJ B-O
3953
+ 4B NOUN B-O
3954
+ , PUNCT B-O
3955
+ respectively ADV B-O
3956
+ ) PUNCT B-O
3957
+ . PUNCT B-O
3958
+
3959
+ Finally ADV B-O
3960
+ , PUNCT B-O
3961
+ as ADP B-O
3962
+ a DET B-O
3963
+ sensitivity NOUN B-O
3964
+ analysis NOUN B-O
3965
+ , PUNCT B-O
3966
+ we PRON B-O
3967
+ constructed VERB B-O
3968
+ five NUM B-O
3969
+ different ADJ B-O
3970
+ genetic ADJ B-LF
3971
+ pigmentation NOUN I-LF
3972
+ scores NOUN I-LF
3973
+ , PUNCT B-O
3974
+ one NUM B-O
3975
+ for ADP B-O
3976
+ each DET B-O
3977
+ pigmentation NOUN B-O
3978
+ trait NOUN B-O
3979
+ ( PUNCT B-O
3980
+ eye NOUN B-O
3981
+ color NOUN B-O
3982
+ , PUNCT B-O
3983
+ hair NOUN B-O
3984
+ color NOUN B-O
3985
+ , PUNCT B-O
3986
+ skin NOUN B-O
3987
+ phototype NOUN B-O
3988
+ , PUNCT B-O
3989
+ and CCONJ B-O
3990
+ the DET B-O
3991
+ presence NOUN B-O
3992
+ of ADP B-O
3993
+ freckles NOUN B-O
3994
+ and CCONJ B-O
3995
+ tanning NOUN B-O
3996
+ ) PUNCT B-O
3997
+ , PUNCT B-O
3998
+ from ADP B-O
3999
+ our PRON B-O
4000
+ data NOUN B-O
4001
+ ( PUNCT B-O
4002
+ S2 PROPN B-O
4003
+ Table PROPN B-O
4004
+ ) PUNCT B-O
4005
+ we PRON B-O
4006
+ analyzed VERB B-O
4007
+ their PRON B-O
4008
+ relationship NOUN B-O
4009
+ with ADP B-O
4010
+ cancer NOUN B-O
4011
+ in ADP B-O
4012
+ the DET B-O
4013
+ same ADJ B-O
4014
+ way NOUN B-O
4015
+ we PRON B-O
4016
+ have AUX B-O
4017
+ described VERB B-O
4018
+ for ADP B-O
4019
+ the DET B-O
4020
+ GPS PROPN B-AC
4021
+ . PUNCT B-O
4022
+
4023
+ SDQ PROPN B-AC
4024
+ , PUNCT B-O
4025
+ Strengths NOUN B-LF
4026
+ and CCONJ I-LF
4027
+ Difficulties NOUN I-LF
4028
+ Questionnaire NOUN I-LF
4029
+ . PUNCT B-O
4030
+
4031
+ In ADP B-O
4032
+ Drosophila PROPN B-O
4033
+ , PUNCT B-O
4034
+ the DET B-O
4035
+ family NOUN B-O
4036
+ of ADP B-O
4037
+ gustatory ADJ B-LF
4038
+ receptors NOUN I-LF
4039
+ ( PUNCT B-O
4040
+ Grs PROPN B-AC
4041
+ ) PUNCT B-O
4042
+ is AUX B-O
4043
+ predicted VERB B-O
4044
+ to PART B-O
4045
+ consist VERB B-O
4046
+ of ADP B-O
4047
+ 68 NUM B-O
4048
+ genes NOUN B-O
4049
+ [ PUNCT B-O
4050
+ 4],[5 NUM B-O
4051
+ ] PUNCT B-O
4052
+ . PUNCT B-O
4053
+
4054
+ DIC PROPN B-AC
4055
+ , PUNCT B-O
4056
+ differential ADJ B-LF
4057
+ interference NOUN I-LF
4058
+ contrast NOUN I-LF
4059
+ ; PUNCT B-O
4060
+ SM PROPN B-O
4061
+ , PUNCT B-O
4062
+ Sperm NOUN B-O
4063
+ Medium NOUN B-O
4064
+ . PUNCT B-O
4065
+
4066
+ In ADP B-O
4067
+ October PROPN B-O
4068
+ 2018 NUM B-O
4069
+ , PUNCT B-O
4070
+ we PRON B-O
4071
+ published VERB B-O
4072
+ a DET B-O
4073
+ systematic ADJ B-O
4074
+ review NOUN B-O
4075
+ of ADP B-O
4076
+ clinical ADJ B-LF
4077
+ practice NOUN I-LF
4078
+ guidelines NOUN I-LF
4079
+ ( PUNCT B-O
4080
+ CPG PROPN B-AC
4081
+ ) PUNCT B-O
4082
+ that PRON B-O
4083
+ provide VERB B-O
4084
+ recommendations NOUN B-O
4085
+ for ADP B-O
4086
+ the DET B-O
4087
+ care NOUN B-O
4088
+ and CCONJ B-O
4089
+ prevention NOUN B-O
4090
+ of ADP B-O
4091
+ adverse ADJ B-O
4092
+ events NOUN B-O
4093
+ associated VERB B-O
4094
+ with ADP B-O
4095
+ vascular ADJ B-O
4096
+ catheter NOUN B-O
4097
+ in ADP B-O
4098
+ adults NOUN B-O
4099
+ . PUNCT B-O
4100
+
4101
+ Aptima PROPN B-LF
4102
+ HIV-1 NOUN I-LF
4103
+ Aptima PROPN B-AC
4104
+ Quant NOUN I-LF
4105
+ Dx NOUN I-LF
4106
+ assay NOUN I-LF
4107
+ Equation NOUN B-O
4108
+ 2 NUM B-O
4109
+ : PUNCT B-O
4110
+ Where SCONJ B-O
4111
+ RMSE PROPN B-AC
4112
+ is AUX B-O
4113
+ root NOUN B-LF
4114
+ mean ADJ I-LF
4115
+ square ADJ I-LF
4116
+ error NOUN I-LF
4117
+ , PUNCT B-O
4118
+ Yi PROPN B-O
4119
+ is AUX B-O
4120
+ ANN PROPN B-AC
4121
+ predicted VERB B-O
4122
+ values NOUN B-O
4123
+ ; PUNCT B-O
4124
+ yi PROPN B-O
4125
+ is AUX B-O
4126
+ experimental ADJ B-O
4127
+ values NOUN B-O
4128
+ ; PUNCT B-O
4129
+ n NOUN B-O
4130
+ is AUX B-O
4131
+ number NOUN B-O
4132
+ of ADP B-O
4133
+ predictions NOUN B-O
4134
+ . PUNCT B-O
4135
+
4136
+ Various ADJ B-O
4137
+ platforms NOUN B-O
4138
+ , PUNCT B-O
4139
+ such ADJ B-O
4140
+ as ADP B-O
4141
+ IHC PROPN B-AC
4142
+ , PUNCT B-O
4143
+ SS PROPN B-AC
4144
+ , PUNCT B-O
4145
+ pyrosequencing NOUN B-LF
4146
+ ( PUNCT B-O
4147
+ PS PROPN B-AC
4148
+ ) PUNCT B-O
4149
+ , PUNCT B-O
4150
+ and CCONJ B-O
4151
+ HRM PROPN B-AC
4152
+ , PUNCT B-O
4153
+ are AUX B-O
4154
+ available ADJ B-O
4155
+ to PART B-O
4156
+ analyze VERB B-O
4157
+ genetic ADJ B-O
4158
+ mutation NOUN B-O
4159
+ profiles NOUN B-O
4160
+ in ADP B-O
4161
+ clinical ADJ B-O
4162
+ tissue NOUN B-O
4163
+ samples NOUN B-O
4164
+ . PUNCT B-O
4165
+
4166
+ One NUM B-O
4167
+ compound NOUN B-O
4168
+ seemed VERB B-O
4169
+ a DET B-O
4170
+ particularly ADV B-O
4171
+ promising ADJ B-O
4172
+ candidate NOUN B-O
4173
+ for ADP B-O
4174
+ this DET B-O
4175
+ sort NOUN B-O
4176
+ of ADP B-O
4177
+ approach NOUN B-O
4178
+ : PUNCT B-O
4179
+ thiabendazole NOUN B-LF
4180
+ ( PUNCT B-O
4181
+ TBZ PROPN B-AC
4182
+ ) PUNCT B-O
4183
+ , PUNCT B-O
4184
+ which PRON B-O
4185
+ has AUX B-O
4186
+ been AUX B-O
4187
+ in ADP B-O
4188
+ clinical ADJ B-O
4189
+ use NOUN B-O
4190
+ as ADP B-O
4191
+ a DET B-O
4192
+ systemic ADJ B-O
4193
+ antifungal ADJ B-O
4194
+ and CCONJ B-O
4195
+ deworming NOUN B-O
4196
+ treatment NOUN B-O
4197
+ for ADP B-O
4198
+ 40 NUM B-O
4199
+ years NOUN B-O
4200
+ . PUNCT B-O
4201
+
4202
+ Though SCONJ B-O
4203
+ long ADJ B-O
4204
+ endemic ADJ B-O
4205
+ in ADP B-O
4206
+ the DET B-O
4207
+ southeastern ADJ B-O
4208
+ U.S. PROPN B-O
4209
+ , PUNCT B-O
4210
+ raccoon NOUN B-O
4211
+ rabies NOUN B-O
4212
+ expanded VERB B-O
4213
+ rapidly ADV B-O
4214
+ along ADP B-O
4215
+ the DET B-O
4216
+ eastern ADJ B-O
4217
+ seaboard NOUN B-O
4218
+ during ADP B-O
4219
+ the DET B-O
4220
+ 1980s NOUN B-O
4221
+ and CCONJ B-O
4222
+ 1990s NOUN B-O
4223
+ from ADP B-O
4224
+ an DET B-O
4225
+ initial ADJ B-O
4226
+ focus NOUN B-O
4227
+ along ADP B-O
4228
+ the DET B-O
4229
+ West PROPN B-O
4230
+ Virginia PROPN B-O
4231
+ – PUNCT B-O
4232
+ Virginia PROPN B-O
4233
+ border NOUN B-O
4234
+ ; PUNCT B-O
4235
+ the DET B-O
4236
+ initial ADJ B-O
4237
+ focus NOUN B-O
4238
+ was AUX B-O
4239
+ linked VERB B-O
4240
+ to ADP B-O
4241
+ the DET B-O
4242
+ long ADJ B-LF
4243
+ - PUNCT I-LF
4244
+ distance NOUN I-LF
4245
+ translocation NOUN I-LF
4246
+ ( PUNCT B-O
4247
+ LDT PROPN B-AC
4248
+ ) PUNCT B-O
4249
+ of ADP B-O
4250
+ rabid ADJ B-O
4251
+ animals NOUN B-O
4252
+ from ADP B-O
4253
+ Florida PROPN B-O
4254
+ [ PUNCT B-O
4255
+ 5 NUM B-O
4256
+ ] PUNCT B-O
4257
+ . PUNCT B-O
4258
+
4259
+ ( PUNCT B-O
4260
+ A X B-O
4261
+ ) PUNCT B-O
4262
+ Two NUM B-O
4263
+ - PUNCT B-O
4264
+ dimensional ADJ B-O
4265
+ representation NOUN B-O
4266
+ of ADP B-O
4267
+ the DET B-O
4268
+ mTufA PROPN B-AC
4269
+ 5′ NUM B-O
4270
+ UTR NOUN B-O
4271
+ . PUNCT B-O
4272
+
4273
+ The DET B-O
4274
+ RNAfold ADJ B-O
4275
+ algorithm NOUN B-O
4276
+ predicted VERB B-O
4277
+ three NUM B-O
4278
+ structured VERB B-LF
4279
+ regions NOUN I-LF
4280
+ : PUNCT B-O
4281
+ SR PROPN B-AC
4282
+ I NOUN B-O
4283
+ ( PUNCT B-O
4284
+ pink NOUN B-O
4285
+ ) PUNCT B-O
4286
+ , PUNCT B-O
4287
+ SR PROPN B-AC
4288
+ II PROPN B-O
4289
+ ( PUNCT B-O
4290
+ violet ADJ B-O
4291
+ ) PUNCT B-O
4292
+ , PUNCT B-O
4293
+ SR PROPN B-AC
4294
+ IIIa NOUN B-O
4295
+ ( PUNCT B-O
4296
+ yellow ADJ B-O
4297
+ ) PUNCT B-O
4298
+ , PUNCT B-O
4299
+ and CCONJ B-O
4300
+ SR PROPN B-AC
4301
+ IIIb NOUN B-O
4302
+ ( PUNCT B-O
4303
+ green NOUN B-O
4304
+ ) PUNCT B-O
4305
+ . PUNCT B-O
4306
+
4307
+ However ADV B-O
4308
+ , PUNCT B-O
4309
+ in ADP B-O
4310
+ some DET B-O
4311
+ studies NOUN B-O
4312
+ , PUNCT B-O
4313
+ we PRON B-O
4314
+ investigated VERB B-O
4315
+ the DET B-O
4316
+ effects NOUN B-O
4317
+ of ADP B-O
4318
+ gp120 NOUN B-O
4319
+ on ADP B-O
4320
+ MDDC PROPN B-AC
4321
+ that PRON B-O
4322
+ were AUX B-O
4323
+ simultaneously ADV B-O
4324
+ induced VERB B-O
4325
+ to PART B-O
4326
+ mature VERB B-O
4327
+ by ADP B-O
4328
+ other ADJ B-O
4329
+ stimuli NOUN B-O
4330
+ , PUNCT B-O
4331
+ notably ADV B-O
4332
+ lipopolysaccharide NOUN B-LF
4333
+ ( PUNCT B-O
4334
+ LPS PROPN B-AC
4335
+ ) PUNCT B-O
4336
+ . PUNCT B-O
4337
+
4338
+ The DET B-O
4339
+ red ADJ B-O
4340
+ dots NOUN B-O
4341
+ represents VERB B-O
4342
+ LCI PROPN B-AC
4343
+ , PUNCT B-O
4344
+ the DET B-O
4345
+ bright ADJ B-O
4346
+ yellow ADJ B-O
4347
+ rectangle NOUN B-O
4348
+ represents VERB B-O
4349
+ RV PROPN B-AC
4350
+ , PUNCT B-O
4351
+ and CCONJ B-O
4352
+ the DET B-O
4353
+ black ADJ B-O
4354
+ triangle NOUN B-O
4355
+ represents VERB B-O
4356
+ the DET B-O
4357
+ /TLCnLCI PROPN B-AC
4358
+ . PUNCT B-O
4359
+
4360
+ LCI PROPN B-AC
4361
+ : PUNCT B-O
4362
+ lung NOUN B-LF
4363
+ clearance NOUN I-LF
4364
+ index NOUN I-LF
4365
+ ; PUNCT B-O
4366
+ RV PROPN B-AC
4367
+ : PUNCT B-O
4368
+ the DET B-LF
4369
+ ratio NOUN I-LF
4370
+ of ADP I-LF
4371
+ residual ADJ I-LF
4372
+ volume NOUN I-LF
4373
+ to ADP I-LF
4374
+ total ADJ I-LF
4375
+ lung NOUN I-LF
4376
+ capacity NOUN I-LF
4377
+ ; PUNCT B-O
4378
+ /TLCnLCI PROPN B-AC
4379
+ : PUNCT B-O
4380
+ normalized ADJ B-LF
4381
+ lung NOUN B-LF
4382
+ clearance NOUN I-LF
4383
+ index NOUN I-LF
4384
+ . PUNCT B-O
4385
+
4386
+ The DET B-O
4387
+ drug NOUN B-LF
4388
+ utilisation NOUN I-LF
4389
+ ( PUNCT B-O
4390
+ DU PROPN B-AC
4391
+ ) PUNCT B-O
4392
+ 90 NUM B-O
4393
+ % NOUN B-O
4394
+ methodology NOUN B-O
4395
+ was AUX B-O
4396
+ used VERB B-O
4397
+ to PART B-O
4398
+ present VERB B-O
4399
+ the DET B-O
4400
+ antibiotics NOUN B-O
4401
+ accounting VERB B-O
4402
+ for ADP B-O
4403
+ 90 NUM B-O
4404
+ % NOUN B-O
4405
+ of ADP B-O
4406
+ all DET B-O
4407
+ antibiotics NOUN B-O
4408
+ prescribed VERB B-O
4409
+ [ PUNCT B-O
4410
+ 19 NUM B-O
4411
+ ] PUNCT B-O
4412
+ . PUNCT B-O
4413
+
4414
+ AC PROPN B-AC
4415
+ and CCONJ B-O
4416
+ CaM PROPN B-AC
4417
+ peptides NOUN B-O
4418
+ were AUX B-O
4419
+ separated VERB B-O
4420
+ over ADP B-O
4421
+ an DET B-O
4422
+ 8 NUM B-O
4423
+ - PUNCT B-O
4424
+ min NOUN B-O
4425
+ gradient NOUN B-O
4426
+ of ADP B-O
4427
+ 5%–40 NUM B-O
4428
+ % NOUN B-O
4429
+ acetonitrile NOUN B-LF
4430
+ ( PUNCT B-O
4431
+ ACN PROPN B-AC
4432
+ ) PUNCT B-O
4433
+ at ADP B-O
4434
+ 40 NUM B-O
4435
+ μL NOUN B-O
4436
+ / SYM B-O
4437
+ min NOUN B-O
4438
+ and CCONJ B-O
4439
+ at ADP B-O
4440
+ 0 NUM B-O
4441
+ ° NOUN B-O
4442
+ C NOUN B-O
4443
+ . PUNCT B-O
4444
+
4445
+ In ADP B-O
4446
+ this DET B-O
4447
+ regard NOUN B-O
4448
+ , PUNCT B-O
4449
+ the DET B-O
4450
+ concept NOUN B-O
4451
+ of ADP B-O
4452
+ mild ADJ B-LF
4453
+ cognitive ADJ I-LF
4454
+ impairment NOUN I-LF
4455
+ ( PUNCT B-O
4456
+ MCI PROPN B-AC
4457
+ ) PUNCT B-O
4458
+ is AUX B-O
4459
+ interesting ADJ B-O
4460
+ since SCONJ B-O
4461
+ it PRON B-O
4462
+ is AUX B-O
4463
+ seen VERB B-O
4464
+ as ADP B-O
4465
+ a DET B-O
4466
+ transitional ADJ B-O
4467
+ zone NOUN B-O
4468
+ between ADP B-O
4469
+ normal ADJ B-O
4470
+ aging NOUN B-O
4471
+ and CCONJ B-O
4472
+ dementia NOUN B-O
4473
+ . PUNCT B-O
4474
+
4475
+ The DET B-O
4476
+ quantity NOUN B-O
4477
+ ρ PUNCT B-O
4478
+ is AUX B-O
4479
+ the DET B-O
4480
+ atmospheric ADJ B-O
4481
+ density NOUN B-O
4482
+ depending VERB B-O
4483
+ on ADP B-O
4484
+ altitude NOUN B-O
4485
+ and CCONJ B-O
4486
+ temperature NOUN B-LF
4487
+ We PRON B-O
4488
+ estimate VERB B-O
4489
+ the DET B-O
4490
+ prevalence NOUN B-O
4491
+ of ADP B-O
4492
+ both CCONJ B-O
4493
+ overall ADJ B-O
4494
+ psychiatric ADJ B-O
4495
+ disorders NOUN B-O
4496
+ and CCONJ B-O
4497
+ specific ADJ B-O
4498
+ diagnoses NOUN B-O
4499
+ based VERB B-O
4500
+ on ADP B-O
4501
+ the DET B-O
4502
+ International PROPN B-LF
4503
+ Classification PROPN I-LF
4504
+ of ADP I-LF
4505
+ Diseases PROPN I-LF
4506
+ ( PUNCT B-O
4507
+ ICD PROPN B-AC
4508
+ ) PUNCT B-O
4509
+ . PUNCT B-O
4510
+
4511
+ We PRON B-O
4512
+ used VERB B-O
4513
+ generalized ADJ B-LF
4514
+ linear ADJ I-LF
4515
+ model NOUN I-LF
4516
+ ( PUNCT B-O
4517
+ GLM PROPN B-AC
4518
+ ) PUNCT B-O
4519
+ estimation NOUN B-O
4520
+ , PUNCT B-O
4521
+ which PRON B-O
4522
+ is AUX B-O
4523
+ a DET B-O
4524
+ Maximum PROPN B-O
4525
+ Likelihood NOUN B-O
4526
+ generalization NOUN B-O
4527
+ of ADP B-O
4528
+ the DET B-O
4529
+ ordinary ADJ B-O
4530
+ linear ADJ B-O
4531
+ regression NOUN B-O
4532
+ approach NOUN B-O
4533
+ . PUNCT B-O
4534
+
4535
+ This DET B-O
4536
+ assay NOUN B-O
4537
+ was AUX B-O
4538
+ used VERB B-O
4539
+ to PART B-O
4540
+ screen NOUN B-O
4541
+ a DET B-O
4542
+ genome NOUN B-O
4543
+ - PUNCT B-O
4544
+ wide ADJ B-O
4545
+ long ADJ B-LF
4546
+ double ADJ I-LF
4547
+ - PUNCT I-LF
4548
+ stranded VERB I-LF
4549
+ RNA NOUN I-LF
4550
+ ( PUNCT B-O
4551
+ dsRNA PROPN B-AC
4552
+ ) PUNCT B-O
4553
+ library NOUN B-O
4554
+ for ADP B-O
4555
+ modulation NOUN B-O
4556
+ of ADP B-O
4557
+ pMAPK PROPN B-AC
4558
+ levels NOUN B-O
4559
+ induced VERB B-O
4560
+ by ADP B-O
4561
+ RASV12 NOUN B-O
4562
+ expression NOUN B-O
4563
+ ( PUNCT B-O
4564
+ Figure NOUN B-O
4565
+ S1B NOUN B-O
4566
+ and CCONJ B-O
4567
+ S1C NOUN B-O
4568
+ ) PUNCT B-O
4569
+ . PUNCT B-O
4570
+
4571
+ The DET B-O
4572
+ results NOUN B-O
4573
+ from ADP B-O
4574
+ this DET B-O
4575
+ primary ADJ B-O
4576
+ screen NOUN B-O
4577
+ and CCONJ B-O
4578
+ all DET B-O
4579
+ subsequent ADJ B-O
4580
+ screens NOUN B-O
4581
+ are AUX B-O
4582
+ made VERB B-O
4583
+ available ADJ B-O
4584
+ online ADV B-O
4585
+ at ADP B-O
4586
+ the DET B-O
4587
+ IRIC PROPN B-O
4588
+ RNAi PROPN B-AC
4589
+ database NOUN B-O
4590
+ ( PUNCT B-O
4591
+ http://www.bioinfo.iric.ca/iricrnai X B-O
4592
+ ) PUNCT B-O
4593
+ . PUNCT B-O
4594
+
4595
+ 309 NUM B-O
4596
+ hit NOUN B-O
4597
+ genes NOUN B-O
4598
+ , PUNCT B-O
4599
+ which PRON B-O
4600
+ reproducibly ADV B-O
4601
+ altered VERB B-O
4602
+ pMAPK PROPN B-AC
4603
+ signal NOUN B-O
4604
+ , PUNCT B-O
4605
+ were AUX B-O
4606
+ identified VERB B-O
4607
+ in ADP B-O
4608
+ the DET B-O
4609
+ primary ADJ B-O
4610
+ screen NOUN B-O
4611
+ ( PUNCT B-O
4612
+ Table NOUN B-O
4613
+ S1 NUM B-O
4614
+ ) PUNCT B-O
4615
+ . PUNCT B-O
4616
+
4617
+ GLA PROPN B-AC
4618
+ , PUNCT B-O
4619
+ grape NOUN B-LF
4620
+ - PUNCT I-LF
4621
+ like ADJ I-LF
4622
+ aggregation NOUN I-LF
4623
+ . PUNCT B-O
4624
+
4625
+ We PRON B-O
4626
+ carried VERB B-O
4627
+ out ADP B-O
4628
+ a DET B-O
4629
+ prospective ADJ B-O
4630
+ multicentre ADJ B-O
4631
+ cohort NOUN B-O
4632
+ study NOUN B-O
4633
+ within ADP B-O
4634
+ the DET B-O
4635
+ Italian PROPN B-O
4636
+ Cystic PROPN B-LF
4637
+ Fibrosis PROPN I-LF
4638
+ Society PROPN B-O
4639
+ involving VERB B-O
4640
+ 32 NUM B-O
4641
+ CF PROPN B-AC
4642
+ centres NOUN B-O
4643
+ following VERB B-O
4644
+ 6597 NUM B-O
4645
+ patients NOUN B-O
4646
+ . PUNCT B-O
4647
+
4648
+ The DET B-O
4649
+ approach NOUN B-O
4650
+ relies VERB B-O
4651
+ on ADP B-O
4652
+ systematic ADJ B-O
4653
+ creation NOUN B-O
4654
+ of ADP B-O
4655
+ genetically ADV B-O
4656
+ modified VERB B-O
4657
+ strains NOUN B-O
4658
+ using VERB B-O
4659
+ the DET B-O
4660
+ synthetic ADJ B-LF
4661
+ genetic ADJ I-LF
4662
+ array NOUN I-LF
4663
+ ( PUNCT B-O
4664
+ SGA PROPN B-AC
4665
+ ) PUNCT B-O
4666
+ methodology NOUN B-O
4667
+ [ PUNCT B-O
4668
+ 13],[14],[23 NUM B-O
4669
+ ] PUNCT B-O
4670
+ , PUNCT B-O
4671
+ which PRON B-O
4672
+ is AUX B-O
4673
+ followed VERB B-O
4674
+ by ADP B-O
4675
+ acquisition NOUN B-O
4676
+ of ADP B-O
4677
+ fluorescent ADJ B-O
4678
+ images NOUN B-O
4679
+ of ADP B-O
4680
+ all DET B-O
4681
+ strains NOUN B-O
4682
+ using VERB B-O
4683
+ a DET B-O
4684
+ high ADJ B-O
4685
+ - PUNCT B-O
4686
+ throughput NOUN B-O
4687
+ automated VERB B-O
4688
+ microscopy NOUN B-O
4689
+ platform NOUN B-O
4690
+ . PUNCT B-O
4691
+
4692
+ Compared VERB B-O
4693
+ to ADP B-O
4694
+ the DET B-O
4695
+ normal ADJ B-O
4696
+ lung NOUN B-O
4697
+ function NOUN B-O
4698
+ group NOUN B-O
4699
+ , PUNCT B-O
4700
+ patients NOUN B-O
4701
+ with ADP B-O
4702
+ SAD PROPN B-AC
4703
+ and CCONJ B-O
4704
+ without ADP B-O
4705
+ AL PROPN B-AC
4706
+ had VERB B-O
4707
+ lower ADJ B-O
4708
+ spirometric ADJ B-O
4709
+ values NOUN B-O
4710
+ , PUNCT B-O
4711
+ poorer ADJ B-O
4712
+ quality NOUN B-O
4713
+ of ADP B-O
4714
+ life NOUN B-O
4715
+ and CCONJ B-O
4716
+ higher ADJ B-O
4717
+ levels NOUN B-O
4718
+ of ADP B-O
4719
+ C NOUN B-LF
4720
+ - PUNCT I-LF
4721
+ reactive ADJ I-LF
4722
+ protein NOUN I-LF
4723
+ ( PUNCT B-O
4724
+ CRP PROPN B-AC
4725
+ ) PUNCT B-O
4726
+ , PUNCT B-O
4727
+ as ADP B-O
4728
+ well ADV B-O
4729
+ as ADP B-O
4730
+ increased VERB B-O
4731
+ cardiovascular ADJ B-O
4732
+ risk NOUN B-O
4733
+ and CCONJ B-O
4734
+ more ADJ B-O
4735
+ vascular ADJ B-O
4736
+ age NOUN B-O
4737
+ . PUNCT B-O
4738
+
4739
+ Similarly ADV B-O
4740
+ , PUNCT B-O
4741
+ 1,25 NUM B-O
4742
+ di NOUN B-O
4743
+ - NOUN B-O
4744
+ hydroxy NOUN B-O
4745
+ vitamin NOUN B-LF
4746
+ D NOUN I-LF
4747
+ D PROPN B-AC
4748
+ can AUX B-O
4749
+ act VERB B-O
4750
+ as ADP B-O
4751
+ a DET B-O
4752
+ modulator NOUN B-O
4753
+ of ADP B-O
4754
+ ERs PROPN B-AC
4755
+ and CCONJ B-O
4756
+ activate VERB B-O
4757
+ the DET B-O
4758
+ nuclear ADJ B-O
4759
+ signaling NOUN B-O
4760
+ of ADP B-O
4761
+ these DET B-O
4762
+ ERs PROPN B-AC
4763
+ in ADP B-O
4764
+ the DET B-O
4765
+ colonic ADJ B-O
4766
+ smooth ADJ B-O
4767
+ muscles[15 X B-O
4768
+ ] PUNCT B-O
4769
+ . PUNCT B-O
4770
+
4771
+ Ethical ADJ B-O
4772
+ approval NOUN B-O
4773
+ was AUX B-O
4774
+ granted VERB B-O
4775
+ by ADP B-O
4776
+ the DET B-O
4777
+ North PROPN B-O
4778
+ West PROPN B-O
4779
+ Greater PROPN B-O
4780
+ Manchester PROPN B-O
4781
+ East PROPN B-O
4782
+ Research PROPN B-O
4783
+ Ethics PROPN B-O
4784
+ Committee PROPN B-O
4785
+ ( PUNCT B-O
4786
+ reference NOUN B-O
4787
+ 18 NUM B-O
4788
+ / NUM B-O
4789
+ NW/0211 NUM B-O
4790
+ ) PUNCT B-O
4791
+ and CCONJ B-O
4792
+ the DET B-O
4793
+ National PROPN B-LF
4794
+ Health PROPN I-LF
4795
+ Service PROPN I-LF
4796
+ ( PUNCT B-O
4797
+ NHS PROPN B-AC
4798
+ ) PUNCT B-O
4799
+ Health PROPN B-O
4800
+ Research PROPN B-O
4801
+ Authority PROPN B-O
4802
+ ( PUNCT B-O
4803
+ project NOUN B-O
4804
+ reference NOUN B-O
4805
+ 244772 NUM B-O
4806
+ ) PUNCT B-O
4807
+ . PUNCT B-O
4808
+
4809
+ For ADP B-O
4810
+ pregnant ADJ B-O
4811
+ women NOUN B-LF
4812
+ living VERB I-LF
4813
+ with ADP I-LF
4814
+ HIV PROPN I-LF
4815
+ HIV PROPN B-AC
4816
+ ( PUNCT B-O
4817
+ WLHIV PROPN B-AC
4818
+ ) PUNCT B-O
4819
+ it PRON B-O
4820
+ is AUX B-O
4821
+ critical ADJ B-O
4822
+ that SCONJ B-O
4823
+ they PRON B-O
4824
+ remain VERB B-O
4825
+ in ADP B-O
4826
+ care NOUN B-O
4827
+ throughout ADP B-O
4828
+ their PRON B-O
4829
+ pregnancy NOUN B-O
4830
+ and CCONJ B-O
4831
+ after ADP B-O
4832
+ so SCONJ B-O
4833
+ that SCONJ B-O
4834
+ they PRON B-O
4835
+ receive VERB B-O
4836
+ the DET B-O
4837
+ full ADJ B-O
4838
+ package NOUN B-O
4839
+ of ADP B-O
4840
+ prevention NOUN B-O
4841
+ of ADP B-O
4842
+ mother NOUN B-O
4843
+ - PUNCT B-O
4844
+ to ADP B-O
4845
+ - PUNCT B-O
4846
+ child NOUN B-O
4847
+ transmission NOUN B-O
4848
+ of ADP B-O
4849
+ HIV PROPN B-AC
4850
+ ( PUNCT B-O
4851
+ PMTCT PROPN B-AC
4852
+ ) PUNCT B-O
4853
+ services NOUN B-O
4854
+ . PUNCT B-O
4855
+
4856
+ Primer NOUN B-O
4857
+ pairs NOUN B-O
4858
+ were AUX B-O
4859
+ designed VERB B-O
4860
+ for ADP B-O
4861
+ three NUM B-O
4862
+ different ADJ B-O
4863
+ open ADJ B-LF
4864
+ reading NOUN I-LF
4865
+ frame NOUN I-LF
4866
+ ( PUNCT B-O
4867
+ ORF PROPN B-AC
4868
+ ) PUNCT B-O
4869
+ regions NOUN B-O
4870
+ of ADP B-O
4871
+ ASH1 PROPN B-O
4872
+ , PUNCT B-O
4873
+ a DET B-O
4874
+ distinct ADJ B-O
4875
+ region NOUN B-O
4876
+ within ADP B-O
4877
+ the DET B-O
4878
+ ORF PROPN B-AC
4879
+ regions NOUN B-O
4880
+ of ADP B-O
4881
+ PMA1 PROPN B-O
4882
+ and CCONJ B-O
4883
+ FBA1 NOUN B-O
4884
+ , PUNCT B-O
4885
+ the DET B-O
4886
+ promoter NOUN B-O
4887
+ , PUNCT B-O
4888
+ coding VERB B-O
4889
+ and CCONJ B-O
4890
+ terminator NOUN B-O
4891
+ regions NOUN B-O
4892
+ of ADP B-O
4893
+ ADH1 PROPN B-O
4894
+ , PUNCT B-O
4895
+ as ADP B-O
4896
+ well ADV B-O
4897
+ as ADP B-O
4898
+ for ADP B-O
4899
+ a DET B-O
4900
+ heterochromatic ADJ B-O
4901
+ control NOUN B-O
4902
+ region NOUN B-O
4903
+ of ADP B-O
4904
+ chromosome NOUN B-O
4905
+ V. NOUN B-O
4906
+ Dahlbäck PROPN B-O
4907
+ et PROPN B-O
4908
+ al NOUN B-O
4909
+ . PUNCT B-O
4910
+
4911
+ observed VERB B-O
4912
+ that SCONJ B-O
4913
+ addition NOUN B-O
4914
+ of ADP B-O
4915
+ APC PROPN B-AC
4916
+ to ADP B-O
4917
+ plasma NOUN B-O
4918
+ of ADP B-O
4919
+ patients NOUN B-O
4920
+ with ADP B-O
4921
+ multiple ADJ B-O
4922
+ thrombotic ADJ B-O
4923
+ events NOUN B-O
4924
+ did AUX B-O
4925
+ not PART B-O
4926
+ result VERB B-O
4927
+ in ADP B-O
4928
+ the DET B-O
4929
+ expected VERB B-O
4930
+ prolongation NOUN B-O
4931
+ of ADP B-O
4932
+ the DET B-O
4933
+ coagulation NOUN B-O
4934
+ time NOUN B-O
4935
+ in ADP B-O
4936
+ an DET B-O
4937
+ activated VERB B-LF
4938
+ partial ADJ I-LF
4939
+ thromboplastin NOUN I-LF
4940
+ time NOUN I-LF
4941
+ ( PUNCT B-O
4942
+ aPTT PROPN B-AC
4943
+ ) PUNCT B-O
4944
+ assay NOUN B-O
4945
+ [ PUNCT B-O
4946
+ 1 NUM B-O
4947
+ ] PUNCT B-O
4948
+ . PUNCT B-O
4949
+
4950
+ Graphs NOUN B-O
4951
+ illustrate VERB B-O
4952
+ performance NOUN B-O
4953
+ for ADP B-O
4954
+ these DET B-O
4955
+ scenarios NOUN B-O
4956
+ , PUNCT B-O
4957
+ ranked VERB B-O
4958
+ in ADP B-O
4959
+ order NOUN B-O
4960
+ of ADP B-O
4961
+ relative ADJ B-O
4962
+ performance NOUN B-O
4963
+ for ADP B-O
4964
+ four NUM B-O
4965
+ metrics NOUN B-O
4966
+ : PUNCT B-O
4967
+ RMSE PROPN B-AC
4968
+ ( PUNCT B-O
4969
+ Root NOUN B-O
4970
+ Mean NOUN B-O
4971
+ Square PROPN B-O
4972
+ Error NOUN B-O
4973
+ ) PUNCT B-O
4974
+ , PUNCT B-O
4975
+ MAE PROPN B-AC
4976
+ ( PUNCT B-O
4977
+ Mean NOUN B-LF
4978
+ Absolute PROPN I-LF
4979
+ Error NOUN I-LF
4980
+ ) PUNCT B-O
4981
+ , PUNCT B-O
4982
+ R NOUN B-O
4983
+ - PUNCT B-O
4984
+ squared NOUN B-O
4985
+ and CCONJ B-O
4986
+ Spearman PROPN B-O
4987
+ correlation NOUN B-O
4988
+ coefficient NOUN B-O
4989
+ . PUNCT B-O
4990
+
4991
+ Risky ADJ B-O
4992
+ sexual ADJ B-O
4993
+ behavior NOUN B-O
4994
+ may AUX B-O
4995
+ result VERB B-O
4996
+ in ADP B-O
4997
+ serious ADJ B-O
4998
+ health NOUN B-O
4999
+ problems NOUN B-O
5000
+ such ADJ B-O
5001
+ as ADP B-O
5002
+ unintended ADJ B-O
5003
+ pregnancy NOUN B-O
5004
+ , PUNCT B-O
5005
+ abortion NOUN B-O
5006
+ , PUNCT B-O
5007
+ and CCONJ B-O
5008
+ sexually ADV B-LF
5009
+ transmitted VERB I-LF
5010
+ infections NOUN I-LF
5011
+ ( PUNCT B-O
5012
+ STIs PROPN B-AC
5013
+ ) PUNCT B-O
5014
+ including VERB B-O
5015
+ HIV PROPN B-AC
5016
+ [ PUNCT B-O
5017
+ 19 NUM B-O
5018
+ ] PUNCT B-O
5019
+ . PUNCT B-O
5020
+
5021
+ In ADP B-O
5022
+ low ADJ B-LF
5023
+ resource NOUN I-LF
5024
+ settings NOUN I-LF
5025
+ ( PUNCT B-O
5026
+ LRSs PROPN B-AC
5027
+ ) PUNCT B-O
5028
+ , PUNCT B-O
5029
+ treatment NOUN B-O
5030
+ of ADP B-O
5031
+ neonatal ADJ B-O
5032
+ jaundice NOUN B-O
5033
+ is AUX B-O
5034
+ often ADV B-O
5035
+ sub ADJ B-O
5036
+ - ADJ B-O
5037
+ optimal ADJ B-O
5038
+ [ PUNCT B-O
5039
+ 4 NUM B-O
5040
+ , PUNCT B-O
5041
+ 5 NUM B-O
5042
+ ] PUNCT B-O
5043
+ . PUNCT B-O
5044
+
5045
+ In ADP B-O
5046
+ 2015 NUM B-O
5047
+ , NOUN B-O
5048
+ the DET B-O
5049
+ prevalence NOUN B-O
5050
+ of ADP B-O
5051
+ low ADJ B-O
5052
+ birth NOUN B-O
5053
+ weight NOUN B-O
5054
+ per ADP B-O
5055
+ 100 NUM B-O
5056
+ births NOUN B-O
5057
+ was AUX B-O
5058
+ greater ADJ B-O
5059
+ in ADP B-O
5060
+ southern ADJ B-O
5061
+ Asia PROPN B-O
5062
+ than ADP B-O
5063
+ in ADP B-O
5064
+ sub ADJ B-O
5065
+ - ADJ B-O
5066
+ Saharan ADJ B-O
5067
+ Africa PROPN B-O
5068
+ ( PUNCT B-O
5069
+ 26.4 NUM B-O
5070
+ % NOUN B-O
5071
+ ; NOUN B-O
5072
+ uncertainty NOUN B-LF
5073
+ range NOUN I-LF
5074
+ [ PUNCT B-O
5075
+ UR PROPN B-AC
5076
+ ] PUNCT B-O
5077
+ : PUNCT B-O
5078
+ 18.6–35.2 NUM B-O
5079
+ versus ADP B-O
5080
+ 14.0 NUM B-O
5081
+ % NOUN B-O
5082
+ , NOUN B-O
5083
+ UR PROPN B-AC
5084
+ : PUNCT B-O
5085
+ 12.2–17.2 NUM B-O
5086
+ ) PUNCT B-O
5087
+ [ PUNCT B-O
5088
+ 28 NUM B-O
5089
+ ] PUNCT B-O
5090
+ . PUNCT B-O
5091
+
5092
+ Three NUM B-O
5093
+ retinoic ADJ B-LF
5094
+ acid NOUN I-LF
5095
+ receptors NOUN B-O
5096
+ ( PUNCT B-O
5097
+ RARα PROPN B-O
5098
+ , PUNCT B-O
5099
+ RARβ PROPN B-O
5100
+ and CCONJ B-O
5101
+ RARγ NOUN B-O
5102
+ ) PUNCT B-O
5103
+ have AUX B-O
5104
+ been AUX B-O
5105
+ identified VERB B-O
5106
+ as ADP B-O
5107
+ cognate NOUN B-O
5108
+ receptors NOUN B-O
5109
+ for ADP B-O
5110
+ RA PROPN B-AC
5111
+ . PUNCT B-O
5112
+
5113
+ These DET B-O
5114
+ RARs NOUN B-O
5115
+ are AUX B-O
5116
+ structurally- ADV B-O
5117
+ and CCONJ B-O
5118
+ functionally ADV B-O
5119
+ - PUNCT B-O
5120
+ conserved VERB B-O
5121
+ nuclear ADJ B-O
5122
+ retinoid NOUN B-O
5123
+ receptors NOUN B-O
5124
+ [ PUNCT B-O
5125
+ 36–39 NUM B-O
5126
+ ] PUNCT B-O
5127
+ . PUNCT B-O
5128
+
5129
+ CCHQ PROPN B-AC
5130
+ = PUNCT B-O
5131
+ Care PROPN B-LF
5132
+ and CCONJ I-LF
5133
+ Comfort PROPN I-LF
5134
+ Hypertonicity PROPN I-LF
5135
+ Questionnaire PROPN I-LF
5136
+ ; PUNCT B-O
5137
+ GMFCS PROPN B-AC
5138
+ = PUNCT B-O
5139
+ Gross ADJ B-LF
5140
+ motor NOUN I-LF
5141
+ functional ADJ I-LF
5142
+ classification NOUN I-LF
5143
+ scale NOUN I-LF
5144
+ ; PUNCT B-O
5145
+ GMFM PROPN B-AC
5146
+ = PUNCT B-O
5147
+ Gross ADJ B-LF
5148
+ Motor PROPN I-LF
5149
+ Function NOUN I-LF
5150
+ Measure NOUN I-LF
5151
+ ; PUNCT B-O
5152
+ MACS PROPN B-AC
data/data_train.conll ADDED
The diff for this file is too large to render. See raw diff